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ABSTRACT
Immunity to Neisseria meningitidis (A/, meningitidis) involves both innate 
and antibody-mediated mechanisms. The acute-phase serum protein C-reactive 
protein (CRP) helps to protect the host from several bacterial pathogens, often 
by binding to surface phosphorylcholine (PC). Pathogenic Neisseria species can 
exhibit phase-variable P C  modification on type 4 pili of class 1 and 2. This 
investigation demonstrates that C R P  can bind to piliated meningococci in a 
calcium-dependent manner that is concentration dependent, of low affinity and 
specific for PC. Separate experiments confirmed that C R P  can bind to both live 
and paraformaldehyde-fixed meningococci, suggesting that C R P  has a role in 
the immune response to meningococci.
C R P  binding to PC on commensal species of Neisseria is known to 
increase serum bactericidal activity by initiating the classical complement 
cascade. In these investigations, CRP-opsonisation did not increase serum 
killing of N. meningitidis. C R P  binding did, however, significantly increase 
phagocytic uptake of fixed meningococci by macrophages and neutrophils (and 
increased uptake by dendritic cells was also indicated). This CRP-mediated 
uptake was attributed to recruitment of the cellular receptor for CRP, FcyR, as 
blocking of these receptors with human IgG abrogated the increased uptake by 
macrophages in a concentration-dependent manner. In contrast, macrophage 
uptake of live meningococci was not increased by CRP-opsonisation and 
preliminary investigations detected no increase in intracellular killing of CRP- 
opsonised meningococci, indicating that live meningococci may evade CRP- 
mediated phagocyte detection.
The absence of a direct killing effect of C R P  led to the hypothesis that 
C R P  provides an indirect advantage to the host by modulation of inflammation 
and antigen presentation by phagocytes. CRP-opsonised N. meningitidis 
induced greater macrophage HLA-DR expression, IL-10 and IL-1(3 secretion 
compared to non-opsonised N. meningitidis in the majority of human donors. 
These studies indicate that C R P  may increase antigen presentation and 
therefore accelerate the development of acquired immunity to meningococcal 
infection, whilst limiting the inflammatory damage to the host via increased IL-10 
production.
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CHAPTER ONE 
GENERAL INTRODUCTION
The N e i s s e r i a c e a e  family of gram negative dipiococci are mostly harmless 
commensals of mucosal tracts. There are, however, two pathogenic species; 
N e i s s e r i a  g o n o r r h o e a  (N . g o n o r r h o e a ) and N e i s s e r i a  m e n i n g i t i d i s  
(A/, m e n i n g i t i d i s , or the meningococcus) which are capable of causing 
devastating local and systemic infections. N .  m e n i n g i t i d i s  is an etiological agent 
of arthritis, pericarditis, metastatic sepsis, conjunctivitis, endophthalmitis, 
urethritis, urithritis and infant vulvovaginitis. The two most common diseases 
caused by N .  m e n i n g i t i d i s , however, are purulent meningitis and severe sepsis. 
Meningococcal disease is a global problem, causing around 1.2 million cases of 
disseminated disease and 135,000 deaths each year (Anonymous,2006). 
Mortality rates can be high, depending on the clinical presentation of infection 
which ranges from meningitis (with mortality rates of 4-6%) to sepsis and septic 
shock (with mortality rates of up to 40%) (Emonts e t  a l . ,2003). This exclusively 
human pathogen can either cause virulent disease or live as a harmless 
commensal within different hosts. It is estimated that 10% of adults worldwide 
are asymptomatic carriers of N .  m e n i n g i t i d i s , which colonises the nasopharynx.
In 2 5 %  of individuals, carriage is of months in duration, in another third of cases, 
carriage lasts from days to weeks and in the remaining 4 0 %  of cases, carriage is 
only transient (Tzeng and Stephens,2000). The bacterium is transmitted between 
hosts by aerosol or contact with infected secretions.
N .  m e n i n g i t i d i s  strains have historically been classified by serological 
typing methods based on capsule characteristics (serogroup), major outer 
membrane proteins (serosubtype and serotype) and lipooligosaccaride 
structures (immunotype). Thirteen serogroups have been identified with the five 
major groups being A, B, C  , W 1 3 5  and Y. Serogroup A  isolates cause 
cerebrospinal meningitis in most countries, with certain genetically defined 
clones being associated with epidemics in Sub-Saharan Africa and Russia 
(Achtman,1994). Serogroup B strains cause epidemics and local outbreaks 
mostly in the western world. In the past 50 years there have been serogroup B 
outbreaks in Norway, Cuba, Brazil, Chile and N e w  Zealand (Borrow e t  a l . ,2006). 
Serogroup C  clones cause some epidemics but are mostly associated with local 
outbreaks of disease in the US, Canada and Europe (Jackson e t  a l . , 1995). 
Serogroup W 1 3 5  was particularly associated with a major worldwide outbreak of 
meningococcal disease following the Hajj pilgrimage to Mecca in 2000 and 2001.
1.1 Epidemiology of meningococcal disease
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Serogroup Y  disease emerged in the mid-1990s and has caused increased rates 
of disease in the United States and Israel (Stephens,2007). The serological 
typing techniques used to classify epidemic populations of bacteria have proven 
insufficient for tracking N e i s s e r i a  strains over time due to the poor resolving 
power of the techniques and the high frequency of phase and/or antigenic 
variation of surface structures displayed by N .  m e n i n g i t i d i s . Modern genotyping 
methods such as multi locus sequence typing (MLST) developed from the 
proteomic method of multi locus electrophoresis typing are now widely used to 
type epidemic strains and clonal complexes (Enright and Spratt,1999).
1.2 The pa th ogen es is of N. meningitidis infection
Meningococcal pathogenesis depends on three factors: the reservoir of 
human hosts (i.e. human transmission and carriage rates), the susceptibility of 
the host and the virulence of the particular strain. Once present in the 
nasopharynx of a susceptible host, virulent meningococci are capable of 
attaching to epithelial cells, entering the cells by endocytosis and accumulating 
within phagocytic vacuoles (Stephens e t  a l . , 1983). Epithelial cells damaged by 
smoking, previous infection or environmental damage also provide a route for 
meningococci to invade the upper respiratory epithelium. From here, 
meningococci are released into inter-epithelial spaces beneath epithelial cell tight 
junctions (Tzeng e t  a l . ,2000). Upon entry into the bloodstream, the 
meningococcus must overcome humoral and phagocytic host defences in order 
to cause meningitis or acute sepsis. The multiplication of meningococci within 
the blood and at secondary sites of infection such as the meninges, pericardium 
and joints causes the systemic release of pro-inflammatory cytokines such as 
Interleukin -1 (IL-1), IL-6, and tumour necrosis factor alpha (TNF-a), which 
increase inflammation and recruit leucocytes to the site of infection. The 
lipopolysaccharide (LPS) of the bacterial membrane is a potent mediator of 
cytokine release which mediates many of the symptoms of meningococcal 
disease including cellular apoptosis, coagulation of blood vessels and ischemia 
(Brandtzaeg e t  a l . , 1992). Recently, however, several non-LPS components of 
N .  m e n i n g i t i d i s  have been shown to influence inflammation. One study, in which 
wild-type and LPS-deficient N .  m e n i n g i t i d i s  were incubated with peripheral blood 
mononuclear cells demonstrated that non-LPS components were responsible for
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a substantial part of TNFa and IL-1 p production and virtually all the interferon 
g a m m a  (IFNy) production by the cells (Sprong e t  a l . ,2001).
1.2.1 The pathogenesis of meningococcal meningitis
The human meninges which surrounds the brain and spinal chord 
consists of the dura mater and the leptomeninges; made up of the arachnoid 
mater, pia mater and membranous trabeculae that traverse the CSF-filled 
subarachnoid space (see figure 1.1) (Feurer and Weller, 1991).
Leptomeninges
Figure 1.1 Schematic of the hard and soft layers of protection of the human brain
(Reproduced from www.medicalook.com)
Below the skull, the brain is protected by the meninges consisting of the hard dura mater and the 
membranous leptomeninges.
Despite decades of study, It is still unclear how N .  m e n i n g i t i d i s  penetrates 
the blood-brain barrier to infect the meninges. One popular theory is that the 
choroid plexus (the part of the brain that produces cerebrospinal fluid (CSF)) 
forms a point of weakness which is permeabilised by the action of TNF-a and IL- 
1 to allow the meningococcus to gain entry to the C S F  (Brandtzaeg e t  a l . , 1992).
It is clear, however, that certain isolates are more adept at penetrating the blood- 
brain barrier than others. A  recent study using humanised CD46-transgenic mice 
and LPS variants of N .  m e n i n g i t i d i s  strain NMB, found wild-type meningococci in 
the C S F  of all infected mice, whereas different LPS variants had different abilities 
to cross into the C S F  (Plant e t  a l . ,2006). In order to progress to the brain, 
meningococci need to traverse a monolayer of tight junction-expressing epithelial 
or endothelial cells. This can be achieved by breaking through the tight junctions 
between cells or by a trans-cellular route through the cells. Evidence for 
N .  m e n i n g i t i d i s  taking the trans-cellular route comes from i n  v i v o  observations 
of meningococci localised within the endothelial cells of the brain of an infected
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patient and from observing i n  v i t r o  that N .  m e n i n g i t i d i s  can traverse tight junction 
forming monolayers of endothelial cells without altering the organisation of tight 
junctions (Nassif e t  a l .,2002).
Interaction of N .  m e n i n g i t i d i s  with cells of the human meninges has been 
modelled i n  v i t r o  by culturing cells from benign tumours of the meninges 
(meningioma cells) (Hardy e t  a l . ,2000). This group highlighted pili as the major 
ligand for facilitating adherence to the human cells, with pilin variation modulating 
the interactions. The authors detected no internalisation of the meningococci by 
the meningioma cells, which is consistent with the apparent impenetrability of the 
leptomeninges to N .  m e n i n g i t i d i s  i n  v i v o  (Hardy e t  a l . ,2000). Inflammatory 
responses to meningococcal infection in the same model included high levels of 
the pro-inflammatory cytokines IL-6, IL-8, monocyte chemotactic protein-1 (MCP- 
1), and lower amounts of R A N T E S  (“regulated upon activation, normal T cell 
expressed, and secreted”) and granulocyte-macrophage colony-stimulating 
factor (GM-CSF) (Fowler e t  a l . ,2004). The pathology of meningococcal 
meningitis is, therefore, clearly influenced by a plethora of pro-inflammatory 
signals. A  recent study demonstrated that although N .  m e n i n g i t i d i s  was 
incapable of invading meningeal cells, the infection caused death of the cells by 
necrosis; thus the bacterium causes tissue damage without the need for 
intracellular access (Fowler e t  a l . ,2006). These recent investigations may have 
underlined the mechanisms of meningeal infection but the route of entry from the 
bloodstream to the brain still remains unclear.
1.3 Age-related incidence of m e n i n g o c o c c a l  carriage a n d  infection
Meningococcal disease incidence is highest in infants (<2 years of age) 
followed by a second peak in young adults (Rosenstein e t  a l . , 1999). The reasons 
for these age-related peaks in disease incidence are complex and not simply 
correlated with carriage rates, as despite up to 4 0 %  of the adult population 
carrying N .  m e n i n g i t i d i s , meningococcal disease in the over 25s is very rare 
(Robinson e t  a l . ,2002). High disease incidence in the very young is thought to 
be due to the absence of protective antibody. Neonates are protected passively 
by maternal antibody but as antibody titres wane, susceptibility to meningococcal 
infection increases (Goldschneider e t  a l . , 1969). The immature immune systems 
of infants are incapable of eliciting effective T-cell memory responses. A  study by 
Pollard and Levin found that even when serogroup B-specific IgG antibodies are
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produced in infants, they are of much lower avidity than those produced in 
adults, which may partly explain the absence of serum bactericidal activity in 
these infants (Pollard and Levin,2000). Thus a window of opportunity for 
meningococcal infection exists between infancy and the time when memory 
lymphocytes are generated after asymptomatic colonisation, often with the 
closely related commensal species N .  l a c t a m i c a .
The reasons behind the second peak in meningococcal disease in 
adolescents are relatively poorly understood. Rates of meningococcal carriage 
increase throughout childhood (Cartwright e t  a l .,1987) and so risks of 
transmission are obviously higher in adolescents than younger children, but this 
is not the only cause. Several environmental factors are thought to be involved 
such as cramped living conditions and changing social behaviours, highlighted 
by the peak incidence of meningococcal disease in new army recruits and 
university students. A  recent population-based study of 15-19 year olds 
published in the British Medical Journal reported that the factors that increased 
the likelihood of disease were previous illnesses, being a student and 
participating in intimate kissing with multiple partners (Tully e t  a l . ,2006).
1.4 SleoingococcaS virulence factors
N .  m e n i n g i t i d i s  possesses an arsenal of virulence factors including 
capsular polysaccharide, outer membrane proteins and LPS. Several of these 
surface structures are subject to frequent alterations allowing adaptation to the 
various micro-environments within the host. Variability is achieved through large- 
scale exchange and mutation of D N A  and phase variation. Phase variation 
occurs when slipped-strand mis-pairing of D N A  strands causes a change in the 
length of simple sequence repeats. This variation can alter the transcriptional 
reading frame and if the repeat is present within a promoter sequence, it will 
affect the transcription of that open reading frame (ORF). The meningococcus is 
also capable of responding to environmental changes directly through 
transcriptional regulation. Indeed the c r g A  gene encodes a transcriptional 
regulator involved in cross-talk between the meningococcus and human 
epithelial cells (Deghmane e t  a l . , 2000). This capacity to adapt to 
microenvironments is key to N .  m e n i n g i t i d i s ’s success in evading immune 
detection. For example, the LPS of serogroup B and C strains can be sialyated, 
which inhibits detection of the bacterium by the host immune system by
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decreasing complement and antibody interactions with molecules of the bacterial 
outer membrane (Vogel and Frosch,1999). Sialyation of LPS also limits detection 
of the meningococcus by receptor-ligand interactions of carcinoembryonic 
antigen-related cell adhesion molecule (CEACAM) receptors with opacity 
proteins (Virji e t  a l . , 1996; McNeil and Virji, 1997). Sialyation of LPS can be 
switched on or off by phase variation of the gene I g t A  (Jennings e t  a l . , 1995). A  
schematic of several of these membrane-bound virulence factors is provided in 
figure 1.2. It is, however, beyond the scope of this introduction to cover all 
virulence factors of the meningococcus. Attention is therefore focused on one 
factor of particular interest; the pilus.
•—  PilC
\ —  PilE /
J  Type IV
Figure 1.2 Schematic representation of N. meningitidis (reproduced from Corbett et 
al.,2004)
Schematic figure showing the major surface adhesins of N . m e n i n g i t i d i s ; pili, opacity proteins and 
LPS, all important in host cell attachment.
1.4.1 The meningococcal pilus
Pili are hair-like structures present in many bacterial species with several 
functions including motility, genetic exchange, protein secretion and host cell 
attachment. Pili have historically been classified on the basis of their morphology 
and ability to agglutinate erythrocytes in the presence or absence of D-mannose 
(Duguid e t  a l . , 1966). Both pathogenic and commensal species of N e i s s e r i a  can
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express type IV pili which facilitate the initial attachment of meningococci to 
respiratory epithelial cells (Soto and Hultgren,1999). The core structure of the 
meningococcal pilus is composed of a single repeated subunit of 145-160 amino 
acids encoded by the p i l E  locus. The p i l C 1  and p i l C  2  genes are also essential 
for piliation and PilC has been confirmed as the major pilus adhesin as piliated 
p i l C -  mutants cannot adhere to epithelial cells (Nassif e t  a l . ,1994). Additional 
genes essential for pilus biogenesis include p i l T ,  p i l G  and p i l Q . PilT is a 
cytoplasmic nucleotide-binding protein which is required for intimate attachment 
to epithelial cells following pilus-mediated adhesion by retracting the pilus fibre 
(Pujol e t a/., 1999). PilG is thought to be a pilus-assembly protein due to its 
homology with a P s e u d o m o n a s  a e r u g i n o s a  gene of that function (Tonjum e t  
a l . ,1995). PilQ shares homology with secretin proteins of other type IV piliated 
species, and reduces pilus expression when mutated (Tonjum e t  a l . , 1998).
Figure 1.3 Immunofluorescent microscope image of piliated N. meningitidis
Reproduced from http://www.necker.fr/u570/images/pilli-xn.jpg. Xavier Nassif.
Red staining shows encapsulated diplococcus with green-stained pili extruding from the surface.
The clinical importance of pili is highlighted by their ubiquity amongst 
meningococcal isolates from invasive disease (Stephens e t a/., 1985). The pilus 
is thought to be essential for host cell binding in encapsulated strains (Tzeng e t  
a l . ,2000). More recently, however, work on Chinese hamster ovary (CHO) and 
C O S  cell lines (an African green monkey kidney cell line) which do not express 
pilus receptors has shown that capsulate bacteria are capable of adhesion to 
host cells via opacity (Opa) proteins in the absence of pili, if the host cell Opa 
receptor density is sufficiently high (Bradley e t  a l . ,2005). The complement 
regulatory protein membrane cofactor protein (MCP or CD46) has been
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postulated as the pilus receptor for N e i s s e r i a  (Kallstrom e t  a l . , 1997). This has 
led to the development of a humanised mouse model expressing CD46 
(Johansson e t  a l . ,2003). No studies to date, however, have confirmed a direct 
interaction between CD46 and the PilC adhesin. Indeed, it has been 
demonstrated in gonococci that the level of CD46 expression does not correlate 
with the level of pilus-mediated bacterial adhesion to epithelial cells (Tobiason 
and Seifert,2001). Other studies also suggest that a CD46-independent form of 
PilC binding occurs between N e i s s e r i a  and epithelial cells. A  recent study at the 
Max Planck institute in Berlin supported the hypothesis of a pilus-specific 
receptor and identified it as an epithelial cell surface protein (Kirchner and 
Meyer,2005). This receptor has yet to be characterised, thus the identity of the 
true pilus receptor or receptors still requires confirmation.
1.5 [Models of N. meningitidis infection
Animal models are extremely useful for vaccine and antibacterial drug 
development but an animal model has been very difficult to develop for 
meningococcal disease due to a number of key characteristics of the infection. 
Firstly, the only natural host for N .  m e n i n g i t i d i s  is humans, due to the specific 
range of surface proteins that interact with the host, including interaction of pili 
with human CD46 (the putative pilus receptor) and Opa and Opc with human 
C D 66 (carcinoembryonic antigen-related cell adhesion molecule 1 or C E A C A M -  
1). Survival within the host also depends on iron uptake systems which are 
specialised to bind the human iron transport proteins such as transferrin and 
iactoferrin. A  good system would also include nasal carriage. Even if these 
issues could be overcome, a further difficulty remains in the complex 
pathogenesis of infection from nasal carriage towards septicaemia and/or 
meningitis.
Current rodent models include the mouse intraperitoneal challenge model, 
infant rat intraperitoneal infection model, intranasal infection models and the new 
humanized mouse model (Gorringe e t  a l . , 2005b). Intraperitoneal mouse models 
require an exogenous iron source to reach high enough infection rates to assess 
active and passive immunisation. They therefore do not represent the 
pathogenesis of the disease, but are useful in modelling the massive 
septicaemia observed in invasive meningococcal disease. Rat intraperitoneal 
models do not require exogenous iron but are limited by short duration of
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bacteraemia and cannot model active protection. Rodent intranasal models have 
been developed in an attempt to mimic the human course of pathogenesis. 
Although high doses of meningococci co-administered with human iron-binding 
proteins result in nasal colonisation and a progression to bacteraemia, this route 
of infection is v i a  pneumonia, which does not occur in humans (Mackinnon e t  
a l . , 1993). Perhaps the most promising rodent model is the humanised mouse 
model. Mice expressing the human CD46 molecule are susceptible to 
meningococcal disease without the need for an exogenous iron source. 
Intranasal challenge with piliated meningococci has been shown to progress to a 
human-like disease, with bacteria crossing the blood-brain barrier of transgenic 
CD46 mice (Johansson e t  a l . , 2003, Gorringe e t  a l . , 2005b). Although the data 
on CD46 as the pilus receptor has been criticised (see section 1.4.1), the 
humanised mouse model presents a useful tool for studying meningococcal 
pathogenesis and for vaccine development. A  recent study incorporating 
bioluminescent imaging of CD46 transgenic mice has, for example, illustrated 
the temporal dynamics of disease progression through the body of the mouse 
during meningococcal infection (Sjolinder,2007).
Several human ex v i v o  models are utilised to study meningococcal 
pathogenesis and immune responses including the use of palatine tonsils after 
tonsillectomy and fresh brain tissue and cultured meningioma cells after 
extraction of brain tumours (Quiding-Jarbrink e t  a l . , 1995; Hardy e t  a l . ,2000). 
Whole blood infection assays and peripheral blood-derived leucocytes are 
commonly used i n  v i t r o  as well as cell lines of monocyte and granulocyte-like 
cells to investigate immune cell responses to whole N .  m e n i n g i t i d i s  and to 
various components of the meningococcal cell (Hauck e t  a l . , 1997; Ison e t  
a l . , 1999).
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1.6 T h e  i m m u n e  r e s p o n s e  to N . meningitidis
Like all pathogens, the meningococcus strives to avoid detection and 
destruction by the immune system in order to proliferate and cause disease. The 
first line of defence to newly acquired and previously unencountered pathogens 
is provided by the cells and products of innate immunity.
1.6.1 Innate immunity to N. meningitidis
Macrophages and immature dendritic cells (DCs) are the sentinels of 
immune surveillance at mucosal surfaces where the meningococcus first 
invades. Upon dissemination into the bloodstream the major phagocytic cells 
encountered will be the granulocytes, most numerous being the neutrophils. 
Phagocytic cells can destroy the bacteria ingested within them, but some can 
also present immunogenic fragments on their surfaces, stimulating the induction 
of an adaptive immune response. Such cells are known as antigen presenting 
cells (APC) and include the macrophages and DCs. DCs are phagocytic in their 
immature state and when a bacterium is encountered by an immature DC, it will 
be phagocytosed and activate the DC. Activated D C  start to differentiate and 
migrate from the tissue through the blood to draining lymph nodes where the 
matured phenotype can present their processed antigens to T cells. The profile 
of co-stimulatory molecule expression and cytokine secretion by the A P C  
determines the type of T cell response induced. DCs are unique amongst A P C s  
in their ability to stimulate naive T cells and determine their differentiation into 
effector or memory cells (Banchereau e t  a l . ,2000).
Several soluble and membrane-bound receptors function as pattern 
recognition receptors (PRR) by recognising molecular motifs common to multiple 
pathogens which are known as pathogen-related molecular patterns (PAMPS). 
This innate immune recognition strategy enables many different pathogens to be 
identified by the same receptor and is, therefore, more general than antibody 
interactions. Membrane bound P R R  which recognise meningococci include the 
LPS receptor C D  14, toll-like receptor 4 (TLR-4), and scavenger receptors. 
Soluble P R R  such as mannose-binding lectin (MBL) and several complement 
proteins act as opsonins once bound to P A M P s  and activate cells v i a  binding to 
their membrane-bound receptors. M B L  binds to opacity-proteins and porins on 
the surface of N .  m e n i n g i t i d i s  (Estabrook e t  a l . ,2004) and M B L  binding has been 
shown to activate complement-mediated killing, phagocytic uptake and killing
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and to increase the production of inflammatory cytokines by phagocytes in 
response to meningococci (Jack e t  a l . ,2001a; Jack e t  a l . ,2001b; Jack e t  a l . ,2005)
1.6.2 Specific immunity to N. meningitidis
Specific immunity to the meningococcus is initiated when meningococcal 
antigens are processed by A P C s  and presented via M H C  molecules to the 
T cell-receptor. This interaction, combined with signalling from co-stimulatory 
molecules stimulates clonal proliferation of naive T lymphocytes specific for 
meningococcal antigens which differentiate into effector or memory cells.
Effector T cells can either be C D 8+ (with cytotoxic killing activity) or C D 4 + T 
helper cells (which secrete specific cytokines to B cells). Upon activation v i a  co­
stimulatory molecules and cytokines from antigen-specific T helper cells, naive B 
cells specific for that antigen are clonally selected and proliferate and 
differentiate into memory B cells and effector B cells. Effector B cells are also 
known as plasma cells, which can produce large amounts of the meningococcal 
antigen-specific antibody. Memory B cells are long lived and can respond with 
much greater efficiency than naive B cells to future exposure to the same 
antigen presented by T cells. This is because they are present at higher numbers 
in lymph organs, and have undergone affinity maturation and class switching to 
provide high-affinity IgG molecules in response to the antigen. Meningococcal- 
specific antibodies can aid destruction of the bacteria by activating the classical 
complement cascade and opsonising bacteria for increased uptake by 
phagocytes.
In addition to antibodies specific to the meningococcus, antibodies 
generated against closely related commensal species can be protective against 
meningococcal disease (Li e t  a l . ,2006). The gold-standard method for testing the 
antimicrobial activity of specific antibodies is the serum bactericidal assay (SBA). 
The S B A  measures antibody-dependent complement-mediated killing of bacteria 
i n  v i t r o  after incubation of bacteria with titrated antibody and baby rabbit or 
human complement (Borrow e t  a l . ,2005). Antibodies can be active for S B A  if the 
antibody-antigen complex fully activates the complement cascade to form the 
membrane attack complex (MAC) on the surface of the bacteria, which leads to 
bacterial death by lysis (see figure 1.4) (Goldschneider e t  a l .,1969). The 
absence of bactericidal antibody, however, does not always correlate with 
susceptibility (Toropainen e t  a l . ,2005), thus other mechanisms of antibody
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protection such as opsonisation and killing by phagocytic cells have recently 
been considered of increased importance. This is particularly relevant with 
respect to serogroup B isolates which experience greater i n  v i t r o  killing by 
opsonophagocytosis than serogroups A, C, Y, or W135, despite equivalent 
amounts of C3 binding to serogroup B and serogroup Y  strains (Ross e t  
a l . , 1987). The opsonophagocytosis assay (ORA) can, therefore, be an accurate 
correlate of protection for anti-meningococcal antibodies (Lehmann e t  a l . , 1997).
Mucosal immunity is another important defence to meningococcal 
infection and the first humoral defence encountered following colonisation. 
Asymptomatic carriers of N .  m e n i n g i t i d i s  have increased concentrations of IgA 
in their saliva (Robinson e t  a l . ,2002). Although this does not prevent further 
colonisation, it may prevent invasion of the epithelial cells, possibly by antibody 
blockade of meningococcal ligands used during invasion (Griffiss JM.1995). 
However, IgA bound to the meningococcus can block complement-mediated 
lysis and opsonophagocytosis v i a  IgM and IgG. This is because surface bound 
IgA can be cleaved by meningococcal Ig1 A  protease at the hinge region into 
F(ab)2 fragments that have no Fc portion for cell signalling or complement 
activation (Jarvis and Griffiss, 1991). This antibody blockade of meningococcal 
targets means that meningococcal-specific IgA can actually increase 
susceptibility to meningococcal disease (Griffiss, 1975; Griffiss and 
Bertram, 1977; Griffiss and Goroff,1983). Thus the role of IgA in protection from 
meningococcal infection is not yet clearly understood.
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1.7 H o s t  genetic factors of m e n i n g o c o c c a l  disease
The entrance of N .  m e n i n g i t i d i s  into the blood stream activates the 
complement cascades and inflammatory response. Several host genetic 
polymorphisms have been identified which are involved in the differences seen in 
susceptibility, severity and outcome of meningococcal disease between 
individual patients (Emonts e t  a l . ,2003).
1.7.1 C o m p l e m e n t  deficiencies
The classical, alternative and lectin complement cascades can all be 
involved in meningococcal disease and are summarised schematically in figure 
1.4. C3 is a key component of all three complement cascades and is associated 
with meningococcal disease susceptibility and severity. C3 is cleaved in all three 
pathways into C3a (a strong chemoattractant and proinflammatory molecule 
alongside C5a) and C3b (an opsonin and component of the C5 convertase, 
capable of cleaving C5 into C5a and C5b). C5b begins the formation of the 
membrane attack complex (MAC) C5b6789n, which forms pores in the 
membrane of the bacterium causing death by lysis. Thus C3 is critical for 
permitting the late events in the complement pathway which result in the 
formation of the M A C  and bacterial death. In addition, deficiency in C3 results in 
individuals with a reduced capacity to opsonise and phagocytose bacteria, 
thereby increasing their susceptibility to meningococcal and bacterial disease in 
general (Janeway e t  a l . , 2001). A  similar outcome is observed for individuals with 
“late complement component deficiency” (LCCD). This disease is characterised 
by recurrent Gram-negative infections due to the failure of M A C  assembly. 
However, although disease incidence is higher, the severity of disease is 
significantly lower compared to the total patient population, reflecting the adverse 
effects of complement activation on the host during meningococcal infections 
(Emonts e t  a l . ,2003).
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Figure 1.4 Complement pathways
The classical, alternative and lectin pathways all generate C3 convertases which cleave C3 into 
C3b which is used in the formation of the C5 convertase allowing the first parts of the membrane 
attack complex (MAC) to associate with the bacterial membrane (C5b, 6.7& 8). Polymerisation of 
C9 in the bacterial membrane then completes the MAC and triggers cell lysis.
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Polymorphisms in receptors for IgG (FcyR’s) have also been 
demonstrated to affect disease severity in L C C D  individuals. A  study of 15 
L C C D  patients and families found the FcyRlla-R/R131 and FcYRHIb-NA2/2 
phenotypes to be over-represented in L C C D  patients who experienced 
meningococcal infection (Fijen e t  a l . ,2000).
Properdin acts in the alternative complement pathway to stabilise the 
alternative C3 convertase C3bBb. Three types of properdin defect have been 
identified to date; with properdin being either absent from patient plasma (type 
1), in low but detectable levels (type 2) or replaced by a normal concentration of 
a dysfunctional variant of the protein (type 3). All three deficiencies are 
correlated with increased susceptibility to meningococcal infection (Emonts e t  
a l . ,2003) presumably because of the decreased efficiency of activation of 
complement-mediated killing of invading meningococci by the alternative 
complement pathway.
Mannose binding Lectin (MBL) is an acute phase protein which forms 
multimers and binds carbohydrates and LPS on bacterial surfaces, causing the 
activation of MBL-associated serine proteases MASP1 and M A S P 2  which in turn 
activate the C4 component of the lectin pathway. Three allelic variants of M B L  
have been described in exon 1, with heterozygotes for the variations displaying 
10% of the normal serum concentrations of MBL, and homozygotes retaining 
only 1 %  of the normal serum level of M B L  (Hibberd e t  a l . ,2001). Children 
displaying the variant alleles appear to show associations with meningococcal 
infection, with homozygosity for the variant alleles associated with slightly less 
severe disease than heterozygotes or wild-type genotypes. M B L  and the lectin 
pathway, therefore, provide an important degree of protection from invading 
meningococci, whilst contributing to the negative side-effects of inflammation. 
The study reporting this phenomenon could not, however, prove that the 
association was statistically significant (Hibberd e t  a l . , 1999).
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1.7.2 innate i m m u n e  system deficiencies
Defects in innate pattern recognition receptors such as toll-like receptors 
(TLR) and lipopolysaccharide-binding protein (LBP) predispose individuals to 
meningococcal disease. A  common polymorphism of TLR4 known as the 
Asp299Gly polymorphism results in hypo-responsiveness to LPS because the 
extracellular domain of the receptor on respiratory epithelial cells is rendered 
non-functional. However, the polymorphism itself is not linked to increased 
susceptibility or severity of meningococcal disease (Read e t  a l . ,2001). LBP 
binds bacterial LPS forming a complex which binds TLR4 v i a  C D  14. Cys98Gly 
and Pro436Leu polymorphisms in LBP have been shown to correlate with poor 
outcomes of bacterial sepsis in men, presumably because of the amplification of 
inflammatory stimuli initiated by certain types of LBP (Hubacek e t  a l . ,2001).
Recently, genetic polymorphisms in another pattern-recognition molecule; 
Surfactant protein-A2 (SPA) have been shown to be associated with increased 
susceptibility to meningococcal disease. S P A  in the respiratory tract binds to 
microbial carbohydrates and activates inflammatory and phagocytic defences. A  
single nucleotide polymorphism which substitutes glutamine with lysine at 
residue 223 in the carbohydrate domain of S P A  has been shown to increase 
both the susceptibility to meningococcal disease and the mortality of the disease 
(Jack e t  a l . ,2006). Thus, many pattern recognition receptors provide important 
protection from the meningococcus in the healthy host.
1.7.3 Specific i m m u n e  system deficiencies
Three families of Fey receptors (I, II & III) are responsible for IgG- 
mediated signalling in a number of cell types and are thought to be highly 
significant in host defence against meningococcal infection. FcyRHa located on 
mononuclear leucocytes and macrophages interacts with lgG2 and lgG3 in man. 
A  single point mutation has been identified at amino acid position 131 in exon 4, 
with the 131R allotype (arginine) showing lower binding efficiency than the 131H 
allotype (histidine). This may lead to speculation that individuals homozygous for 
the 131R allele may be more susceptible to meningococcal disease, but 
association studies between the FcyRHa 131 polymorphism and meningococcal 
disease have so far proved inconclusive due to the limitations of small scale 
retrospective studies (Emonts e t a l . , 2003).
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1.7.4 Cytokine deficiencies
TNFa is centra! to activation of the inflammatory response and levels are 
raised in all patients with meningococcal disease. TNFa activates inflammatory 
mediators such as IFNy, IL- 6 and IL-8. Its many effector functions include 
stimulating the up-regulation of expression of adhesion molecules on leucocytes 
(such as ICAM-1) which allow cells to adhere to receptors (such as integrins) on 
the vascular epithelium and eventually cross by diapedesis to reach sites of 
inflammation in the tissues. Polymorphisms in the TNFa genes seem to affect 
meningococcal sepsis but the relative importance of the known polymorphisms 
remains unclear, partly due to age and genetic differences in the groups studied 
(Emonts e t  a l . ,2003). Polymorphisms in IL-1, IL-6 and IL-10 have also been 
associated with altered susceptibility and severity of meningococcal disease 
(Emonts e t  a l . ,2003) with non-survivors of meningococcal disease having 
significantly higher levels of the pro-inflammatory IL-6 than survivors. Families 
producing high levels of the anti-inflammatory cytokine IL-10 also have a 20-fold 
higher risk of fatal meningococcal disease than the normal population 
(Kornelisse e t  a l . , 1996; Westendorp e t  a l . , 1997). Thus, survival from 
meningococcal disease depends on a delicate balance between too little pro- 
inflammatory signalling to promote bacterial clearance and too much 
inflammatory signalling leading to systemic tissue damage.
1.8 M e n i n g o c o c c a l  vaccine d e v e l o p m e n t
Serogroup B disease is now the most common form of meningococcal 
disease in the United States and Europe (Mariagrazia Pizza e t  a l . ,2000) and 
there is no broadly cross-protective vaccine available against all strains. 
Successful polysaccharide and polysaccharide-conjugate vaccines have been 
developed for serogroups A, C, Y  and W-135 as both single and multivalent 
vaccines. The serogroup B capsule, however, contains (a2-8)-linked polysialic 
acid which is poorly immunogenic even when coupled to carrier proteins 
because it is identical to structures on the human neural cell adhesion molecule, 
N - CAM (Finne e t  a l . , 1987). Additionally, the generation of antibodies cross­
reactive with host molecules would not be desirable for vaccine safety.
Alternative serogroup B vaccines are under development using specific outer- 
membrane proteins (OMP) and entire outer-membrane vesicles (OMV) which are 
membrane blebs, naturally shed from the surface of the meningococcus.
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Individual O M P s  such as PorA can be highly immunogenic but are subject to 
antigenic variation and each type provides protection against a limited range of 
strains (Morley and Pollard.2001). Specific O M P s  can be useful, however, in 
targeting a vaccine against specific clonal complexes which cause epidemics of 
disease. An example of a valuable narrow-range O M V  vaccine is the M e N Z B  
vaccine developed in N e w  Zealand against the epidemic clone causing the 
majority of disease in that country. M e N Z B  is specific for group B meningococci 
subtype P1.7b,4, and is now routinely administered to N e w  Zealand residents 
aged 6 weeks to 19 years (O'Hallahan e t  a l . ,2005). Previous to this, a similar 
approach was also successful in Cuba (Sierra e t  a l . ,1991) and has been used in 
several other countries where clonal epidemics have been experienced.
In less geographically remote areas where meningococcal disease is 
multiclonal, such as much of Europe and the USA, a more broad-range vaccine 
is needed to provide immunity against the full range of strains that may be 
encountered. This means finding an immune target or panel of targets present in 
the whole meningococcal population. Thus the search continues for cross­
reactive protective antigens in the meningococcus. A  classical route to vaccine 
development is the use of attenuated mutants. The p h o P  mutant of a serogroup 
B N .  m e n i n g i t i d i s  strain was generated by allele exchange at the University of 
Surrey (Newcombe e t  a l . ,2004). PhoP is part of a two-component regulatory 
system which, when inactivated, leads to avirulence in pathogenic organisms 
including S a l m o n e l l a  species (Miller e t  a l . , 1989). The p h o P  knock-out mutant in 
N .  m e n i n g i t i d i s  was avirulent in a mouse intraperitoneal challenge model and 
provided cross-reactive bactericidal activity against a range of meningococcal 
strains from different serogroups and serotypes (Newcombe e t  a l . ,2004). This 
data suggests that the p h o P  mutant shows potential as a live attenuated vaccine, 
as well as being a useful tool for investigating cross-reactive immunogenic 
antigens.
Several other routes have been taken in pursuit of a broadly cross- 
protective serogroup B vaccine. The discovery of de-N-acetyl sialic acid residues 
in meningococcal LPS that do not cross-react with host tissues has renewed 
interest in targeting a bactericidal antibody response to the serogroup B capsule 
(Moe e t  a l . ,2005). O M V  from N .  l a c t a m i c a  have also been shown to be cross- 
protective against N .  m e n i n g i t i d i s  infection in mice, without targeting the hyper­
variable PorA antigen (as this is absent in N .  l a c t a m i c a ). There is, however, no
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bactericidal antibody activity in response to N .  l a c t a m i c a  O M V  and the 
mechanism of protection of the vaccine is unconfirmed (Gorringe e t  a l . , 2005a). 
The process of “Reverse Vaccinology” has been utilised to identify surface 
exposed targets common to ail disease-causing isolates following the publication 
of the complete meningococcal genome sequence. This approach has enabled 
the development of a vaccine formulation against 5 such targets which has 
produced promising pre-clinical data (Giuliani e t  a l . ,2006). A  further technique for 
vaccine development has been to load O M V  with over-expressed recombinant 
meningococcal antigens such as factor H-binding protein, which generates a 
much stronger antibody response as part of an O M V  vaccine than as a protein- 
based vaccine (Koeberling e t  a l . ,2007).
1.9 C-Reactive Protein a n d  the acute p h a s e  r e s p o n s e
The acute phase response describes the non-specific physiological and 
biochemical responses of higher eukaryotes to infection, inflammation and tissue 
damage. The response is characterised by the rapid upregulation of synthesis of 
certain proteins (such as plasma lectins) and down regulation in the production 
of other proteins (such as albumin and transferin) within liver hepatocytes as a 
result of cytokine release from the source of pathology. The two proteins 
showing the most significant range of synthesis during the acute phase response 
are C-Reactive Protein (CRP) and the related protein serum amyloid A  (SAA). 
Other acute phase reactants include proteinase inhibitors, complement and 
transport proteins (Pepys and Baltz,1983). C R P  is the major acute phase protein 
in humans and was discovered and named in 1930 because of its ability to react 
with the cel! wall C-polysaccharide of S t r e p t o c o c c u s  p n e u m o n i a e  
( S .  p n e u m o n i a e ) (Tillet, Jr., 1930). C R P  is part of a phylogenetically ancient 
family of pentameric proteins known as "pentraxins” with homologous proteins 
present in species as remote as the 70 million year old horseshoe crab, L i m u l u s  
p o l y p h e m u s .
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1.10 The structure of C R P
The C R P  pentamer measures 102A in diameter with a 30A central pore. 
The structure has been determined by X-ray crystallography at 3 A  resolution 
and confirmed as five noncovalently associated protomers arranged around the 
central pore as shown in figure 1.5 (Emsley e t  a l .,1994). Each protomer is 
around 36A in diameter and consists of 206 amino acids folded into two 
antiparallel (3 sheets with “flattened jellyroll topology” (Volanakis,2001). The 
pentameric structure displays a five-fold symmetry axis with the “top” face of the 
ring designated as the “effector face” and the underside known as the 
“recognition face” (Shrive e t a/., 1996). An unusual cleft on the effector face is 
formed by the positioning of a long a helix folded against one of the two (3 sheets 
and by parts of the amino and carboxyl termini of the promoter. This narrow cleft 
is believed to house the C1q-binding site for complement activation (Agrawal e t  
a/.,2001) and the Fey receptor binding site for phagocytic cell recruitment 
(Marnell e t a/., 1995). The recognition face contains two C a 2+ ions attached to 
side chains and main chain carbonyls on each protomer which both participate 
in ligand binding (Volanakis,2001).
a b
Figure 1.5 The molecular structure and morphology of CRP (reproduced from Pepys and 
Hirschfield,2003).
(a) Ribbon diagram of crystal structure showing pentameric form with 2 calcium ions (grey 
spheres) in the ligand binding site of each promoter, (b) Space-filling model of CRP showing a 
single PC molecule in the ligand-binding site of each protomer.
The principal ligand for C R P  is phosphorylcholine (PC). Crystallographic 
analysis of CRP-PC complexes has shown that two oxygens of the phosphate 
group directly associate with the two C a 2+ bound to CRP, while the choline group 
rests within the hydrophobic pocket (Thompson e t a/., 1999). Site-directed
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mutagenesis has confirmed the importance of the hydrophobic pocket for PC 
binding (Agrawal e t  a l . , 1992). The affinity of C R P  for P C  is moderate (in the 
micromolar range) but multipotent attachment of C R P  to surfaces containing a 
high density of P C  groups makes the avidity very strong.
Primary synthesis of C R P  occurs in liver hepatocytes as part of the acute 
phase response. C R P  is also expressed and secreted in the respiratory tract by 
epithelial cells (Gould and Weiser,2001) and by peripheral blood mononuclear 
cells (Haider e t  a l . ,2006). C R P  synthesis in the liver is stimulated by factors 
including IL-6, IL-1, and corticosteroids (Du Clos T W  and Mold C,2004). Blood 
concentrations of C R P  can rise from resting levels of less than 1 pg/m! to greater 
than 1Q00pg/ml at the height of an acute phase response. The protein is highly 
stable and has a half-life of 19 hours (Vigushin e t  a l . , 1993). Monomers of C R P  
are produced and assembled as a pentamer within the endoplasmic reticulum 
(ER) of hepatocytes. In the resting state, C R P  is retained within the ER, bound to 
carboxyl esterases (Macintyre e t a l . ,  1994). W h e n  stimulated by certain 
cytokines, binding decreases and the transit time from the E R  to secretion is 
greatly reduced (Macintyre e t  a l . , 1985). This enables high levels of C R P  to 
rapidly appear in serum during the acute phase response. Indeed, C R P  levels 
rise and fall more dramatically than any other acute phase marker, making it 
particularly useful for following clinical disease course and response to therapy.
The human C R P  gene is found on the long arm of chromosome 1q23.3. 
No genetic deficiencies in C R P  have been identified and only fleetingly rare 
single nucleotide polymorphisms have been discovered (Crawford e t  a l . ,2006). 
Genetic determinants of baseline C R P  level regulation have, however, been 
identified due to variations in the number of dinucleotide repeats in the intronic 
region of the C R P  gene (Robey and Liu, 1981). Although no association has 
been observed between this polymorphism and human disease, two additional 
polymorphisms have recently been discovered which do correlate with disease 
susceptibility and severity. One mutation occurs in the 3’ untranslated region 
and the other is found in exon 2. Both these polymorphisms were found to be 
associated with lower basal levels of serum C R P  and disease in a cohort of 
families suffering from systemic lupus erythematosus (SLE) a systemic 
autoimmune disease (Russell e t  a l . ,2004). This finding supports the hypothesis
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that C R P  is important in limiting inflammatory pathologies as reduced levels of 
C R P  can fail to remove potentially immunogenic material from the tissues, 
resulting in auto-immune inflammatory damage.
The interaction of C R P  with Fey Receptors (FcyR) was first reported in 
1977 (Mortensen and Duszkiewicz,1977). FcyRI was first shown to bind to C R P  
by transfecting C O S  cells with FcyRI and knocking out FcyRI on mouse cells and 
measuring C R P  binding to these cells (Crowell e t a/., 1991; Marnell e t  a l .,1995). 
These findings were then supported by data from surface plasmon resonance 
experiments, which determined that the affinity of C R P  for FcyRI was greater 
than the receptor’s affinity for IgG (Bodman-Smith e t  a l . , 2002b), thereby 
confirming FcyRI as a cellular receptor for CRP.
Further studies with transfected C O S  cells identified FcyRHa as a second 
C R P  receptor (Bharadwaj e t  a l . ,2001). FcyRHa exists in two allelic forms; with 
arginine at position 131 (R131) or histidine at this position (H131). C R P  binding 
to FcyRHa on neutrophils and monocytes was shown to increase phagocytosis of 
CRP-opsonised particles, with C R P  preferentially binding to the homozygous 
R131 phenotype (Stein e t  a l . , 2000a). Binding of C R P  to FcyRHa was confirmed 
by binding and phagocytosis of CRP-opsonised PC-labelled sheep red blood 
cells by FcyRHa transfected C O S  cells and the subsequent inhibition of these 
events by F(ab’)2 anti-CRP antibodies (Bodman-Smith e t  a l . ,2004). Individuals 
who are homozygous for R131 are statistically more susceptible to bacterial 
infections (including infection by N .  m e n i n g i t i d i s ) possibly because, although this 
polymorphism shows higher affinity for CRP, lgG2 binding is of lower affinity than 
in the H131 genotype (Bredius e t a/., 1994). The two polymorphisms exhibit no 
difference, however, in IL8 production or N A D P H  oxidase activity upon 
phagocytosis of CRP-opsonised S. p n e u m o n i a e  (Rodriguez e t  a l . ,2004), 
suggesting a role for other C R P  receptors such as FcyRI in these effects.
Site-directed mutagenesis has identified individual residues that are 
important for binding of C R P  to FcyRI, FcyRHa and the C1q complement 
component. Thr173 and Asn186 are vital for C R P  binding to FcyRHa. Lys114 
and Leu176 are needed for binding to FcyRI but not FcyRHa. Additionally, 
alterations at Lys 114, Asp169, Thr 173, Tyr 175 and Leu 176 altered C R P  
binding to C 1q, These data indicate that the three binding sites are overlapping
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on the C R P  surface, lending further evidence to support the hypothesis that 
FcyR binds to the effector face of the protein (Bang e t  a l . ,2005). It is notable that 
C R P  does not bind the highly pro-inflammatory FcyRIII expressed on 
neutrophils, inflammatory macrophages, mast cells and natural killer (NK) cells 
(Du Clos T W  e t  a l . ,2004). This observation lends support for a role for C R P  as 
an immune-modulator rather than an inflammation activator.
1.13 T h e  functions of C R P
C R P  recognises pathogens and damaged or apoptotic cells and facilitates 
their removal by recruiting the complement cascade and phagocytic cells. It has 
also been postulated as a key player in inflammatory diseases such as arthritis 
and atherosclerosis. C R P  binds to P C  residues with highest affinity, which is a 
moiety almost universally expressed by eukaryotic cells (Harnett and 
Harnett, 1999). P C  is displayed on the teichoic acids of S. p n e u m o n i a e  (Brundish 
and Baddiley,1968), on the LPS of H a e m o p h i l u s  i n f l u e n z a e  and P s e u d o m o n a s  
a e r u g i n o s a  ( G i l l e s p i e  e t  a l . ,  1 9 9 6 ) , on the surface of N .  m e n i n g i t i d i s  and 
N .  g o n o r r h o e a s  (Kolberg e t  a l . ,1997) and on P r o t e u s  m o r g a n i i and A s p e r g i l l u s  
f u m i g a t u s  (Jensen e t  a l . , 1986). C R P  has been shown to bind to most of these 
species (excepting pathogenic N e i s s e r i a  before the completion of this thesis) 
and has been shown to increase host protection (Du Clos and Mold,2001). C R P  
can also bind to the lipophosphoglycan of the intracellular parasite L e i s h m a n i a  
d o n o v a n i (L d o n o v a n i )  (Culley e t  a l . , 1996) which appears to use C R P  to 
increase access to its intracellular niche, without the host benefiting from 
increased killing of the pathogen (Bodman-Smith e t  a l . , 2002a).
1.13.1 CRP-mediated clearance of apoptotic and tumorigenic cells
In human cells, P C  is found in the outer membrane leaflet as the polar 
head-group of lecithin and sphingomyelin. C R P  associates with damaged and 
necrotic cell membranes, but not healthy cells (Kushner and Kaplan, 1961). The 
reason for this exclusivity is that cell damage or apoptosis causes an exchange 
of phospholipids between the inner and outer membrane leaflets. This “flip-flop” 
results in the enrichment of the outer leaflet with phosphatidylethanolamine and 
phosphatidylserine which are normally present within the inner leaflet. These 
phospholipids are then susceptible to hydrolysis by human secretory 
phospholipase A 2, generating lysophospholipds such as lysolecithin which allows
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binding of C R P  to the P C  polar headgroup on the cell surface (Hack e t  a l . , 1997). 
In this context, C R P  binding of apoptotic cells and cell debris leads to increased 
phagocytic uptake to clear potentially pro-inflammatory stimuli from the blood 
and tissues. C R P  may, however, have a less beneficial role in the response to 
tumours as C R P  can bind to FcyR on myeloma tumour cells and protect these 
cells from chemotherapy drug-induced apoptosis (Yang e t  a l . ,2007). Thus C R P  
binding to host cells can be either protective or deleterious depending on the 
nature of the receptors involved in the interaction.
1.13.2 CRP-mediated activation of c o m p l e m e n t
W h e n  human C R P  is aggregated or bound to macro-molecular ligands of 
microorganisms or autologous ligands of host cells, it is recognised by C1q. This 
causes the potent activation of the classical complement pathway by activating 
the complement protein C3, and can result in formation of M A C  C5-C9 as 
described in figure 1.4 (Volanakis,1982). C R P  can, however, inhibit complement 
activation v i a  the alternative complement pathway by binding to the complement 
regulatory protein, factor H (Mold C  e t  a l . , 1986). Factor H inhibits the alternative 
pathway amplification loop, inhibiting the formation of the C3 convertase which is 
needed for the formation of the alternative pathway C5 convertase.
Subsequently, the formation of the M A C  v i a  the alternative pathway is inhibited.
It has been postulated that C R P  deposited at sites of injury and inflammation 
may limit tissue damage by its interaction with factor H. I n  v i v o  evidence to 
support this role has come from observations of C R P  colocalised to myocardial 
infarction lesions, and the discovery of complexes of C R P  and C3 /C4 split 
products in the circulation of patients suffering from sepsis (Wolbink e t  a l . , 1996; 
Lagrand e t  a l . , 1997).
There has been much interest during the last two decades in the various 
structural forms of C R P  and changes in biological activity associated with the 
different forms. The pentameric disc shape of native C R P  is now known to 
disassemble into individual monomers upon contact with negatively charged lipid 
monolayers and by treatment with heat, acid, urea or by immobilising onto 
polystyrene surfaces (Kresl e t  a l . ,1998; W u  e t  a l . ,2003). This modified C R P  
(mCRP) has newly exposed antigenic epitopes and causes greater activation of 
platelets, granulocytes and monocytes than native C R P  i n  v i t r o  (Potempa e t  
a l . , 1988). m C R P  also shows an increased ability to bind to complement
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regulatory proteins i n  v i t r o  (Biro e t  a l . ,2007). The i n  v i v o  relevance of this finding 
is, however, under scrutiny as although imuno-histochemical staining has 
labelled m C R P  in vascular tissues, native C R P  is highly stable and requires 
harsh denaturing conditions to be separated into protomers and there is no 
compelling evidence that denatured m C R P  can persist i n  v i v o  (Diehl e t a/.,2000; 
Pepys e t  a l . ,2003).
1.13.3 C R P  protection from S. pneumoniae infection
The interaction between C R P  and S. p n e u m o n i a e  has received much 
attention since the initial discovery of CRP, with particular interest in the 
protective effect of C R P  against streptococcal infection in mouse models. C R P  is 
not an acute phase protein in mice, and human C R P  (either administered 
passively or generated by mice transgenic for human CRP) protects mice from 
lethal S. p n e u m o n i a e  infection (Mold e t  a l . , 1981; Szalai e t  a l . , 1995). It was 
initially supposed that protection was provided by two of the known actions of 
CRP; complement activation and increased opsonophagocytosis via FcyR 
recruitment. The latter mechanism was discounted after observations that C R P  
protected FcyR deficient mice from streptococcal infection equally as well as 
wild-type mice (Mold e t  a f . ,2002). Subsequent attention turned to C R P ’s role in 
activating complement. A  C R P  mutant that can bind P C  but not C1q was shown 
to protect mice from S. p n e u m o n i a e  infection equally as well as wild type CRP, 
thus C R P  does not need to bind complement to afford protection (although a 
complete complement system is needed) (Suresh e t  a l . ,2006). In addition, C R P  
mutants that are incapable of binding to S. p n e u m o n i a e  were shown to be 
equally effective as wild type C R P  in protecting mice from 
S. p n e u m o n i a e  infection (Suresh e t  a l . ,2007). This led to the conclusion that 
C R P  may influence the cells of the immune system independently of binding to 
bacteria and may therefore be of use in loading antigen presenting cells to 
enhance treatment of bacterial infections (Suresh e t  a l . ,2007). These studies 
also revealed that although human C R P  activates human complement by binding 
C1q, human C R P  is incapable of binding to mouse C1q which limits the 
usefulness of the mouse model in studying C R P ’s involvement in antibacterial 
protection.
C R P  has recently been shown to increase the acquired immune response 
to S. p n e u m o n i a e  as CRP-opsonisation increases uptake of streptococci into
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DC. This enhanced uptake results in an increased memory IgG response to 
streptococcal antigens and protection from virulent streptococci after transfer of 
CRP-opsonised streptococci-pulsed D C  into recipient mice (Thomas-Rudolph e t  
a l . ,2007). All these effects were absent in mice deficient in Fey chain expression 
and were, therefore, attributed to uptake v i a  Fey receptors (Thomas-Rudolph e t  
a l . ,2007). The use of C R P  opsonization to enhance the effectiveness of 
S. p n e u m o n i a e  vaccination is therefore being investigated (Du Clos T W  e t  
a l . ,2004).
1.13.4 CRP-inducecf inflammatory cytokine production
Binding of C R P  to Fey receptors on neutrophils and monocytes leads to 
the production of cytokines including the pro-inflammatory cytokines 1L-1(3, IL-6 
and TNFa. The production response of these cytokines is dose-dependent on 
the level of CRP, with a maximal response seen at around SOpg/ml. (Ballou and 
Lozanski,1992). In alveolar macrophages, C R P  also causes the release of 1L-1|3 
and TNFa (Galve-de Rochemonteix e t a/., 1993). These two observations 
support the role of C R P  in enhancing the human inflammatory response at tissue 
sites of inflammation. However, other experimental data suggests that C R P  may 
also be involved in down-regulation of the inflammatory response. For example, 
human peripheral blood mononuclear cells (PBMCs) stimulated by C R P  
produced higher quantities of the anti-inflammatory cytokine IL-1-receptor 
agonist (IL-1RA) than the pro-inflammatory cytokine IL-1 (Tilg e t  a l . , 1993). 
Although the cytokines produced as a response to C R P  in monocytes and 
macrophages are similar to those induced by aggregated IgG, the fact that C R P  
does not bind to the highly pro-inflammatory FcyRIII means a more modest 
inflammatory response is seen from C R P  (Du Clos T W  e t  a l . ,2004). It is the 
moderately acute-phase levels of C R P  that are most effective in inducing 
cytokine production, and this effect is synergistic with the response to LPS and 
other microbial products. As higher levels of C R P  induce lower levels of 
macrophage inflammatory cytokine secretion than moderate levels, C R P  can 
have both pro- and anti- inflammatory effects in different settings (Bodman- 
Smith, unpublished., Nabata e t  a l . , 2007).
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1.14 T h e  principal ligand for C R P  is e x p r e s s e d  o n  the pill of 
M, meningitidis
The expression of P C  by bacteria appears to be a critical factor in the 
colonisation of the human respiratory tract, but can also enhance complement- 
mediated killing in human serum (Weiser e t  a l .,1998b). No reports have been 
published (previous to this investigation) on the binding of C R P  to P C  on the pili 
of pathogenic species of N e i s s e r i a . However, binding has been demonstrated 
between C R P  and P C  decoration found on the LPS of commensal species such 
as N .  l a c t a m i c a  and N .  s u b f l a v a  (Serino and Virji,2000). Unlike commensal 
species, pathogenic N e i s s e r i a  do not express P C  on their LPS, but the epitope 
has been detected on both class I and class II pili of N .  m e n i n g i t i d i s  and 
N .  g o n o r r h o e a e  (Weiser e t  a l . , 1998a). Interestingly, although some commensal 
N e i s s e r i a  posses pili homologous to class II pili of pathogenic strains, these 
commensal pili do not react with anti-PC antibody (Serino e t  a l . , 2000).
The absence of P C  on the LPS of pathogenic N e i s s e r i a  species may 
protect from bactericidal activity triggered by anti-PC antibodies. P C  decoration 
on the pili of pathogenic N e i s s e r i a  has been shown to be phase variable, much 
like the expression of the pili themselves (Weiser e t  a l . , 1998a), which may be a 
useful way of hiding an important virulence factor from immune detection. P C  is 
expressed on the surface of the pilus by action of the pilin phosphorylcholine 
transeferase A  gene ( p p t A )  which was discovered by insertional inactivation of 
candidate O R F s  and western analysis with and anti-PC antibody (Warren and 
Jennings,2003). Thus despite the absence of any published data on C R P  
binding to N .  m e n i n g i t i d i s  at the onset of this study, much evidence was available 
to suggest that C R P  may be able to interact with P C  on the surface of the 
meningococcus.
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1.15 Hypothesis
The hypothesis of this thesis is that C R P  is capable of binding to PC- 
expressing N .  m e n i n g i t i d i s  and that this binding will have immunological 
consequences in the way that ceils and proteins of innate immunity respond to a 
meningococcal infection
1.16 Objectives
1. To discover if C R P  is able to bind to the PC moiety displayed on the pilus of 
N .  m e n i n g i t i d i s  and to characterise the specificity and kinetics of this binding.
2. To explore the effect of C R P  binding to N .  m e n i n g i t i d i s  on the innate immune 
response to meningococcal infection. This will involve targeting the defence 
mechanisms known to be involved in C R P  protection from other organisms, 
namely serum killing, phagocytosis by and activation of professional phagocytes 
and the consequent production of inflammatory cytokines to further progress the 
response to infection.
3. To ascertain from the results of the above investigations whether C R P  binding 
to N .  m e n i n g i t i d i s  will be of net benefit to the pathogen or to the host.
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CHAPTER TWO 
MATERIALS AND METHODS
2.1 Materials
2.1.1 Bacterial strains
S. p n e u m o n i a e  strain R36A was used for assay development as a 
positive control for C R P  binding. R36A is a non-encapsulated variant of virulent 
S. p n e u m o n i a e  capsular type 2 (D39) (Avery e t a/.,1944). Piliated serogroup B 
N .  m e n i n g i t i d i s  strain C 3 1 1 and a natural non-piliated mutant of the same strain 
(C311p-) were kindly donated by Professor Mumtaz Virji at the university of 
Bristol. An isolate of N .  m e n i n g i t i d i s  H44/76 containing a Green Fluorescence 
Protein (GFP)-expressing plasmid “p E G 2 ” was gratefully received from Dr Myron 
Christodoulides, University of Southampton (Christodoulides e t  a l . , 2 0 0 0 ) . This 
plasmid is a hybrid shuttle vector containing the red-shifted gfp ( r s - g f p )  gene 
under the control of a p o r A  promoter and has been modified by replacing the 
ampicillin resistance cassette ( b l a )  with an erythromycin resistance cassette 
( e r m C ) , resulting in “pEG2-Ery” (M. Christodoulides unpublished). The mouse- 
virulent serogroup C N .  m e n i n g i t i d i s  strain L91543 and a p h o P  knockout mutant 
of this strain were received from Jane Newcombe, University of Surrey. The 
p h o P  knockout was generated by allele exchange (Newcombe e t a ! . , 2004).
All bacterial cultures were stored in Mueller Hinton broth (MHB) supplemented 
with 15% glycerol at -80°C.
2.1.2 Bacterial culture media
® Mueller Hinton broth was prepared from powder stocks as per 
manufacturer’s instructions (Oxoid, UK).
• Brain heart infusion agar was prepared from powder stocks as per 
manufacturer’s instructions (Oxoid, UK).
• Columbia blood agar (CBA) was prepared from powder stocks as per 
manufacturer’s instructions (Oxoid, UK) and supplemented with 5 %  
defibrinated horse blood (Tissue culture systems, UK).
2.1.3 Cell lines
The human monocyte-like cell lines THP-1 and U937 were purchased from the 
European Collection of Cell Cultures (ECACC, UK) and confirmed as 
mycoplamsa free by a commercial ELISA-based Mycoplasma detection kit 
(Roche, Germany).
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2.1.4 Buffering solutions
Buffering solutions were prepared and autoclaved wherever possible. All 
chemicals were purchased from Sigma-Aldrich U K  unless stated otherwise.
Bicarbonate buffer (0.1 M)
0.2M N a C 2C0 3 was slowly added to 0.2M N a H C 0 3 until a pH of 9 was reached. 
Citrate-phosphate buffer
257ml of 0.2M dibasic sodium phosphate was added to 243ml 0.1M citric acid 
and 500ml double distilled water. pH was adjusted to 5.0 where necessary.
F A C S  buffer
Phosphate-buffered saline (PBS) was prepared from tablets and supplemented 
with 1 %  bovine serum albumin and 0.05% sodium azide. 1 %  normal human 
serum was added immediately before use.
S D S - P A G E  resolving buffer (4X)
1.5M Tris-HCI was adjusted to p H 8.8 before adding 0.4% weight/volume sodium 
dodecyl sulphate (SDS). This was a 4X concentration stock.
S D S - P A G E  stacking buffer (4X)
0.5M Tris-HCI was adjusted to pH 6.8 before adding 0.4% weight/volume SDS. 
This was a 4X concentration stock.
S D S - P A G E  protein tank buffer (10X)
A  solution containing 0.5M Tris and 0.55M glycine was supplemented with 1 %  
weight/volume S D S  (pH 8.3). The solution was diluted 1 in 10 with double 
distilled water before use in the protein gel tank.
S D S - P A G E  sample loading buffer (2X)
A  stock of 2X loading buffer was prepared by adding 5ml of 4X stacking buffer to 
2ml glycerol, 1.8ml of 10% SDS, 1.2% sterile distilled water and 10mg of 
bromophenol blue. The stock was supplemented with 10% 2-mercaptoethanol 
immediately before use.
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12% S D S - P A G E  resolving gel
6ml of 3 0 %  acrylamide/bis solution (37.5:1 ratio, Biorad, UK) was added to 
3.75ml of 4X resolving buffer, 200pl 10%SDS, 50pl 10% ammonium persulphate, 
4ml sterile distilled water and 10pl tetramethylethylenediamine (TEMED).
4 %  S D S P A G E  stacking gel
1.625ml acrylamide/bis solution was added to 2.5ml of 4X stacking buffer, 100pl 
10% SDS, 50pl 10% ammonium persulphate, 5.275ml sterile distilled water and 
3pl TEMED.
Western transfer buffer
A  solution of 2 5 m M  Tris and 0.2M glycine was prepared with 8 0 %  distilled water 
and 20%  methanol.
2.1.5 Antibodies
The anti-pilin antibody SM1 was generated in rabbits using highly purified 
pili of N .  g o n o r r h o e a e  M S 2 1 1 ms (Jonsson efa/.,1991) and has been shown to 
bind to a highly conserved region within the 5’ end of class 1 PilE of 
N .  m e n i n g i t i d i s , with the minimum epitope identified as the linear peptide EYYLN 
(Virji e t a/.,1989;Jonsson e t  a l . , 1991). Anti-CRP was purchased as goat anti­
human C R P  affinity purified Immunoglobulin (Biogenesis, Poole, UK). Anti- 
phosphorylcholine antibody was purchased as mouse IgA TEPC15 (Sigma- 
Aldrich, UK). Anti-serogroup B and anti-serogroup C  meningococcal monoclonal 
antibodies were purchased from NIBSC, UK. Anti-S. p n e u m o n i a e  antibody was 
purchased from Biogenesis, U K  as polyclonal rabbit anti-S. p n e u m o n i a e .  
Antibodies were controlled for isotype during Fluorescence Activated cell 
Scanning (FACS) analysis (mouse lgG1 (Sigma-Aldrich,UK), mouse IgA (BD 
biosciences, UK) and ChromaPure goat IgG F(ab’)2 fragment (Jackson 
ImmunoResearch, USA)). Secondary antibodies for F A C S  analysis were 
fluorescein isothiocyanate (FITC)-conjugated from Sigma-Aldrich, U K  (anti­
mouse IgA-FITC, anti-mouse IgG-FITC, anti-goat IgG-FITC and anti-rabbit IgG- 
FITC). Secondary antibodies for Western blot analysis were peroxidase- 
conjugated (anti-mouse IgG, anti-mouse IgA and anti-goat IgG-peroxidase 
conjugates, all from Sigma-Aldrich, UK). For the high sensitivity C R P  ELISA,
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antibodies were purchased from Dako Cytomation, Denmark (polyclonal rabbit 
anti-human C R P  and peroxidise-conjugated polyclonal rabbit anti-human CRP).
For F A C S  analysis of activation marker expression on macrophages, 
antibodies were directly conjugated to FITC or Phychoerythrin (PE). Anti-CD11b, 
ICAM-1 and CD14, were all from Sigma-Aldrich, UK. Anti-CD11c, CD64 and 
HLA-DR were all from B D  Biosciences, UK. Isotype controls were from BD 
Biosciences, U K  and Serotec, UK. For double-staining F A C S  analysis, CD11b, 
ICAM-1 and CD14 antibodies were FITC-conjugated whereas CD11c, CD64 and 
HLA-DR antibodies were PE-conjugated.
For TNF a  ELISAs, mouse anti-human TNFa and biotinylated mouse anti­
human TNFa were purchased from B D  Biosciences, UK. All antibodies were 
titrated to determine concentrations for optimal activity before use in assays.
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2.2 Methods
2.2.1 Bacteria! culture and growth curve experiments
Bacteria were sub-cultured from frozen stocks onto Columbia blood agar 
(CBA) with 5 %  horse blood and incubated overnight. Agar plates were 
supplemented with antibiotics for the selection of mutant strains (10pg/ml 
erythromycin for GFP-expressing strains, 100pg/ml kanamycin for the p h o P  
mutant of N .  m e n i n g i t i d i s ) . Plates were used to inoculate warm broth (MHB for 
N .  m e n i n g i t i d i s  and brain-heart infusion (BHI) broth for S. p n e u m o n i a e )  to a 
known optical density at 595nm or 600nm (usually O D  0.1 for S. p n e u m o n i a e  
and O D  0.02 for N .  m e n i n g i t i d i s ) . For experiments using the serogroup C  strain 
L91543 and the p h o P  mutant, M H B  was supplemented with 2 0 m M  MgCI2. 
Cultures were shaken at 35°C for N .  m e n i n g i t i d i s  and 37°C for S. p n e u m o n i a e  
and aliquots of culture were taken at regular intervals to measure optical density 
and to serially dilute cultures in PB S  to allow enumeration of colonies formed 
from bacteria in 10pl drops plated in quadruplicate onto CBA.
Initial experiments revealed that when N .  m e n i n g i t i d i s  strain C311 was 
grown for 4 hours from a starting optical density at 595nm of 0.02 and cultures 
were serially diluted in PB S  and plated out overnight on CBA, a bacterial density 
of 1 X  108 colony forming units/ml (cfu/ml) was achieved when the bacterial 
suspension was of an optical density of 1 at 595nm.
For most experiments with fixed N .  m e n i n g i t i d i s , cultures were grown in 
20mls of M H B  in small tissue culture flasks from an optical density at 595nm of 
0.02 for 4 hours at 35°C with shaking at 125rpm before transferring to 50ml 
centrifuge tubes and spinning at 1000 x gfor 15 minutes, measuring the optical 
density and fixing overnight in 4 %  paraformaldehyde. Fixed cultures were then 
washed twice in P B S  before use in assays.
2.2.2 Construction of a Green Fluorescence Protein-expressing 
N .  m e n i n g i t i d i s  strain C311
The GFP-containing plasmid pEG2-Ery was harvested from strain H44/76 
using a standard kit, according to the manufacturer’s instructions (QIAprep 
miniprep, Qiagen, UK). The plasmid was then transformed into strain C311 as 
follows. Strain C 3 1 1 was subcultured from frozen stocks onto a C B A  plate and 
incubated overnight. 20 bacterial colonies were suspended in 1ml M H B  
supplemented with 1 0 m M  MgCI2. 500pl of this suspension was transferred to a
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sterile 1.5ml tube with 500ng of plasmid and incubated at 35°C for one hour. The 
remaining 500pl of bacterial suspension was incubated alongside as a negative 
control. 4.5mls of M H B  containing 1 0 m M  MgCI2was added to each bacterial 
suspension and the cultures were incubated with gentle shaking for 4.5 hours at 
35°C. 500pL aliquots were plated onto C B A  plates supplemented with 10pg/ml 
erythromycin and the plates were incubated at 35°C for up to 48 hours. 
Transformed cultures grew on the selective agar and separate colonies were 
subcultured onto C B A  supplemented with erythromycin and frozen down as 
stock cultures. G F P  expression was confirmed by fluorescence microscopy.
2.2.3 H u m a n  cell culture
Primary cell cultures and monocytic cell lines were maintained in complete 
RPMI media containing 100units/ml penicillin, 100|jg/ml streptomycin, 2 m M  L- 
glutamine and 10% heat inactivated foetal bovine serum (all from Invitrogen,
UK).
2.2.3.1 Culture of monocytic cell lines
The monocyte-like cell lines THP-1 and U937 were maintained in 
complete RPMI media. For differentiation into adherent macrophage-like 
morphology, THP-1 cells were seeded at4x105/ml (400pl/well) in 8-well plastic 
chamber slides (Nunc, UK) in media containinglOnM phorbol myristate acetate 
(PMA, Sigma-Aldrich, UK) for 72 hours prior to experiments. Similarly, U937 
cells were seeded at 2x105/ml and were differentiated with 10nM P M A  for 72 
hours and 100nM Vitamin D 3 and 100nM retinoic acid for 24 hours (both Sigma- 
Aldrich, UK).
2.2.5.2 Culture of macrophages and dendritic cells from peripheral blood
Mononuclear cells were extracted from healthy consenting volunteer 
blood in accordance with Local Research Ethics Committee (LREC) guidelines 
(LREC 04/Q1909/19RSCH) and separated using Histopaque 1077 as per the 
manufacturer’s instructions (Sigma-Aldrich, UK). Peripheral blood mononuclear 
cells (PBMCs) were seeded at 3x106/ml in 8 well plastic chamber slides 
(400pl/well) or 6 well plates (3ml/well) in RPMI without serum and positively 
selected for by plastic adherence after 2 hours culture at 37°C in serum-free 
media. Approximately 10% of the cells adhered after vigorous washing. Adherent
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cells were washed and cultured in complete RPMI (with 10% heat-inactivated 
foetal calf serum). Monocytes were cultured for 7 days with one change of media 
at day 3-4 to allow differentiation into macrophages. Monocytes were 
differentiated into dendritic cells by the addition of 1000 units/ml Granulocyte 
Monocyte-Colony Stimulating Factor (GM-CSF, Peprotech, UK) and 100units/ml 
human IL-4 (Perotech, UK) on the day of seeding and 2 and 4 days after 
seeding. Dendritic cells were used as immature day 5 cells. Morphology was 
examined by light-microscopy.
2.2.3.3 Culture of granulocytes from peripheral blood
Granulocytes were extracted from healthy consenting volunteer blood 
using Polymorphoprep as per the manufacturer’s instructions (Axis-Shield, 
Norway). Granulocytes were seeded at 2><107/ml in chamber slides in RPMI 
without serum and positively selected for by plastic adherence after 20 minutes 
incubation at 37°C.
2.2.4 Preparation of h u m a n  C R P
Purified human C R P  (>97%) was purchased from The Binding Site, U K  
and further purified by affinity column chromatography based on the method 
detailed by Volanakis (Volanakis e t a l . ,  1978). A  purifying column was prepared 
by suspending 3g of activated C H  sepharose 4B (GE healthcare, UK) in 15ml 
1 m M  HCI and the gel was allowed to swell for fifteen minutes at room 
temperature. Beads were washed 4 times with ice-cold 1 m M  HCI by 
centrifugation at 10°C. P-amino phosphorylcholine (Sigma-Aldrich, UK) was 
dissolved in 10ml coupling buffer (0.1M NaHCOs, pH8 + 0.5M NaCl2) and added 
to 5mls of sepharose gel and rotated overnight at4°C. Excess ligand was 
removed with 4 changes of coupling buffer and any remaining active groups on 
the beads were blocked with 0.1M Tris-HCI at room temperature. The gel was 
washed with 3 cycles of 50ml 0.1 M  sodium acetate pH4 + 0.5M NaCI2 followed 
by 50ml 0.1M Tris-HCI pH8 + 0.5M NaCI2. The gel was equilibrated with 10 bed 
volumes of Tris-buffered saline (TBS) and incubated with human C R P  in TBS + 
0.5mM CaCI2 overnight at 4°C with rotation. The gel was gently poured Into a 
column and 1ml fractions collected whilst adding TBS + 0.5mM CaCI2 until the 
absorbance of fractions at 280nm reached 0. The bound C R P  was then eluted in 
0.5ml fractions with T B S  + 1 0 m M  E D T A  until the absorbance of fractions at
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280nm reached 0. The most concentrated fractions were pooled and 
concentration established by absorbance at 280nm using the specific extinction 
coefficient for pure C R P  of 1.75 for 1 mg/ml (Nelson e t  a l . , 1991). The purified 
C R P  was then dialysed for 12 hours at a time, twice in TBS and 3 times in 
phosphate-buffered saline (PBS, Sigma-Aldrich, UK) to remove traces of TBS 
and sodium azide and purity was confirmed by S D S - P A G E  under reducing 
conditions.
Recombinant human CRP, sourced from Calbiochem, U K  was also used 
in non-cellular assays. Recombinant C R P  was produced in E s c h e r i c h i a  c o l i as a 
non-glycosylated polypeptide chain of molecular mass 115kDa with the same 
amino acid sequence as native human C R P  as cited by W o o  e t  a l . (Woo e t  
a l . , 1985). The recombinant protein was purified at Calbiochem, UK, using 
phosphorylcholine affinity chromatography and was determined pure by SDS- 
P A G E  analysis as described in section 2.2.6. The product was reported by the 
manufacturers to contain only 9ng/ml LPS as determined by the limulus 
amoebocyte lysate assay.
2.2.4.1 Conjugation of alkaline phosphatase to recombinant C R P
C R P  was conjugated to alkaline phosphatase (AP) using gluteraldehyde 
in a standard one-stage procedure (Avrameas,1969). 2000 units of alkaline 
phosphatase (Sigma-Aldrich, UK) was spun at 15000 * gfor6 minutes, 
resuspended in 1ml PB S  and dialysed for 24 hours in PBS at4°C. 0.8mg of 
recombinant C R P  was then added to the A P  with a final concentration of 0.2% 
gluteraldehyde (Sigma-Aldrich, UK) and rolled in darkness for 2 hours at room 
temperature. The AP-conjugated C R P  was then dialysed for 48 hours in 4 
changes of PB S  before adding 1 %  B S A  and 0.02% N a N 3 (Sigma-Aldrich, UK). 
The stock was then filter-sterilized through a 0.2pM filter and stored at 4°C.
2.2.5 Preparation of bacterial samples for Western blot analysis
N .  m e n i n g i t i d i s  cultures were grown for 4 hours and spun down as per 
section 2.2.1. Cells were resuspended to an O D 595 of 1 in P B S  with 0.5mM CaCI2 
or P B S  with 0.5mM CaCI2 and 1 0 m M  EDTA. Cell suspensions were opsonised 
with 50pg/ml recombinant C R P  (or mock opsonised with P B S  alone) for 30 
minutes. Non-bound C R P  was washed off with P B S  during 3 spins of 2 minutes
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at 4000 x g. To increase the sensitivity of detection, samples were concentrated 
to 1/5th of their original volumes in PBS.
2.2.6 S D S - P A G E  and Western blot of samples
Cell suspensions were prepared as per 2.2.5. Human C R P  was further 
purified as per section 2.2.4 and diluted in PBS. Samples were mixed with equal 
volumes of S D S - P A G E  sample loading buffer and boiled for 5 minutes before 
loading onto a 12% polyacrylamide gel with 5 %  stacking gel alongside pre­
stained protein standard molecular weight markers (BioRad, UK). The gel was 
run at 8 0 m V  in S D S - P A G E  tank buffer and blotted overnight onto polyvinylidene 
fluoride membrane (PVDF, Roche) soaked in Western transfer buffer. Replicate 
gels were stained for 1 hour with coammassie stain (0.1% (w/v) coomassie blue 
R350, 2 0 %  (v/v) methanol, and 10% (v/v) acetic acid) and washed in destaining 
solution (50% (v/v) methanol in water with 10% (v/v) acetic acid) to ensure equal 
loading of wells,
2.2.7 Immunoprobing of Western blots
Western blots prepared as per section 2.2.6 were divided into sections 
and blocked for 1 hour in Western blocking buffer (PBS, 0.05% Tween 20, 2 %  
BSA). Sections were then placed inside universal tubes and rolled for 1 hour at 
room temperature with primary antibodies in diluting buffer (PBS, 0.05% Tween 
20, 1 %  BSA). Primary antibodies were specific for class 1 pili (SM1 antibody,- 
gift from Professor Mumtaz Virji University of Bristol), phosphorylcholine (TEPC- 
15, mouse IgA, Sigma-Aldrich, UK) and human C R P  (goat anti-human C R P  IgG, 
Biogenesis, UK). Blot sections were washed for 30 minutes with three changes 
of diluting buffer then rolled for 1 hour at room temperature with peroxidase- 
conjugated secondary antibodies (anti-mouse IgA A4789, anti-mouse IgG 
A2304 and anti-goat IgG A4174, all Sigma-Aldrich, UK). Blot sections were 
washed for 30 minutes with three changes of diluting buffer then soaked in 
Luminal solution (Roche, UK) and developed onto BioMax light film (Kodak, UK). 
Films were dried then overlaid over blots to allow the position of pre-stained 
molecular weight markers to be traced onto the film.
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2.2.7.1 Immunoprobing of phosphorylchoiine expression in N .  m e n i n g i t i d i s  
Cultures of piliated C3 1 1 and the non-piliated mutant C311p- were grown
in MHB, washed and resuspended in sample buffer every 2 hours over a 10 hour 
time-course. Cell lysates were subjected to S D S - P A G E  and Western blotting as 
per sections 2.2.5 and 2.2.6 and probed with anti-PC antibody (TEPC-15, Sigma- 
Aldrich, UK) as per section 2.2.7. The blots were photographed using a Gene 
Genius bioimaging system and densitometry of bands was performed using 
GeneTools software (Synoptics, UK).
2.2.8 High sensitivity ELISA for the measurement of C R P
Nunc maxisorp ELISA plates were coated, 50pl/well with 0.5pg/ml 
polyclonal rabbit anti-human C R P  in 0.1 M  bicarbonate buffer and incubated 
overnight at 4°C. Plates were washed with PBS-Tween (PBS-T,0.05%) and 
blocked with 2 %  B S A  in P B S  for 1 hour at 37°C. Plates were washed with PBS- 
T and D A K O  C R P  standards were diluted from 100mg/ml to 100ng/ml, 30 ng/ml, 
10 ng/ml, 3 ng/ml, 1 ng/ml, 0.3 ng/ml, 0.1 ng/ml, 0.03 ng/ml, and 0.01 ng/ml in 
PBS-T-BSA (0.2%). Control and test samples were added in triplicate at 
50pl/well and the plates were incubated for 1 hour at 37°C. Plates were washed 
with PBS-T and 50pl/well peroxidase-conjugated rabbit anti-human C R P  was 
added at 1pg/ml in PBS-BSA (0.2%) for 1 hour at 37°C. Plates were washed 
again with PBS-T followed by a wash with citrate-phosphate buffer (0.05M, pH5). 
Substrate was prepared by adding 1 tablet of T M B  substrate (3,3',5,5'- 
tetramethylbenzidine, Sigma-Aldrich, UK) per 10ml 0.05M citrate-phosphate 
buffer, pH5 + 2pl 3 0 %  H 2O2). T M B  substrate was added, 50pl/well and plates 
incubated at room temperature for 10 minutes. The reaction was halted with 
12.5pl/well 2 M  H 2S 0 4 and plates read at450nM on a Biotek, U S A  ELISA plate 
reader.
2.2.8.1 Preparation of supernatant samples for high-sensitivity C R P  ELISA
N .  m e n i n g i t i d i s  and S. p n e u m o n i a e  cultures were prepared as per section
2.2.1 and grown for 4 or 6 hours respectively. Cells were spun for 10 minutes at 
1000 x g  and resuspended in PBS with 0.5mM CaCI2 to an optical density of 10 
at 595nm for N e i s s e r i a  and an optical density of 2 at 600nm for Streptococci. 
Bacteria were opsonised in a final concentration of 50pg/ml purified human C R P  
(either in P B S  with 0.5mM CaCI2 alone, or with 1 0 m M  E D T A  or 1 mg/ml soluble
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phosphorylcholine-caicium salt) for 30 minutes at 37°C. Bacteria were spun at 
6000 x g  for 3 minutes and supernatants reserved. Pellets were washed twice in 
PB S  and spun at 6000 x g for 3 minutes, reserving supernatants and pooling 
each sample’s supernatants from the 3 spins. Pooled supernatants were filter 
sterilised and diluted for measuring C R P  concentrations in an in-house high 
sensitivity C R P  ELISA as per section 2.2.8.
2.2.8.2 Preparation of eluted samples for high sensitivity C R P  ELISA
N .  m e n i n g i t i d i s  cultures were prepared as per section 2.2.1 and grown for 
4 hours in M H B  with 100pg/ml C R P  or in plain MHB. Bacteria were washed with 
three spins at 1000 xg for 4 minutes and resuspended in PBS. After the third 
spin, cultures were resuspended in P B S + 1 0 m M  E D T A  and left to elute for 10 
minutes. Cultures were spun a fourth time and the supernatant collected and 
filter sterilised. Eluents were then serially diluted and assayed for C R P  
concentration using the high sensitivity C R P  ELISA as per section 2.2.8.
2.2.9 Microtitre plate-based assay to measure C R P  binding to 
N .  m e n i n g i t i d i s
Bacteria were grown and fixed as per section 2.2.1 then spun at 4000 x g 
for 6 minutes and resuspended in RPMI at an optical density of 5 at 595nm. The 
method used to determine C R P  binding to N .  m e n i n g i t i d i s  was based on a 
method developed for L .  d o n o v a n i (Culley e t  a l . ,2000). Briefly, 50pl aliquots of 
(washed) fixed bacterial culture were dispensed onto 96 well Nunc maxisorp 
ELISA plates alongside RPMI-only controls. Plates were dried overnight in an 
incubator at 35°C and the dried wells were blocked with 1 %  bovine serum 
albumin (Sigma-Aldrich, UK) in PBS for 1 hour. Wells were washed with PBS 
and 25pl of treatments were added to each well in triplicate. Treatments were 
prepared in P B S  and included PBS only, 1 0 m M  EDTA, and phosphorylcholine- 
caicium salt at a range of concentrations (Sigma-Aldrich, UK). AP-conjugated 
C R P  (CRP-AP) was prepared as per section 2.2.4.1. CRP-AP was diluted to 
20pg/ml in PBS + 1 m M  CaCI2 and added in 25pl volumes to wells (final 
concentrations of 10pg/ml C R P  and 0.5mM CaCI2). Plates were incubated in the 
dark for 2 hours then washed 3 times with PBS and once with 0.1 M  bicarbonate 
buffer pH9.6. Plates were developed with 50pL/well pnitrophenyl phosphate 
(pNPP, Sigma-Aldrich, UK) at 1 mg/ml in 0.1 M  bicarbonate buffer pH 9.6
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containing 2 m M  MgCI2. Plates were incubated in the dark for a further hour and 
read at 405/490nm on a microplate reader (Biotek, USA).
For time-course binding experiments, the standard binding assay was 
performed on cultures harvested between 2 and 10 hours of incubation. For 
saturation experiments, the assay was carried out with a range of concentrations 
of CRP-AP. Competitive inhibition assays used the original concentration of 
CRP-AP with added phosphorylcholine-calcium salt (Sigma-Aldrich, UK) diluted 
in P B S  at a range of concentrations.
Dose-response experiments, to find the optimal density of bacteria to 
detect CRP-AP binding, utilised bacteria in a range of doubling dilutions from an 
optical density of 10 down to an optical density of 0.3 at 595nm.
2.2.10 Immunoglobulin G  depletion of h uman plasma
Laboratory volunteers were used according to University ethical 
guidelines (Local Research Ethics Committee 04/Q1909/19RSCFI). 5 x 9ml 
Vacutainer tubes with E D T A  (Greiner Bio-one, UK) of peripheral blood were 
taken from each volunteer. Blood was transferred to 50ml centrifuge tubes and 
spun at 2000 x g for 10 minutes and the plasma layer collected with a Pasteur 
pipette. Plasma was snap-frozen in a boiling dry ice waterbath in cryovial tubes 
and stored at -80°C. On the assay day, plasma was gently defrosted on ice. In 
the cold room, a 10ml syringe was filled with ice cold Hanks balanced salt 
solution (HBSS) and connected drop-to-drop (to avoid air bubbles) to a 1 ml 
protein-G sepharose column (GE Biosciences, UK). The column was 
equilibrated with 10mls H B S S  at a rate of 1ml per minute then 1ml of plasma 
was added to the column at a rate of 1ml per minute. The column was incubated 
on ice for 5 minutes then plasma run through the column into a pre-weighed tube 
using 2ml ice cold HBSS. The tube was weighed to estimate the dilution factor of 
the original sample. The column was washed with 10mi H B S S  then 5ml elution 
buffer (0.1M glycine-HCI) and fractions were collected for analysis. The column 
was then washed with 10ml H B S S  and stored in H B S S + 2 0 %  ethanol. IgG- 
depleted plasma was filter sterilised and stored on ice until use. Purity was 
confirmed retrospectively by running IgG-depleted plasma on a 12% SDS-P A G E  
gel and comparing to the original sample and to the eluted IgG fractions.
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2.2.11 Adapted serum bactericidal assay
The piliated N .  m e n i n g i t i d i s  strain C311 and the non-piliated mutant 
C311p- were grown and spun as per section 2.2.1 then resuspended in 
bactericidal buffer (HBSS + 0.5mM CaCI2 + 1 %  BSA) to an optical density of 0.1 
at 595nm. Cultures were diluted 1 in 2000 in bactericidal buffer with a final 
concentration of 50pg/ml C R P  or bactericidal buffer alone. Bacteria were 
incubated with or without C R P  for 15 minutes at 35°C then equal volumes of 
bacteria were added to a 1 in 5 dilution of IgG-depleted or complete human 
plasma (final dilution 1 in 10) in duplicate for each sample. Inoculum was serially 
diluted and plated out onto C B A  for enumeration and plates were incubated at 
35°C for 30 minutes. After incubation with plasma, 2 x 10pl aliquots of each 
sample were dispensed onto C B A  plates tilted at 45° to allow the droplets to 
spread down the length of the plate. C B A  plates were incubated at 35°C 
overnight and colonies counted the following morning.
2.2.12 Activation of macrophages by CRP-opsonised bacteria
To investigate the effect of CRP-opsonised bacteria on the expression of 
markers of activation by macrophages, bacteria were prepared as per section
2.2.1 then adjusted to an optical density at 595nm of 4 or 0.2 before opsonising 
with either 100pg/ ml CRP, 50pg/ml CRP, or PBS alone for 30 minutes. THP-1 
and U937 cell lines were differentiated into macrophages and peripheral blood- 
derived macrophages were prepared as per section 2.2.3 in small flasks, 10mls 
per flask at a density of 2-4 x 105 cells/ml. On the assay day, media was 
aspirated, cells gently washed with serum-free media and media replaced with 
5mls serum-free media. For negative controls, 500pl P B S  was added to the 
flask. For positive controls, final concentrations of 100 units/ml Interferon g a m m a  
(IFNy, R & D  Systems, UK) and 1pg/ml lipopolysaccharide (LPS, Sigma-Aldrich, 
UK) were added to the cells. For C R P  treatment, 500pl of C R P  at 100pg/ml or 
50pg/ml C R P  with 5pg/ml polymixin B was added to cells (final C R P  
concentrations of 10 & 5 pg/ml respectively). For bacterial treatments, 500pl of 
the PBS-opsonsied meningococci was added to cells. For CRP-opsonised 
bacterial treatment, 500pl of the CRP-opsonised meningococci was added to the 
cells. All cells were incubated for 24 hours before staining for F A C S  analysis.
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2.2.13 Fluorescence activated cell scanning (FACS) of bacteria and 
phagocytic cells
Bacterial and mammalian cells were prepared for F A C S  analyses as per 
sections 2.2.13.1-4. Bacteria and single-labelled cell lines were examined using 
a Becton Dickinson FACscan flow cytometer (BD, UK) and data were analysed 
using WinMDI software (http://facs.scripps.edu). All other cells were examined 
on the B D  FACScanto flow cytometer using FACSdiva software (BD, UK). The 
cell populations were gated by size and granularity to exclude debris and at least 
10,000 cells were counted in any test.
2.2.13.1 Defection of C R P  binding to bacteria by F A C S
S. p n e u m o n i a e  or N  . m e n i n g i t i d i s  C311p- and C311p+ cultures were 
prepared as per section 2.2.1. Cultures were adjusted to 5*106CFU/ml in PBS + 
0.5mM CaCI2 (approximate optical density of 0.05 at 595nm where previous 
inoculum counts revealed that an O D 595 of 1 corresponds to 1 *108 CFU/ml for 
N .  m e n i n g i t i d i s  C 3 1 1). Purified C R P  was added at 50pg/ml and tubes were 
incubated for 30 minutes at 37°C then washed twice with cold PBS and 2 minute 
15000 x g  spins and resuspended in FAC S  buffer. Primary antibodies were first 
titrated to determine optimal activity concentrations and ultimately diluted to 
0.5pg/ml in F A C S  buffer (mouse IgA anti-phosphorylcholine (TEPC), goat IgG 
anti-human CRP, mouse IgG anti- S. p n e u m o n i a e  or mouse IgG anti-serogroup 
B N e i s s e r i a  m e n i n g i t i d i s )  and incubated on ice with cells for 1 hour. Cells were 
washed twice with cold P B S  for 2 minutes spinning at 15000 x g and 
resuspended in F A C S  buffer. Tubes were incubated with FITC-conjugated 
secondary antibodies (anti-mouse IgA, anti-mouse IgG and anti-goat IgG 
respectively) for 1 hour on ice. Cells were washed twice with cold PBS for 2 
minutes at 15000 x g then fixed in 4 %  paraformaldehyde before examining on 
the B D  FACScan flow cytometer as per section 2.2.13.
2.2.13.2 Detecting association of GFP-expressing N .  m e n i n g i t i d i s  with 
hu m a n  phagocytes using F A C S
The GFP-expressing N .  m e n i n g i t i d i s  strain C3 1 1 was grown and fixed as 
per section 2.2.1. Bacteria were then washed, and resuspended in P B S  with 
0.5mM CaCI2 to an optical density of 4 at 595nm before opsonising with either 
100pg/ml purified human C R P  in PB S  with 0.5mM CaCI2or plain PBS with
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0.5mM CaCI2 for 30 minutes at 37°C. Macrophages (either PMA-differentiated 
THP-1 cell line or peripheral blood derived 7 day old macrophages) were 
collected from plastic surfaces by gentle scraping before washing in serum-free 
media and resuspending in serum free media to a density of approximately 5 * 
105/ml. 100pl of opsonised bacteria was added to each ml of cells in universal 
tubes which were incubated at 37°C for 2 hours. Tubes were then spun at 250 x 
g  for 5 minutes and washed in PBS 3 times before fixing in 2 %  
paraformaldehyde for at least 30 minutes before examining on the flow 
cytometer as per section 2.2.13.
2.2.13.3. Investigating the expression of activation markers on 
macrophages by single and double-labelled F A C S
Macrophages were prepared and incubated with controls or bacteria as 
per section 2.2.12. After 24 hours incubation, supernatants were collected and 
stored at -80°C and cells were washed in H B S S  without calcium or magnesium, 
trypsinised (with 0.05%Trypsin-EDTA, Invitrogen, UK) and harvested in FACS 
buffer (PBS + 2 %  bovine serum albumin + 0.05% N a N 3). Cells were washed in 
FA C S  buffer and resuspended in 1m! F A C S  buffer with 1 %  normal human serum 
to block Fc receptors. For single staining, cells were resuspended in 40pl 
aliquots of FSB with the following concentrations of antibody:
Antibody (pg of Ab) Isotype controls (pg of Ab)
CD11b 0.5 lgG1 - FITC 0.5
ICAM-1 0.5 lgG1-PE 0.125
FcyR1 (CD64) 0.125 lgG2a-PE 0.03
HLA-DR 0.03
Table 1. Amounts of antibody used in FACS staining
For double staining experiments, each aliquot of cells was incubated with 
both a PE-conjugated and a FITC-conjugated specific antibody. For double- 
staining F A C S  analysis, the FACScanto was pre-calibrated using B D  calibration 
beads coated with the same concentrations of antibodies used in the staining 
procedure. This allowed for compensation for any possible leaching between red 
and green fluorescence channels.
For both single and double-stained cells, plates were incubated on ice in 
the dark for 1 hour before washing 3 times with F A C S  buffer and resuspending in 
2 %  paraformaldehyde after the final wash. Fixed cells were analysed as per 
section 2.2,13.
2.2.14 Confocal fluorescence microscopy
Human granulocytes and macrophages were prepared from volunteers 
and adhered to 8-well plastic chamber slides (Nunc, UK) as detailed in section 
2.2.3.2-3. Cells were treated with bacteria with and without C R P  as per sections
2.2.14.1 - 2.2.14.4. Slides were either fixed in 4 %  paraformaldehyde after the 
experiment and mounted in vectashield soft-set mounting media with propidium 
iodide (PI) or stained with the lipophilic dye FM6-46 before fixing and mounting in 
vectashield soft-set mounting media without PI. In all cases, coverslips were 
applied and sealed with clear nail polish before examining on the Zeiss LSM5.1 
confocal fluorescent microscope on at least *400 maginification. The microscope 
was set up to read Cy2 and CY3 channels to allow both red and green 
fluorescence to be detected simultaneously. Images were scanned and saved for 
analysis using L S M  image browser (www.zeiss.com). For each chamber slide 
well examined, at least 10 randomly selected fields of view were recorded.
2.2.14.1 Investigating the effect of CRP-opsonisation on association of 
meningococci with h u m a n  phagocytes using immunolabelled bacteria
Macrophages were prepared and adhered to chamber slides as detailed 
in section 2.2.3.2. S. p n e u m o n i a e  R36 A  and A/, m e n i n g i t i d i s  C 3 1 1 p- and 
C311 p+ cultures from overnight plates were suspended at 8><107 cfu/ml in PBS 
and opsonised for 30 minutes at 35°C with 50pg/ml C R P  in PB S  containing 
0.5mM CaCI2, or 50pg/ml C R P  in PB S  with 0.5mM CaCI2 and 1 0 m M  E D T A  or 
CRP-free control (PBS containing 0.5mM CaCI2 alone). Cultures were spun at 
1000 x g  for 10 minutes, washed once in PBS and resuspended to the original 
volume in RPMI. 40pl of bacterial suspension was added to each of 6 wells per 
chamber slide and the slides were incubated at 35°C for 2 hours then gently 
washed with warm P B S  before fixing overnight with 4 %  paraformaldehyde. Fixed 
chamber slides were gently washed 3 times with PB S  and cells were 
permeabilsied with 0.1% TRITON X-100 (Sigma-Aldrich, UK) for 5 minutes. Fc 
receptors were blocked by incubating with 1 %  normal human serum (Sigma- 
Aldrich, UK) for 20 minutes. Slides were washed and incubated with mouse anti- 
meningococcal antibody at a 1 in 100 dilution in PB S  with 1 %  normal human 
serum for 1 hour. Slides were washed thoroughly then incubated with goat f(ab’)2 
anti mouse IgG-FITC at a 1 in 100 dilution in PBS with 1 %  normal human serum
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for 1 hour. Slides were washed thoroughly then mounted in soft-set mounting 
media with PI and examined as per section 2.2.14.
2.2.14.2 Investigating the effect of CRP-opsonisation on association of 
meningococci with h u m a n  phagocytes Using GFP-expressing 
meningococci
GFP-expressing bacteria detailed in section 2.2.2 were prepared as per 
section 2.2.1 then fixed overnight in 4 %  paraformaldehyde, washed and 
resuspended in P B S  containing 1 0 m M  CaCI2 to an optical density at 595nm of 
4.00. Bacteria were then treated for 30 minutes with equal volumes of either 
pooled normal human serum, 50pg/ml purified C R P  or PBS. Treated bacteria 
were added in 40pl volumes, in duplicate, to a final volume of 400pl/well of 
differentiated monocytic cell lines or peripheral blood derived macrophages and 
incubated for 2 hours at 37°C + 5 %  C 0 2 to allow phagocytosis to occur. For the 
granulocyte uptake assays, phagocytosis was allowed to occur for 20 minutes 
only. The wells were washed 4 times with PBS, fixed with 1 %  paraformaldehyde 
then prepared for confocal microscopy as per section 2.2.14. At least 100 cells 
from 10 randomly selected fields of view were analysed for enumeration of 
phagocytes and co-localised bacteria. The presence of internalised bacteria was 
confirmed by staining macrophages post-infection with a lipophilic membrane 
dye (FM 4-64FX, Molecular Probes, UK) as per the manufacturers instructions 
and mounting in vectashield soft-set mounting media without PI. This allowed a 
z-stack of images to be taken through the depth of the cell.
2.2.14.3 IgG blocking of Fey receptors
The method detailed in section 2.2.14.2 was modified to investigate the 
effect of blocking Fey receptors on CRP-mediated uptake by macrophages. 
Before adding opsonised or unopsonised bacteria to macrophages adhered to 
chamber slides, macrophages were first treated for 30 minutes with human IgG 
(Sigma-Aldrich, UK) at 100pg/ml, 10pg/ml, 1pg/ml or Opg/ml in serum-free RPMI. 
Non-bound IgG was then washed off and slides incubated with bacteria and 
examined as per the section 2.2.14.
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2.2.14.4 Association of live meningococci with macrophages examined by 
confocal fluorescence microscopy
The method detailed in section 2.2.14.2 was modified to allow detection of 
uptake of live meningococci by macrophages. Macrophages were cultured on 
chamber slides as usual but on the assay day, all procedures were carried out in 
the N e i s s e r i a  class 1 safety cabinet. Bacteria were opsonised with PBS alone or 
a final concentration of 100pg/ml C R P  before infecting macrophages at a 1 in 10 
dilution for 2 hours. Chamber slides were washed 4 times with PBS then fixed 
overnight in 4 %  paraformaldehyde before examining on the microscope the 
following day as per section 2.2.14.
2.2.15 Association of live meningococci with macrophages assayed by 
gentamicin exclusion
Peripheral blood and cell line-derived macrophages were prepared as per 
section 2.2.3.1-2 and cultured in 24-well plates. Meningococci were prepared as 
per section 2.2.1 and resuspended in PBS + 0.5mM CaCI2 to an optical density 
of 4 at 595nm. Bacteria were opsonised for 30 minutes with either 100pg/ml 
CRP, 2 5 %  heat inactivated normal human serum or PB S  alone then added to 
macrophages at a 1 in 10 dilution. Macrophages were allowed to phagocytose 
for 2.5 hours before washing and either lysing with 1 %  saponin in PBS to 
enumerate adherent and intracellular bacteria or incubating with 200pg/ml 
gentamicin for 1 hour before lysing with saponin to enumerate intracellular 
organisms only. Saponin treated macrophage lysates were serially diluted in 
P B S  alongside bacterial inocula and dispensed onto C B A  plates to count the 
numbers of intracellular and adherent bacteria.
2.2.16 Measuring the effect of C R P  on intracellular killing by time-kill assay
Macrophages in tissue culture plates were infected with CRP-opsonised 
and non-opsonised meningococci as per section 2.2.15. At regular intervals, 
duplicate wells were washed and incubated with gentamicin for one hour and 
lysed with saponin for enumeration of intracellular bacteria as per 2.2.15. This 
procedure was repeated at regular intervals throughout a time-course.
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2.2.17 Quantification of macropage -secreted TNF a  by ELISA
An in-house TNFa ELISA was optimised to quantify TNFa production in 
cell culture supernatants. 96-well ELISA plates were coated with 50pl/well 
0.5pg/ml anti-human TNFa (BD Biosciences, UK) in 0.1 m M  N a 2HP04, pH 9. 
Plates were incubated overnight at 4°C then washed four times with PBS-T 
(0.05%) before blocking for 1 hour with 2 %  B S A  in PBS-T. Plates were washed a 
further three times before incubating with either control standards or test 
samples. Control standard TNFa (NIBSC, UK) was serially diluted in PBS-T-BSA 
(0.2%) from 20ng/ml down to 9pg/ml. Test and control samples were incubated 
in triplicate, 50pl/well at 4°C overnight then washed four times with PBS-T and 
incubated at room temperature for 1 hour with 50|jl/well biotin-conjugated anti­
human TNFa (BD Biosciences, UK) diluted to 1pg/ml in PBS-T-BSA (0.2%). 
Plates were washed five times with PBS-T then incubated for 30 minutes with 
50pl/well of avidin-HRP (BD Biosciences, UK) at 2pg/ml in PBS-T-BSA (0.2%). 
Plates were washed 5 times with PBS-T followed by 3 washes with citrate- 
phosphate buffer (pH5). Plates were developed by adding 50pl/ well T M B  
substrate dissolved in citrate-phosphate buffer (pH 5) with 60 parts per million 
H 20 2 as per the manufacturer’s instructions. The reaction was stopped by adding 
12.5pl of 2 m M  H 2S 0 4 per well. Plates were read at 450nM using a Biotek 
microplate reader. The standard dilutions were used to construct a calibration 
curve of TNFa concentration which was used to calculate corresponding TNFa 
concentrations for test samples on each plate.
2.2.18 Quantification of inflammatory cytokines by Cytometric Bead Array
A  B D  biosciences Human Inflammation Cytometric Bead Array kit was 
used as per the manufacturer’s instructions to measure IL-1(3, IL-6, IL-8, IL- 
12p80, IL-8 and TNFa concentrations from cell culture supernatants. In principal, 
the cytometric bead array consists of 6 populations of beads with distinct 
fluorescence intensities that are coated with capture antibodies for the 6 
inflammatory cytokines listed. This allows simultaneous quantification of 
cytokines from cell culture supernatants after incubating with test and control 
samples and a PE-conjugated secondary antibody. The in-house TNFa assay 
results were used to choose appropriate dilutions of samples to use in the assay. 
Cytometric bead arrays were run on the B D  FACScalibur with Dr Mark Bodman- 
Smith at St Georges Hospital, University of London.
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2.3 S tatis tica l a n a lyse s
Data are expressed as arithmetic means + standard deviation (SD) or 
standard error of the mean (SE). Means were compared using Students t-test for 
paired data. Analysis of variance was used to measure coefficients of variation 
for 3 or more groups of variables using the 1-way ANOVA, correcting with Tukey 
post test for multiple comparisons. All data was analysed using GraphPad Prism 
4 software. For all analyses, P values of less than 0.05 were considered 
statistically significant.
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CHAPTER THREE
INVESTIGATING THE ABILITY OF C-REACTIVE 
PROTEIN TO BIND TO NEISSERIA MENINGITIDIS
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3.1 Rati onal e a n d  a i m s
The principal ligands for C R P  are phosphorylcholine (PC) and other 
phosphorylated carbohydrates which are found on the surface of a variety of 
eukaryotic and prokaryotic cells (Gillespie e t  a l . , 1996; Jansen ef a/.,1999; Culley 
e t  a l . ,2000; Chang e t  a l . , 2 0 0 2 ) . P C  has been identified on the pilus of 
pathogenic strains of N e i s s e r i a  (Weiser e t  a l .,1998a), although there was no 
published evidence of C R P  binding to this ligand before the onset of this 
investigation. It was, therefore, considered important to determine whether C R P  
was capable of binding to this target at physiologically relevant concentrations.
The first aim of this chapter was to develop a suitable method to detect 
C R P  binding to piliated meningococci and to investigate the specificity and 
affinity of this interaction. The piliated serogroup B meningococcal strain C311 
was utilised for these studies because it was a clinical isolate that had 
previously been shown to express P C  (Weiser e t  a l . , 1998a). The C311 strain 
was also valuable because of the availability of a non-piliated spontaneous 
mutant that could be used as a negative control in binding experiments.
The second aim of this chapter was to investigate if C R P  bound to live as well 
as fixed meningococci as these two events may have very different down­
stream immunological effects. The final aim of this chapter was to examine C R P  
binding to other meningococcal strains. A  second serogroup B strain H44/76 
was tested for CRP-binding ability as was a virulent Serogroup C  strain L91543 
and a p h o P  knockout mutant made from this strain, which shows reduced 
virulence in mouse models of meningococcal infection (Newcombe e t  a l . ,2004). 
These last two strains were tested to investigate whether differences in the 
transcriptome of strains resulted in differences in C R P  binding.
Initial development of CRP-binding assays utilised S. p n e u m o n i a e  
because this gram positive organism has been well characterised in its ability to 
bind C R P  and can be manipulated using standard containment level 2 
conditions. Following this, CRP-binding to N .  m e n i n g i t i d i s  was investigated 
using several methodologies and the specificity and affinity of the interaction 
was explored. Several additional strains of N .  m e n i n g i t i d i s  were also tested for 
C R P  binding ability. Following the characterisation of CRP-binding to fixed 
meningococci, binding to live organisms was investigated using a high- 
sensitivity CRP-ELISA.
3.2.1 Development of a fluorescence activated cell scanning (FACS) assay 
to demonstrate C R P  binding to S. p n e u m o n i a e
To capture S. p n e u m o n i a e  cultures at an actively dividing growth phase, 
growth curve experiments were performed as described in 2.2.1. Figure 3.1 
shows a representative example of a growth curve in which the 6 hour time- 
point was chosen as an appropriate mid-log phase time point to harvest
S. p n e u m o n i a e .
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Figure 3.1 Growth curve of S. pneumoniae R36A
S. p n e u m o n i a e  R36A was used to inoculate BHI broth. Cultures were shaken and aliquots 
taken at 2 hour time points for serial dilution in PBS and plating out onto Columbia blood agar 
for enumeration. Data are from one representative experiment.
3.2 Results
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F A C S  analysis of CRP-opsonised S. p n e u m o n i a e  cultures was 
performed as described in 2.2.1. Bacteria were opsonised with human CRP, 
washed and probed with anti-CRP antibody and FITC-conjugated secondary 
antibody as described in 2.2.13.1. Figure 3.2 demonstrates the results of the 
proof of principle experiments using S. p n e u m o n i a e , with a clear right shift in 
fluorescence of the population of cells opsonised with C R P  (geometric mean 
277.7) when compared to cells not opsonised with C R P  (geometric mean 8.3)
Figure 3.2 Representative histogram showing relative fluorescence of anti-CRP probed 
S. pneumoniae
S . p n e u m o n i a e  strain R36A was probed with anti-CRP antibody and FITC-conjugated 
secondary antibody after opsonising with CRP (black) or mock-opsonising with PBS (Red).
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3.2.2 Development of a F A C S  method to investigate C R P  binding to 
N .  m e n i n g i t i d i s
Following the detection of C R P  bound to the surface of S. p n e u m o n i a e  
by F A C S  analysis, the method was optimised for use with Paraformaldehyde- 
fixed N .  m e n i n g i t i d i s . Initially, the cell surface structures of capsule and pili 
were targeted to act as positive controls for the assay. All antibodies were 
titrated before use in the assay and compared to isotype-matched non-specific 
controls. Figure 3.3 demonstrates that probing with the anti-capsular antibody 
gave a clear right-shift of the cell population fluorescence compared to the 
negative control (which was probed with non-specific isotype-matched antibody, 
geometric means 404.2 and 12.5 respectively). Probing with the anti-pili 
antibody, however, did not result in an increase in fluorescence as compared to 
the isotype control (geometric means 11.2 and 12.5 respectively). This indicated 
that the anti-pili antibody was unable to bind to the meningococci in this assay 
(the activity of the antibody had previously been confirmed by Western blot 
analysis of denatured meningococcal whole cell lysates, see figure 3.16).
Figure 3.3 Representative histogram showing relative fluorescence of anti-pili and anti­
capsule probed meningococci
N . m e n i n g i t i d i s  C311 was stained with anti-meningococcal antibody (green), anti-pilin antibody 
(red) or isotype control antibody (black). Data are from one representative experiment.
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The lack of staining of N. meningitidis strain C311 with the anti-pili 
antibody could be a result of pili being lost during the many washing steps of the 
assay. To investigate this, meningococci were probed with anti-PC antibody. 
Figure 3.4 shows the effect of staining with anti-PC antibody with the geometric 
mean of fluorescence recorded as 5.7 in the isotype control and 6.7 in the PC- 
stained population. This indicated that the PC antibody was unable to bind to 
the cells in these assay conditions. The activity of the anti-PC and anti-pilin 
antibodies had previously been confirmed by Western blot analysis, as shown 
in figure 3.16, but SDS-PAGE gels present antigen in a denatured form which 
may be different from the native form of protein presented on the bacterial 
surface. For this reason it could not be confirmed whether pili and PC were 
being lost in the washing steps or if the antibodies were unable to label their 
targets in their native states on the surface of the bacteria.
Figure 3.4 Representative histogram showing relative fluorescence of anti-PC stained 
meningococci
N. meningitidis C311 was probed with anti-PC antibody (red) or isotype control antibody (black) 
and FITC-conjugated secondary antibody. Data are from one representative experiment.
CRP binding to PC is a calcium-dependent process. Thus to examine 
CRP binding to the meningococcus, N. meningitidis strain C311 was opsonised 
with CRP in the presence of calcium, or calcium with EDTA before washing and 
probing with anti-CRP antibodies and FITC-conjugated secondary antibodies. 
Figure 3.5 reveals that the cells probed with anti-CRP antibody did not show 
increased fluorescence compared to isotype controls (geometric mean 8.84), 
either in the presence of calcium (geometric mean 5.39) or in a calcium- 
depleted solution (geometric mean 6.15 or 6.84 with isotype control antibody). 
The relative fluorescence of all cell populations was less than 10 suggesting
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that CRP does not bind to the piliated N. meningitidis strain in the conditions of 
this FACS assay.
Figure 3.5 Histogram showing relative fluorescence of anti-CRP probed cells
N. meningitidis C311 was opsonised with CRP in the presence of calcium and probed with anti- 
CRP antibody (red) or isotype control antibody (black). Control opsonisation was in the 
presence of EDTA followed by anti-CRP antibody (blue) or isotype control antibody (green).
Data are from one representative experiment.
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3.2.3 CRP binds to piliated meningococci in a microtitre plate-based assay
In order to control for the possible loss of pili during washing steps, a 
new strategy was devised to investigate CRP binding to the meningococcus. 
Large numbers of meningococci grown in broth to specific time-points were 
fixed and immobilised on the base of a microtitre plate and probed with AP- 
conjugated recombinant human CRP (CRP-AP) in a binding assay detailed in 
section 2.2.9. CRP binding to N. meningitidis strain C311 was investigated over 
a 10 hour time-course of growth. As can be seen in figure 3.6, CRP binding 
was observed in the presence of calcium after 2 hours and peaked at 4 hours of 
growth. Binding then rapidly decreased to negligible levels by 8 hours and 
remained low up to the final 10 hour time-point. The maximum CRP binding at 
the 4 hour time-point corresponded with the end of lag phase/early log phase in 
the growth curve of N. meningitidis C311 in MHB (see figure 3.6). At six hours, 
growth of N. meningitidis was still exponential but CRP binding was almost 
halved. No CRP binding was observed in the absence of calcium, supporting 
the hypothesis that CRP binds to the meningococcus by the classical calcium- 
dependent binding via the ligand binding face of the molecule.
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Figure 3.6 CRP binding to piliated N. meningitidis over a time-course of growth
N. meningitidis C311 (Nm) was grown in MHB, dried onto microtitre plates and probed with 
CRP-AP in the presence of calcium (red squares) or EDTA (blue triangles). Plates were washed 
thoroughly and bound CRP-AP was detected by adding pNPP substrate and measuring the 
absorbance at 405nm with a reference wavelength of 490nm. The dashed green line represents 
the growth curve of the cultures used as measured by optical density. Data are expressed as 
mean of 4 replicate experiments +/- standard deviation.
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To establish the concentration of bacteria which should be used in the 
CRP binding assay, 4 hour old cultures of N. meningitidis were serially diluted 
from an optical density of 10 down to 0.3 at 595nm before drying onto plates 
and performing the standard CRP binding assay. Figure 3.7 reveals that a 
bacterial suspension of optical density 5 at 595nm gave the greatest differential 
between CRP binding in the presence and absence of calcium and accordingly, 
this concentration of bacteria was used for all further experiments.
Density of bacteria (OD595)
Figure 3.7 Dose response of density of bacterial suspension vs CRP binding
N. meningitidis C311 was serially diluted from an optical density of 10 at 595nm down to an 
optical density of 0.3 before drying onto a microtitre plate and probing with CRP-AP in the 
presence (red line) or absence (blue line) of available calcium.
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3.2.4 CRP binding to N. meningitidis requires the presence of pili and 
calcium
As optimum CRP binding to piliated N. meningitidis was observed after 4 
hours growth in MHB, the adapted ELISA was repeated at this time-point and 
compared to CRP binding to a spontaneous non-piliated mutant of the same 
strain (C311p-). Figure 3.8 demonstrates that negligible CRP binding of either 
strain was observed in the absence of calcium, whereas in the presence of 
calcium, the piliated strain bound significantly more CRP than the non-piliated 
mutant (p = 0.011). The piliated strain also bound significantly more CRP in the 
presence of calcium compared to binding in the absence of available calcium 
(p= 0.002) and there was no significant difference in the binding of CRP to non- 
piliated C311p- in the presence or absence of available calcium (p=0.181).
0.75n
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Figure 3.8 CRP binding to piliated and non-piliated N. meningitidis in the presence or 
absence of calcium
The piliated strain C311 (red) and non-piliated mutant C311p- (blue) were dried onto microtitre 
plates and incubated with CRP-AP in the presence of calcium (calcium rich) or EDTA (calcium 
depleted). Data are expressed as the mean absorbance of six replicate experiments + standard 
error of the mean. (* denotes a p value < 0.05).
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In order to confirm that CRP binding to the piliated strain was dependent 
on the presence of calcium rather than the absence of EDTA, CRP was 
incubated with the meningococcus with zero added CaCI2 or increasing 
concentrations of CaCI2 up to the standard 0.5mM concentration (Figure 3.9). 
CRP binding increased with calcium concentration and was significantly higher 
in the standard 0.5mM CaCI2 compared to the both zero and 0.005mM CaCI2 
(p=0.029 and p=0.031 respectively).
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Figure 3.9 Titration of calcium for CRP binding to N.meningitidis
Strain C311 was dried onto microtitre plates and probed with CRP-AP at a range of calcium 
concentrations or without added calcium. Data are expressed as the mean absorbance of 3 
replicate experiments plus standard deviation (* denotes p value <0.05).
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3.2.5 CRP binding to N. meningitidis correlates with phosphorylcholine 
expression
To investigate whether the differences seen in CRP binding at different 
time-points (figure 3.6) were due to changes in PC expression, Western blots of 
whole cell lysates of N. meningitidis grown from 2 to 10 hours were probed with 
anti-PC antibody. In these experiments, PC was not expressed in the non- 
piliated strain at any point during the time-course, whereas PC was detected in 
the piliated strain at all time-points tested. Figure 3.10 displays the results of 
densitometry analysis of the bands from one representative experiment. PC 
expression in the piliated strain peaked at 4 hours of culture growth; the time 
point that also gave maximum CRP binding. PC expression dropped over two 
and a half times between 4 and 6 hours of growth and remained low for the 
remaining time-points, correlating with CRP binding data.
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Figure 3.10 PC expression by piliated N. meningitidis with time
N. meningitidis C311 (red squares) and non piliated C311p- (green triangles) were grown in 
broth culture and harvested at 2 hour intervals. Whole cell lysates were subjected to SDS- 
PAGE and Western blot and probed for PC expression. The blot was captured digitally and 
densitometry performed to quantify relative expression of PC. Data are from one representative 
experiment. CRP binding data from figure 3.6 for the piliated strain C311 is plotted in grey for 
comparison to PC expression.
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3.2.6 GRP binding to N. meningitidis is inhibited by free 
phosphorylcholine
Further to the discovery that CRP binding correlates with PC expression 
in the meningococcus, it was decided to investigate the specificity of binding by 
adding increasing concentrations of soluble PC to the CRP binding assay 
detailed in section 2.2.9. Figure 3.11 demonstrates that PC concentrations 
below 1pM did not inhibit binding of CRP to piliated meningococci, but 
concentration-dependent inhibition was demonstrated above 5pM. 50% 
inhibition was seen at a PC concentration of 20pM and the inhibitory effect was 
saturated at concentrations of PC above 100pM. This provides further evidence 
that binding between CRP and the meningococcus is specific for PC.
F ig u re  3.11 P C  in h ib it io n  o f  C R P -b in d in g  to  p ilia te d  N. meningitidis
N. meningitidis C311 were dried on to microtitre plates and incubated with CRP-AP containing 
soluble PC at a range of concentrations. Data are expressed as mean percentage of inhibition 
of absorbance of 3 replicate experiments +/- standard deviation.
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3.2.7 CRP binding to N. meningitidis is concentration dependent and of 
low affinity
The affinity of binding between CRP and piliated N. meningitidis was 
investigated by saturation binding experiments as described in section 2.2.9. 
CRP-AP was added at increasing concentrations to microtitre plates coated with 
a constant number of meningococci. The binding of CRP to the wells is 
expressed as a percentage of the value recorded for 10pg/ml CRP-AP to 
overcome inter-plate/day variation of the assay. As can be seen from figure 
3.12, CRP binding to N. meningitidis was concentration-dependent and began 
to plateau at 20pg/ml, whereas CRP concentrations below 1pg/ml did not result 
in detectable binding to immobilised meningococci.
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F ig u re  3 .1 2  S a tu ra t io n  o f  C R P  b in d in g  to  p ilia te d  N. meningitidis
Meningococci were dried onto microtitre plates and incubated with CRP-AP at a range of 
concentrations. Data are expressed as mean percentage of maximum absorbance of 3 
replicate experiments +/- standard deviation.
Scatchard analysis is a method of linearising saturation binding data by 
plotting specific binding/free ligand concentration on the Y axis vs. specific 
binding on the X axis. This gives a straight line with the following equations 
Y intercept = Bmax/Kd 
X intercept = Bmax 
Slope = 1/Kd
Where Bmax is the point where all receptors are saturated with ligand and Kd is 
the dissociation constant, a measure of affinity of binding between a receptor 
and ligand in terms of how easy it is to separate the receptor-ligand complex.
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Scatchard analysis is a good way to visualise saturation binding data but the 
most accurate way to determine binding constants is by fitting a hyperbola 
directly to the non-linearised data and using graphical programmes to calculate 
the constants from this line. Figure 3.13 displays the results of Scatchard 
analysis and non-linear regression of the saturation data giving a dissociation 
constant Kq of 2.18 * 10'4M.
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F ig u re  3 .1 3  B in d in g  c u rv e  a n d  S c a tc h a rd  p lo t o f  C R P  b in d in g  to  p ilia te d  N. meningitidis
Data from saturation binding experiments in figure 2.13 were utilised for examining the affinity of 
binding of CRP for N. meningitidis. Non-linear regression analysis was performed using 
GraphPad Prism 4.1 Mean values of triplicate data from one representative experiment are 
shown.
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3.2.8 CRP binding to other important strains of meningococci
A second serogroup B strain of N. meningitidis, strain H44/76 was 
examined for its ability to bind CRP over a 10 hour time course of growth using 
the standard assay as described in section 2.2.9. Figure 3.14 clearly 
demonstrates that CRP is able to bind to the meningococcal strain H44/76 in 
the presence of available calcium. Maximum CRP-binding was seen at 4 hours 
of growth, as was the case for strain C311.
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Figure 3.14 Time-course of CRP binding to N. meningitidis strain H44/76
N. meningitidis strain H44/76 (Nm) was grown in MHB, dried onto microtitre plates and probed 
with CRP-AP in the presence of calcium (red squares) or EDTA (blue triangles). The dashed 
green line denotes the growth curve of the cultures used as measured by optical density at 
595nm. Data are expressed as mean of 3 replicate experiments +/- standard deviation.
The virulent serogroup C strain of N. meningitidis L91543 and the phoP 
knockout mutant were both examined for CRP-binding ability during a 10 hour 
time course. Figure 3.15 shows that both strains bound CRP at all time-points 
in their growth curves and the phoP mutant bound significantly more CRP at the 
8 hour time point compared to the wild type strain at this time-point (p=0.02). 
When EDTA was added to the assay, binding of CRP to both strains was 
negligible. Growth of the phoP mutant is known to be magnesium-dependent, 
but even in magnesium supplemented broth, the mutant strain did not grow as 
fast as the wild type and reached its maximum optical density at 8 hours,
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compared to the wild type which continued to grow to a higher optical density 
after 10 hours of incubation.
Growth of Nm culture (hours)
Figure 3.15 Time course of CRP binding to N. meningitidis L91543 wild type and phoP 
mutant
N. meningitidis of strain L91543 and the phoP knock-out mutant of the same strain (Nm) were 
both grown in MHB supplemented with 10pg/ml MgCI2. During 10 hour time-course, cultures 
were collected and measured for optical density (dashed lines, orange wild type and green 
phoP) and dried onto plates for CRP-binding assay (red squares wild type, blue triangles phoP). 
The grey dashed line shows the maximum CRP binding of either strain in the presence of 
EDTA. Data are expressed as mean of 3 replicate experiments +/- standard deviation.
3.2.9 Development of assays to detect CRP binding to live meningococci
All CRP-binding results detailed in section 3.2.2-3.2.8 utilised PFA-fixed 
meningococci to reduce the variability of assays (as bacteria are fixed at a 
chosen time-point of growth) and to enable experiments to be performed 
outside the category 2* containment laboratory. It was, however, considered 
important to investigate the capacity of CRP to bind to live meningococci as this 
interaction may result in different down-stream immunological effects. 
Accordingly, assays were developed to investigate CRP binding to live 
meningococci.
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3.2.9.1 Investigation of CRP binding to live N. meningitidis by Western blot 
analysis
Piliated and non piliated live meningococci were opsonised with purified 
CRP in the category 2* facility and subjected to Western blot analysis as 
detailed in sections 2.2.5 -  2.2.7. Figure 3.6 displays a representative Western 
blot of non-piliated and piliated strains of C311 probed separately with anti-PC 
antibody (columns B and C) and anti-pili antibody (columns D and E). Both 
antibodies bound to the piliated strain only. Non-piliated and piliated strains 
were opsonised with CRP in the presence of EDTA and probed with anti-CRP 
antibody which did not bind in these conditions (columns G and H). Non- 
piliated and piliated strains were also opsonised with CRP in the presence of 
calcium which resulted in minimal binding of the anti-CRP antibody to the non- 
piliated strain but greater binding to the piliated strain (columns I and J ). All 
CRP-positive bands were in the correct position for the 23kD relative molecular 
mass of the CRP subunit.
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F ig u re  3 .1 6 . R e p re s e n ta t iv e  W e s te rn  b lo t a n a ly s is  o f  C R P  o p s o n is e d  liv e  N. meningitidis
Non-piliated and piliated meningococci were opsonised with CRP in the presence of EDTA 
(columns G&H respectively) or calcium chloride (columns l&J) run in an SDS-PAGE gel, blotted 
onto PVDF membrane and probed with anti-CRP antibody. A CRP control was included for 
comparison (column K) alongside molecular weight markers (A &F). Separate blots were 
probed with anti-pili antibody (columns D&E) and anti-PC antibody (columns B&C).
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3.2.9.2 Use of a high sensitivity CRP enzyme-linked immunosorbant assay 
(ELISA) to demonstrate CRP binding to live bacteria
Western blot analysis suggested that CRP was capable of binding to the 
live meningococcus. Consequently, a more sensitive method was developed to 
measure CRP binding to live meningococci. Initially, S. pneumoniae was utilised 
as a positive control organism to examine the suitability of the method to detect 
CRP binding to bacteria.
S. pneumoniae was incubated with CRP in the presence of calcium 
alone or with EDTA or soluble PC (to act as a competitive inhibitor of binding). 
The amount of CRP bound to the bacteria was then calculated indirectly by 
measuring how much CRP was left in supernatants by high sensitivity CRP- 
ELISA, as described in section 2.2.8. Figure 3.17 demonstrates that 
significantly less CRP was measured in culture supernatants of S. pneumoniae 
incubated with CRP in the presence of calcium (2.83± 0.99 pg/ml) as compared 
to the bacteria incubated with CRP in the presence of soluble PC (6.75 ± 1.97 
pg/ml, p= 0.042). More CRP was present in the supernatants of streptococci in 
the presence of the calcium-chelating agent EDTA (5.38 ±2.24 pg/ml) than in 
supernatants with calcium, although this difference was not statistically 
significant (p= 0.162).
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Figure 3.17 Measurement of residual CRP post-incubation with live S. pneumoniae
Streptococci of strain R36A were incubated with CRP in the presence of calcium (red) or EDTA 
(blue) or soluble phosphorylcholine (green). Bacteria were spun and the supernatants collected 
and pooled with washing supernatants before measuring the concentration of CRP in the 
supernatants by high-sensitivity CRP ELISA. Data are expressed as the mean of 4 replicate 
experiments plus standard deviation. (* denotes p<0.05).
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Following the successful detection of CRP binding to the pneumococcus 
by high sensitivity CRP ELISA, the method was adapted to measure CRP 
binding to N. meningitidis. It can be seen in figure 3.18 that although the mean 
CRP concentration in the supernatant after incubation with N. meningitidis in the 
presence of calcium was lower than for bacteria incubated in the presence of 
EDTA or PC, the difference was much smaller than that seen for 
S. pneumoniae and was not statistically significant. This may, in part, be due to 
the large variation seen in the assay as evidenced by the spread of the error 
bars.
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Figure 3.18 Measurement of residual CRP post-incubation with live N. meningitidis
Non-piliated (C311p-) and piliated (C311p+) meningococci were incubated with CRP in the 
presence of calcium (red) or EDTA (blue) or soluble phosphorylcholine (green). Bacteria were 
spun and the supernatants collected and pooled with washing supernatants before examining 
concentration of CRP in the supernatants by high-sensitivity CRP ELISA. Data are expressed 
as the mean of 4 replicate experiments plus standard error.
Estimating CRP binding to bacteria by measuring the concentrations of 
unbound CRP in the supernatant is an indirect way of measuring CRP binding.
It was, therefore, decided to measure the quantity of CRP bound to the 
meningococcus by eluting the bound CRP from the surface of the cells with 
EDTA after washing off any non-bound protein. CRP was then measured by the 
standard high-sensitivity ELISA. Figure 3.19 demonstrates that although some 
CRP was detected on the surface of the non-piliated strain of N. meningitidis 
(2.25 ± 0.28 pg/ml), the piliated strain C311 bound significantly more CRP (5.85 
±1.19 pg/ml, p= 0.03).
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Figure 3.19 Analysis of CRP binding to N. meningitidis as measured by high sensitivity 
ELISA of CRP eluted from the surface of the bacteria
Non-piliated (red) and piliated (blue) meningococci were incubated with CRP in the presence of 
calcium. Bacteria were spun and washed 3 times then CRP bound to the surface of the bacteria 
was eluted with EDTA. The CRP concentration in the eluent was measured by high-sensitivity 
CRP ELISA. Data are expressed as the mean of 3 replicate experiments plus standard 
deviation (* denotes p<0.05).
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The aim of this chapter was to identify and characterise binding between 
CRP and N. meningitidis. CRP was shown to bind to piliated N. meningitidis in a 
calcium-dependent manner that was of low affinity and specific for PC. CRP 
was shown to bind to several virulent strains of paraformaldehyde-fixed 
meningococci and also to live organisms.
3.3.1 Characterisation of CRP binding to N. meningitidis strain C311
Initial experiments to investigate CRP binding to the surface of the 
meningococcus utilised fluorescence activated cell scanning (FACS) 
methodology to detect fluorescently labelled anti-CRP antibodies on the surface 
of the bacteria. The method was developed using S. pneumoniae as a positive 
control organism because it is well established that CRP binds to the PC of the 
pneumococcus. Fluorescent anti-CRP antibodies could be detected bound to 
the surface of the pneumococcus after opsonisation with CRP. Subsequently, 
the method was optimised for use with meningococci. The meningococcal 
capsule could be clearly labelled, however, the pilus was not detectable using 
the SM1 anti-class II pili antibody and PC was also undetectable on the surface 
of the bacteria using an anti-PC antibody. Anti-CRP antibodies were not 
detected on the meningococcal surface following opsonisation with CRP.
The absence of staining with anti-pili and anti-PC antibodies could be 
due to either a lack of antibody binding or a lack of target structures on the 
surface of the organism during the experiment. The anti-PC and anti-pilin 
antibodies have both been used extensively in the literature to label denatured 
proteins in SDS-PAGE gels and blots, but their binding ability for native pili and 
PC has not been established. Pili (and consequently PC on the pili) may not 
have been present on the surface of the bacterium when passing through the 
flow cytometer as pili are very long and brittle hair-like structures, easily shed 
through mechanical shearing and could be lost in the staining process. The 
protocol included 8 spins at 15,000 x g which could shear the pilus from the cell 
surface and any CRP bound to the pilus would be lost during washing and not 
detected in the FACS analysis. Slower spin speeds were investigated, but the 
number of spins needed to adequately wash cells meant that labelling of pili 
was still not possible (data not shown). Because of the difficulty in detecting the
3 . 3  D i s c u s s i o n
pilus in this way, it was decided to develop less aggressive methods to visualise 
CRP binding to the meningococcus.
A microtitre plate-based method was developed with large numbers of 
fixed bacteria immobilised on the surface of the plates. This assay revealed 
that CRP bound to the piliated strain C311 but not to the non-piliated mutant of 
the same strain, suggesting that the pilus is a crucial factor in CRP binding. The 
non-piliated mutant used in these assays was a natural mutant, making it 
possible that the failure of this isolate to bind CRP might be due to other 
uncharacterised changes to the surface of the bacterium. This possibility is, 
however, highly unlikely in view of the fact that the pilus has been confirmed as 
the structure expressing PC on N. meningitidis by Western blot analysis of 
purified pili from C311 and other piliated strains (Weiser ef a/.,1998a). In 
addition, a panel of 64 pathogenic Neisseria strains were screened for the 
presence of the PC epitope and only the pilin subunits of class I and class II 
piliated strains were positive for PC expression (Serino and Virji,2000). Thus it 
is implied that the pilus is critical for CRP binding to N. meningitidis. Further 
confirmation of this would be possible by examining CRP binding to 
meningococcal mutants with deliberately inactivated pilin genes.
CRP did not bind to the piliated strain C311 in the presence of EDTA 
(which chelates calcium and therefore prevents calcium-dependent binding). To 
ensure that CRP binding to the meningococcus was due to the presence of 
available calcium rather than the absence of EDTA, calcium-free media was 
used for binding assays and calcium was titrated back in. These experiments 
revealed a dose-response for CRP binding with increasing concentrations of 
calcium, confirming that CRP binds to its ligand via the classical calcium- 
dependent mechanism reported for its principal ligand; PC. Subsequently, PC 
expression was measured in the piliated strain throughout a growth-curve 
experiment. In these assays, PC expression correlated with the level of CRP 
binding over a 10 hour time-course of bacterial growth, strongly suggesting PC 
as the target for CRP on the meningococcus. Both PC expression and CRP 
binding peaked at 4 hours, coinciding with the early log phase of growth but 
decreased thereafter, dropping to negligible levels in the late log phase of 
growth. The factors involved in control of PC modification of pili during cell 
growth are currently unclear, but may play a significant role in the interaction of 
N. meningitidis with the immune system, as growth rates of the meningococcus
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may vary in different tissues within the host. Also, different capacities for PC 
expression may make strains better adapted for different environments, indeed, 
Weiser et al. tested 31 isolates from blood, cerebro-spinal fluid and throat 
cultures and found that PC expression was lower in the N. meningitidis isolates 
taken from blood compared to isolates from other sites (Weiser et al.,1998a). 
Final confirmation that CRP binding was PC specific was provided by 
competition experiments in which the addition of soluble PC inhibited CRP 
binding to meningococci in a dose-dependent fashion, with 50% inhibition 
observed at 20pM PC.
Several studies have highlighted the increase in circulating CRP levels 
during infectious disease, with CRP levels in bacteraemic patients reported as 
10-100pg/ml compared to less than 10pg/ml in non-infected controls (Gill et 
al., 1981; McCabe and Remington,1984). The saturation binding experiments 
performed in this investigation revealed that CRP binding to N. meningitidis was 
concentration-dependent, with negligible binding occurring below 1 pg/ml and 
the beginning of a plateau at 100pg/ml, well within the clinical range expected 
during a bacterial infection.
Saturation binding experiments were used to estimate the binding affinity 
of CRP for N. meningitidis (dissociation constant (Kd) = 2.18 x 10'4M). This 
binding affinity was low when compared to the affinity of CRP for PC itself 
(estimated as 1.8 x 10‘7M by capillary electrophoresis (Heegaard and 
Robey, 1993)) and for other organisms such as L  donovani, which has a Kdof 
10*11M (Culley et al., 1996). L. donovani, however, is an intracellular parasite 
which utilises the opsonic properties of CRP to increase uptake into human 
macrophages (Culley et al., 1996) without increasing activation or killing ability of 
the phagocytes (Bodman-Smith et a I.,2002a). In contrast, N. meningitidis is an 
extracellular pathogen and would not be expected to benefit from increased 
uptake into macrophages where, classically, phagocytosis results in clearance 
of the organism from the host. For this reason a lower affinity of binding is not 
unexpected for the meningococcus.
3.3.2 CRP binds to other important strains of N. meningitidis
It was considered important to determine if CRP could bind to other 
virulent strains of meningococci of serogroup B. The clinical isolate FI44/76 was 
examined for its ability to bind CRP and was shown to bind in a similar pattern
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to strain C311 throughout a 10 hour time-course of bacterial growth. PC 
expression was not measured throughout this time-course but it could be 
hypothesised that PC expression would correlate with CRP binding as seen for 
strain C311. It would be interesting to investigate a wider range of piliated 
serogroup B strains to see if the same binding pattern occurs for each, or if 
inter-strain variation causes differences in CRP binding throughout the growth- 
curve of the organism.
The availability of a virulent serogroup C strain of N. meningitidis L91534 
and a phoP knockout mutant of the strain which shows reduced virulence in 
mice (Newcombe et al.,2004) provided the opportunity to investigate if CRP 
binding could vary in strains of differing virulence. CRP was able to bind to both 
of these strains throughout the 10 hour time-course and in the second half of 
the time-course, the phoP mutant bound more CRP than the wild type with 
significantly more CRP bound by the mutant at the 8 hour time-point. The 
difference in CRP binding of wild type and phoP mutant at the 8 hour time-point 
is particularly interesting because it could mean that CRP binding is associated 
with reduced virulence in meningococci, although this speculation would of 
course need to be investigated further with many more strains.
The observed difference between CRP binding to the L91534 wild type 
and the phoP mutant could be due to the difference in individual growth rates, 
or due to differences in their expression profiles. Several genes involved in 
biogenesis of the pilus are down-regulated in the phoP mutant compared to the 
wild type when grown on blood agar for four hours (Newcombe et al.,2005) and 
the pilin phosphorylcholine transferase A (pptA) gene was also downreguiated 
by a 0.4 fold-change in the phoP mutant (JohnJoe McFadden, personal 
communication). The time-course assay in these studies utilised very different 
experimental conditions to those used in the microarray study. If, however, a 
down-regulation in pilus expression did occur in the phoP mutant during our 
assay, it would mean that the increased CRP binding would be due to increased 
PC expression, possibly by upregulation of the pptA gene, which was not 
observed in the studies by Newcombe ef al. To investigate such a theory would 
require Western blot analysis of PC and pili expression throughout the time- 
course as well as quantitative PCR analysis of the pptA and pili genes.
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3.3.3 CRP binds to live meningococci as well as fixed organism
One study of CRP binding to S. pneumoniae and other bacterial 
pathogens found that CRP bound dead streptococci significantly better than live 
streptococci (De Beaufort et a/.,1997). It was, therefore, considered important 
to examine if CRP could bind live meningococci as well as PFA-fixed 
meningococci. Due to the constraints of working with the biological hazard of 
live meningococci, a Western blot immuno-detection method was developed to 
examine CRP binding to live meningococci. This method confirmed the 
presence of pili and PC on the C311 p+ strain and their absence in the C311 p- 
strain. Minimal binding of CRP was indicated in the non-piliated strain but much 
greater CRP binding was seen for the piliated strain in the presence of calcium. 
Neither strain was shown to bind CRP in the presence of EDTA, indicating that 
binding was calcium-dependent. The small amounts of CRP detected on the 
non piliated strain could either be non-specific binding or small amounts of CRP 
binding to a non pilus-associated site on the surface of the cells.
The Western blot method was useful in confirming the piliated and PC- 
decorated phenotype of the C311p+ strain and for indicating CRP binding to 
this strain but the result was not quantitative or highly sensitive. Attempts to 
reduce non-specific binding by increasing the number of washes resulted in a 
loss of anti-CRP antibody binding in all conditions (data not shown). 
Subsequently, a quantitative assay was developed to determine CRP binding to 
live meningococci. A high sensitivity CRP ELISA was used to calculate CRP 
bound to bacteria indirectly by measuring residual CRP in the supernatants 
from several washing steps after incubation of CRP with bacteria. This method 
was validated using the positive control organism (S. pneumoniae) where the 
amount of CRP present in the cell washing supernatants from streptococci 
incubated with CRP in the presence of calcium was significantly lower than in 
supernatants from bacteria incubated with CRP in the presence of soluble PC. 
Following this proof of principle experiment, the method was used with piliated 
and non-piliated meningococci of strain C311. In these experiments, less CRP 
was detected in the supernatant of cells opsonised with CRP in the presence of 
calcium than either the EDTA or PC conditions, but these differences were not 
statistically significant due to considerable inter-assay variation. As the non- 
piliated strain does not express PC (as confirmed by FACS and Western blot 
analysis ) it would not be expected to show differences in the amount of residual
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CRP in the cell washing supernatants whether cells were opsonised with CRP 
in the presence of calcium alone, or calcium with EDTA or PC. The amount of 
CRP left in supernatants did, however, show variation but this was smaller than 
the variation between assays.
Estimating CRP bound to cells indirectly by measuring CRP 
concentration of supernatants is clearly not a robust technique. CRP could be 
lost from supernatants by sticking to the sides of tubes, or by disturbing the 
pellets during the several washing steps. A more direct method was 
subsequently developed by washing opsonised cells thoroughly then eluting 
bound CRP with EDTA and measuring eluted CRP with the CRP ELISA. This 
method detected significantly more CRP bound to the piliated strain than the 
non-piliated strain of N. meningitidis, providing further evidence that CRP can 
bind to live as well as dead meningococci.
CRP binding of live meningococci may have differing and additional 
effects to binding of dead meningococci. CRP binding to dead organisms may 
have downstream effects on antigen processing and presentation as well as on 
the clearance of bacterial debris from the body, but binding of CRP to live 
meningococci may also affect how phagocytes recognise and destroy the 
infectious organisms. The binding experiments using live N. meningitidis 
provide evidence that CRP can bind to the live meningococcus, although it was 
not possible to determine the relative affinity of binding between live and dead 
meningococci as different methods were used to measure binding in each state.
3.3.4 Conclusions
In conclusion, the development and optimisation of several methods to 
examine CRP binding to the meningococcus resulted in the development of a 
robust and quantitative microtitre plate-based method which demonstrated that 
CRP can bind to piliated, PC expressing N. meningitidis in a calcium-dependent 
manner that is specific for PC. Further investigation into the kinetics of binding 
revealed that CRP binding to the meningococcus was of relatively low affinity 
and that CRP could also bind to live organisms as well as PFA fixed unviable 
bacteria. This exciting discovery opens up many questions as to the biological 
consequences of this binding in the human response to meningococcal infection 
and those questions are the focus of the following chapters of this thesis.
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Following the discovery and characterisation of CRP binding to piliated 
meningococci, the focus of the investigation moved to the immunological 
consequences of CRP-opsonisation. These studies utilised in vitro models of 
important host defence mechanisms of the innate immune system; namely 
bactericidal serum killing and clearance of bacteria by macrophages.
Serum killing by complement activation is a defence mechanism 
characteristic of innate immunity and can also be initiated by specific antibody 
opsonisation. CRP is a soluble pattern recognition receptor which is capable of 
activating the classical complement cascade in human serum (Kaplan and 
Volanakis,1974; Siegel et al., 1974; Claus et al., 1977; Gaboriaud et al.,2003). 
CRP-dependent complement killing has been characterised for several species 
closely related to N. meningitidis including H. influenzae and commensal 
species like N. lactamica (Weiser et al., 1998b; Serino and Virji,2002). CRP- 
mediated serum killing of commensal Neisseria species directly correlates with 
expression levels of PC (Serino et al.,2002). It was, therefore, considered 
important to examine if PC on the pili of N. meningitidis resulted in increased 
CRP-mediated serum killing of this pathogenic species.
The second aim of these studies was to investigate the effect of CRP- 
opsonisation on the recognition and killing of meningococci by macrophages. 
Macrophages are important professional phagocytes that act as sentinels in the 
tissues to detect and destroy invading pathogens. The recruitment of 
macrophages to a site of infection enables defences of both innate and specific 
immunity to be activated as macrophages can phagocytose and kill the 
pathogen, secrete immuno-modulatory cytokines, and also present antigen to 
T lymphocytes in order to initiate adaptive immunity. In this chapter, the effect of 
CRP-opsonisation on recognition and killing of meningococci by macrophages is 
investigated in vitro using both human macrophage-like cell lines and monocyte- 
derived macrophages from the peripheral blood of volunteers.
4 . 1  R a t i o n a l e  a n d  a i m s
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To investigate the effect of CRP binding on the killing of meningococci by 
human serum, a modified serum-bactericidal assay was performed with and 
without pre-opsonisation of the bacteria with CRP. The effect of CRP- 
opsonisation on association of dead and live meningococci with macrophages 
was also investigated using macrophages differentiated from 2 monocyte-like 
cell lines; THP-1 & U937 as well as peripheral blood mononuclear cell (PBMC)- 
derived macrophages from healthy volunteers. The involvement of Fey receptors 
was investigated by blocking receptors with human IgG before infecting 
macrophages with non-opsonised and CRP-opsonised meningococci. The effect 
of CRP-opsonisation on adherence and invasion of macrophages by 
meningococci was also investigated using PBMC-derived macrophages.
4.2.1 CRP-opsonisation does not increase serum killing of N. meningitidis
N. meningitidis strain C311 and the non-piliated mutant C311 p- were 
prepared as per section 2.2.1 and subjected to a CRP serum-bactericidal assay 
as detailed in section 2.2.11 using complete or IgG-depleted plasma from one 
donor as described in section 2.2.10. Titration experiments revealed a final 
plasma dilution of 1 in 10 to be the highest concentration of IgG-depleted plasma 
that did not cause bacterial lysis in the absence of CRP (data not shown). This 
concentration was, therefore, used in serum-bactericidal assays. Figure 4.1 
demonstrates that despite inoculating with identical numbers of each 
meningococcal strain, fewer non-piliated bacteria survived than piliated bacteria 
in complete plasma, IgG depleted plasma and heat inactivated plasma (used as 
a negative control for bactericidal killing). This pattern occurred whether the 
bacteria were unopsonised or CRP-opsonised, although the difference was only 
statistically significant in heat-inactivated plasma (p=0.004). Pre-opsonisation 
with CRP had no effect on the bactericidal activity of complete plasma for either 
the non-piliated or piliated strain as comparable numbers of bacteria survived in 
the plasma with and without CRP. Survival of all bacteria was greater in IgG- 
depleted plasma and more comparable to the heat-inactivated control, but there 
was no effect of CRP-opsonisation on bactericidal activity in either the non- 
piliated or the piliated strain.
4 . 2  R e s u l t s
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Figure 4.1 Effect of CRP-opsonisation on the survival of non-piliated and piliated 
meningococci in complete human plasma
Non-piliated (red) and piliated (green) N. meningitidis strain C311 were opsonised with purified 
human CRP (checks) or PBS alone (plain) before incubating with complete human plasma, IgG- 
depleted plasma or heat inactivated plasma. Aliquots of culture were plated onto CBA agar to 
allow enumeration of surviving bacteria. Data are expressed as means of 3 replicate experiments 
+ standard deviation.
4.2.2 Investigating macrophage association with CRP-opsonised 
N. meningitidis using immunofluorescence
THP-1-derived macrophages were adhered to chamber slides as per 
section 2.2.3.1 and infected with paraformaldehyde-fixed CRP-opsonised or 
unopsonised meningococci to investigate the effect of CRP-opsonisation on 
association of meningococci with macrophages. After infecting, washing and 
fixing, slides were immuno-labelled with anti-meningococcal capsule antibody 
and FITC-conjugated secondary antibody (as per section 2.2.14.1) and 
examined by confocal fluorescence microscopy (as per section 2.2.14). Initial 
experiments produced high amounts of background staining with the FITC- 
conjugated secondary antibody even in the absence of bacteria. Blocking with 
heat inactivated normal human plasma before immuno-labelling was carried out 
to decrease this non-specific staining. However, as figure 4.2 demonstrates, the 
non-specific background staining remained high and the effect of CRP- 
opsonisation on association with the macrophages could not be determined.
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Figure 4.2 Immuno-labelling of N. meningitidis to examine association of CRP-opsonised 
bacteria with macrophages
Macrophages were incubated with PBS alone (a) or N. meningitidis (b), washed and stained with 
anti-capsule antibody and FITC-conjugated secondary antibody. Macrophages were stained red 
with propidium iodide. Images are from one representative experiment.
4.2.3 CRP-opsonisation increases association of Green Fluorescent 
Protein (GFP)-expressing N. meningitidis with cell line-derived 
macrophages
Dr Myron Christodoulides at the University if Southampton kindly 
provided an isolate of N. meningitidis strain H44/76 containing a plasmid for the 
expression of Green Fluorescence Protein (GFP). This plasmid was transformed 
into strain C311 (as described in section 2.2.2). GFP-expressing strain C311 
could now be visualised directly on the confocal fluorescence microscope after 
incubating with macrophages on chamber slides. This method was used to 
investigate the effect of CRP-opsonisation on association of the meningococcus 
with macrophages as per section 2.2.14.2. Figure 4.3 displays a representative 
confocal fluorescence microscope image of THP-1-derived macrophages 
incubated with non-opsonised, heat inactivated serum-opsonised and CRP- 
opsonised GFP-expressing N. meningitidis. These images demonstrate that 
fewer non-opsonised bacteria than CRP-opsonised bacteria were associated 
with macrophages and that heat inactivated serum resulted in an even greater 
association of bacteria with macrophages.
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Figure 4.3 Confocal fluorescence microscopy images of opsonised N. meningitidis 
incubated with THP-1-derived macrophages
THP-1-derived macrophages were incubated with GFP-expressing N. meningitidis opsonised 
with heat-inactivated normal human serum (a), purified human CRP (b) or PBS only (c). 
Macrophages were stained red with propidium iodide. Images are from one representative 
experiment.
Uptake experiments were replicated at least 3 times with macrophages 
differentiated from the THP-1 and U937 cell lines. For each experiment, at least 
100 macrophages in 10 randomly selected fields of view were analysed. Figure
4.4 shows that a significantly higher percentage of THP-1-derived macrophages 
co-localised with CRP-opsonised bacteria compared to non-opsonised bacteria 
(p=0.045). A significantly higher average number of bacteria per cell was 
calculated for CRP-opsonised meningococci compared to non-opsonised 
meningococci in this cell line (p =0.014). Using U937 cells, a similar pattern was 
seen with CRP-opsonisation resulting in a higher percentage of macrophages 
associating with bacteria and a higher average number of cell-associated 
bacteria per macrophage, but these differences were not statistically significant 
(p=0.48 and p=0.11 respectively).
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Figure 4.4 Association of GFP-expressing meningococcal strain C311 with cell line- 
derived macrophages
Enumeration of CRP-opsonised bacteria (red) and unopsonised bacteria (blue) co-localised with 
THP-1- and U937-derived macrophages. The percentage of macrophages associated with 
bacteria was calculated (a) as well as the mean number of adherent or intracellular bacteria per 
macrophage (b). Data are expressed as means of at least 3 replicate experiments + standard 
deviation. (* denotes a p value < 0.05, “nsd” denotes no statistical difference).
The serogroup B meningococcal strain H44/76 was also used for uptake 
assays as detailed in section 2.2.14.2. Figure 4.5 reveals that a significantly 
higher percentage of THP-1-derived macrophages were associated with CRP- 
opsonised bacteria compared to non-opsonised bacteria (p=0.032) and that a 
significantly higher level of association (bacteria per cell) was seen for CRP- 
opsonised meningococci in this cell line (p =0.03). U937 macrophages also 
demonstrated an increased percentage of macrophages associated with H44/76 
bacteria and mean number of bacteria per macrophage when meningococci 
were opsonised with CRP, but these differences were not statistically significant 
(p=0.42 and p=0.11 respectively).
THP-1 U937 THP-1 U937
Figure 4.5 Association of GFP-expressing meningococcal strain H44/76 with cell line- 
derived macrophages
CRP-opsonised (red) and unopsonised (blue) meningococci strain H44/76 were incubated with 
THP-1- and U937-derived macrophages. The percentage of macrophages associated with 
bacteria was calculated (a) as well as the mean number of adherent or intracellular bacteria per 
macrophage (b). Data are expressed as means of at least 3 replicate experiments + standard 
deviation. (* denotes a p value < 0.05, “nsd” denotes no statistical difference).
4.2.4 CRP-opsonisation increases association of GFP-expressing 
N. meningitidis with human peripheral blood-derived macrophages
Following the discovery that CRP-opsonisation increased the association 
of two GFP expressing strains of N. meningitidis with THP-1-derived 
macrophages, the method detailed in section 2.2.14.2 was used to examine the 
effect of CRP-opsonisation on the association of paraformaldehyde-fixed 
meningococci with PBMC-derived macrophages from volunteers. Figure 4.6 
displays representative fluorescence microscopy images of PBMC-derived 
macrophages incubated with bacteria that were pre-opsonised with CRP or PBS 
only. These images demonstrate that a higher number of CRP-opsonised 
meningococci were associated with the macrophages as compared to non- 
opsonised bacteria. Figure 4.7 shows that in 4 replicate experiments with 
separate donors, CRP-opsonisation significantly increased the number of 
macrophages associated with meningococci (p = 0.032) and significantly 
increased the mean number of cell-associated bacteria per macrophage 
(p=0.013) compared to PBS-opsonised meningococci.
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Figure 4.6 Confocal fluorescence microscopy images of N. meningitidis incubated with 
PBMC-derived macrophages
Representative images of PBMC-derived macrophages incubated with N. meningitidis opsonised 
with PBS only (a) or purified human CRP (b). Macrophages were stained red with propidium 
iodide.
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Figure 4.7 Association of GFP-expressing meningococci strain C311 with PBMC-derived 
macrophages
Heat inactivated serum-opsonised bacteria (red), CRP-opsonised bacteria (blue) and 
unopsonised bacteria (green) were incubated with PBMC-derived macrophages. The percentage 
of macrophages associated with bacteria was calculated (a) as well as the mean number of 
adherent or intracellular bacteria per macrophage (b). Data are expressed as means of at 4 
replicate experiments + standard deviation. (* denotes a p value < 0.05).
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Propidium iodide staining allowed the percentage of macrophages 
associated with meningococci to be enumerated but did not permit differentiation 
between cell-associated and intracellular bacteria. Therefore, in separate 
experiments, macrophage membranes were stained with the lipophilic dye 
FM646 instead of propidium iodide in order to allow Z-stacking through the depth 
of the cell to reveal the presence of intracellular bacteria (as described in 2.2.14). 
Figure 4.8 displays the results of one such experiment with several bacteria 
clearly positioned within the cell walls of the macrophage.
Figure 4.8 Internalised N. meningitidis within macrophages
Representative confocal fluorescent microscope image of PBMC-derived macrophages 
incubated with CRP-opsonised GFP-expressing meningococci. Macrophage membranes were 
stained with a fluorescent lipophilic dye post infection to enable z-stacking through the 
macrophage to reveal internalised bacteria. The arrow points to an example of meningococci 
within the macrophage cell wall.
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4.2.5 Non-adherent macrophages exhibit a small increase in association 
with meningococci when opsonised with CRP
Macrophages adhered to microscope slides may show different 
phagocytic activity to non-adhered macrophages in a liquid suspension. It was 
considered prudent, therefore, to investigate the effect of CRP-opsonisation on 
the association of paraformaldehyde-fixed meningococci with PBMC-derived 
macrophages that were removed from tissue-culture plastic surfaces with gentle 
scraping before incubating with bacteria in suspension as detailed in section
2.2.13.2. These assays revealed that although more CRP-opsonised 
meningococci were taken up by the macrophages compared with PBS- 
opsonised meningococci, the increase in association caused by CRP- 
opsonisation was not statistically significant (p=0.093, figure 4.9).
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Figure 4.9 Effect of CRP-opsonisation on association of GFP-expressing meningococci 
with macrophages in suspension
PBMC-derived macrophages were infected with CRP-opsonised (green) and PBS mock- 
opsonised (blue) GFP-expressing meningococci (GFP-Nm) or left uninfected (red). Association of 
GFP-expressing bacteria with macrophages was measured by FACS analysis of macrophages 
on the FL-1 channel. Data are expressed as the mean percentage of cells positive for bacteria 
from 4 replicate experiments + standard deviation.
104
4.2.6 Blocking of Fey receptors inhibits CRP-mediated association of 
meningococci with macrophages
Following the discovery that CRP-opsonisation increased the association 
of meningococci with macrophages adhered to chamber slides, it was decided to 
explore the mechanism of this increased association. CRP is known to increase 
uptake of opsonised cells by recruiting Fey receptors on the surface of 
phagocytes (Mortensen and Duszkiewicz,1977; Bodman-Smith etal.,2002b), 
therefore the involvement of Fey receptors in CRP-mediated association of 
paraformaldehyde-fixed meningococci with macrophages was investigated. 
PBMC-derived macrophages were pre-incubated with a range of concentrations 
of human IgG. Residual IgG was washed off before allowing phagocytosis of 
opsonised meningococci to take place. Slides were then examined by 
fluorescence microscopy as described in section 2.2.14.3.
Figure 4.10 demonstrates that PBS-opsonised meningococci were 
associated with the same percentage of macrophages regardless of the 
concentration of IgG the macrophages were pre-incubated with. There was also 
no statistical difference in the mean number of bacteria per macrophage for 
PBS-opsonised meningococci incubated with macrophages at the different IgG 
concentrations (see figure 4.10b). CRP-opsonised meningococci were co­
localised with a significantly higher percentage of macrophages and resulted in a 
higher average number of cell-associated bacteria per macrophage than PBS- 
opsonised meningococci when macrophages were not pre-incubated with IgG 
(figure 4.10 a & b, p= 0.043 & p - 0.023 respectively).
When macrophages were not pre-incubated with IgG, a higher percentage 
of macrophages were co-localised with CRP-opsonised meningococci compared 
to macrophages that had been pre-incubated with 0.1%, 1%, or 10% human IgG 
(p=0.112, p=0.049 and p=0.055 respectively). Additionally, when macrophages 
were not pre-incubated with IgG, the average number of cell-associated bacteria 
per macrophage was higher for CRP-opsonsied meningococci when compared 
to macrophages that had been pre-incubated with 0.1%, 1%, or 10% human IgG 
(p=0.021, p=0.090 and p=0.013 respectively). Thus blocking of Fey receptors 
significantly reduced CRP-mediated association of meningococci with 
macrophages.
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Figure 4.10 IgG blocking of CRP-mediated association of N. meningitidis with PBMC- 
derived macrophages
PBMC-derived macrophages were incubated with a range of concentrations of human IgG before 
washing and incubating with GFP expressing N. meningitidis strain C311 opsonised with CRP 
(red) or mock-opsonised with PBS (blue). The percent of macrophages that were found co­
localised with bacteria (a&c) were calculated alongside the mean number of cell-associated 
bacteria per macrophage (b&d). Data are expressed as mean values from 7 replicate 
experiments + standard error. (* denotes p<0.05).
4.2.7 CRP-opsonisation does not increase association of live GFP- 
expressing meningococci with THP-1-derived macrophages
Following the discovery that paraformaldehyde-fixed meningococci can 
bind CRP and that this binding causes an increase in association of the bacteria 
with monocytic cell line- and PBMC-derived macrophages and that live 
meningococci can also bind CRP, it was considered important to investigate the 
effect of CRP-opsonisation on the association of live meningococci with 
macrophages.
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Live meningococci were opsonised with CRP and incubated with THP-1 - 
derived macrophages as detailed in section 2.2.14.4. Figure 4.11 reveals that 
the percentage of macrophages associated with CRP-opsonised live 
meningococi was not different from the percentage of macrophages associated 
with PBS-opsonised meningococci (p=0.345). The mean number of cell- 
associated bacteria per macrophage was also unaffected by opsonisation with 
CRP compared to PBS alone (p=0.520). As expected, the percentage of 
macrophages associated with bacteria and the mean number of bacteria per 
macrophage for heat-inactivated serum-opsonised meningococci was greater 
than results for CRP-opsonised meningococci, although this difference was not 
statistically significant (p=0.090 and p=0.105 respectively).
Figure 4.11 Association of live GFP-expressing meningococci with THP-1-derived 
macrophages
Macrophages on chamber slides were incubated with GFP-expressing meningococci that had 
been pre-opsonised with heat-inactivated human serum (red), CRP (blue), or mock-opsonised 
with PBS alone (green). Slides were visualised on the confocal fluorescence microscope to allow 
enumeration of the percentage of macrophages colocalised with meningococci (a) and to 
calculate the mean number of cell-associated bacteria per macrophage (b). Data are presented 
as the mean of 4 replicate experiments + standard deviation.
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4.2.8 CRP-opsonisation does not increase adhesion to or invasion of 
THP-1-derived macrophages by live N. meningitidis
Confocal fluorescent microscopy of macrophages incubated with live 
meningococci revealed that CRP-opsonisation did not increase the association 
of macrophages with the bacteria. Working with live meningococci enabled the 
use of gentamicin exclusion assays to enumerate the number of viable 
intracellular bacteria as well as total numbers of cell-associated bacteria after 
incubating macrophages with CRP-opsonised meningococci as detailed in 
section 2.2.15.
It is evident from figure 4.12 that CRP-opsonisation did not increase the 
total number of bacteria both inside and adhered to macrophages or the number 
of true intracellular bacteria. It is notable, however, that even heat-inactivated 
serum did not increase adherence or phagocytosis of the bacteria in this assay, 
and overall numbers of bacteria recovered from the assay were extremely low.
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Figure 4.12 Adherence to and invasion of cell line-derived macrophages by CRP- 
opsonised meningococci
THP-1-derived macrophages were infected with live meningococci (Nm) that had been pre- 
opsonised with heat inactivated serum (red), CRP (blue) or mock-opsonised with PBS (green). 
Macrophages were washed and either lysed immediately to enumerate both intracellular and 
bound extracellular meningococci (a) or macrophages were incubated with gentamicin for 1 hour 
before lysing to enumerate intracellular meningococci only (b). Data are expressed as the mean 
values from 3 replicate experiments + standard deviation.
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4.2.9 CRP-opsonisation does not increase adhesion to or invasion of 
PBMC-derived macrophages by live N. meningitidis
Following the observation that THP-1-derived macrophages demonstrated 
poor association with serum-opsonised meningococci, the assays detailed in 
section 2.2.15 were repeated using PBMC-derived macrophages to overcome 
any peculiarities of the cell line. Figure 4.13 reveals that although the number of 
adherent and intracellular bacteria per macrophage was slightly higher overall in 
PBMC-derived macrophages compared to THP-1-derived macrophages, there 
was still no difference between the numbers of CRP-opsonised, PBS-opsonised, 
or heat-inactivated serum-opsonised meningococci adhered to or inside 
macrophages (a). The average number of intracellular CRP-opsonised 
meningococci per cell was actually lower than the average number of PBS- 
opsonised meningococci per cell, but this difference was not statistically 
significant (p=0.243).
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Figure 4.13 Adherence to and invasion of PBMC-derived macrophages by CRP-opsonised 
meningococci
PBMC-derived macrophages were infected with live meningococci (Nm) that had been pre- 
opsonised with heat-inactivated serum (red), CRP (blue) or mock-opsonised with PBS (green). 
Macrophages were washed and either lysed immediately to enumerate both intracellular and 
bound extracellular meningococci (a) or macrophages were incubated with gentamicin for 1 hour 
before lysing to enumerate intracellular meningococci only (b). Data are expressed as the mean 
values from 3 replicate experiments + standard deviation.
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4.2.10 CRP-opsonisation has no effect on intracellular killing of 
N. meningitidis within macrophages
To investigate whether CRP binding affects intracellular killing of live 
N. meningitidis by macrophages, a time-course assay of intracellular killing was 
performed on CRP-opsonised and non-opsonised meningococci. Equal numbers 
of live bacteria were incubated with macrophages for 3 hours before 
enumerating intracellular bacteria at this time point and 2 and 5 hours later as 
detailed in section 2.2.16. Figure 4.14 demonstrates that although an increased 
number of CRP-opsonised meningococci were found to be viable inside the 
macrophages at the 3 hour time-point, this difference was not statistically 
significant and the numbers of intracellular bacteria were comparable for CRP- 
opsonised and PBS-opsonised meningococci by the 5 hour time point. All 
intracellular bacteria were destroyed 8 hours after infection.
Incubation (hours)
Figure 4.14 Time-course analysis of macrophages infected with CRP-opsonised 
meningococci
CRP-opsonised (red) and unopsonised (blue) N. meningitidis (Nm) were incubated with PBMC- 
derived macrophages in 6-well plates. At regular intervals, gentamicin was added to replicate 
wells to kill extracellular bacteria. Intracellular bacteria were enumerated by lysing the cells and 
plating the lysate onto agar plates. Data are presented as mean values for 3 replicate 
experiments ± standard deviation.
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4.3  D iscuss ion
The aim of this chapter was to uncover the effect of CRP-binding on 
several innate immune defences to meningococcal infection. This was achieved 
by firstly investigating the effect of CRP-opsonisation on serum-killing of 
meningococci, followed by an exploration of the effect of CRP-opsonisation on 
the phagocytosis of dead and live N. meningitidis by macrophages.
4.3.1 N. meningitidis does not exhibit increased serum killing in the 
presence of CRP
CRP binding to commensal species of Neisseria has been reported to 
increase serum killing via activation of the complement cascade (Serino et 
al.,2002). To investigate whether CRP had a similar effect on pathogenic 
species, CRP-opsonised and non-opsonised meningococci were incubated with 
human plasma as a complement source. CRP-opsonisation had no effect on 
serum killing of pathogenic meningococci in either IgG-depleted plasma or 
complete plasma (which is likely to contain antibodies capable of binding to the 
meningococcus).
The difference in the effect of CRP binding on serum killing seen between 
pathogenic and commensal Neisseria may be due to differences in the way that 
PC is exposed on the different species. Commensal Neisseria have been shown 
to incorporate choline from growth media in order to produce PC on their LPS, 
which requires the expression of 4 genes (LicA-D) that are present in 
N. lactamica but are absent from the meningococcal genome (Serino and 
Virji,2000). Pathogenic Neisseria, conversely, only express PC on class 1 and 2 
pili but never on their LOS and expression is dependent on the gene pptA 
(Weiser et al., 1998a; Warren and Jennings,2003). In the closely related species 
H. influenzae, the PC moiety is incorporated into the LPS at different sites (on a 
chain extension from heptose III or heptose I of the LPS) and the differences in 
location have been shown to affect the level of detection by CRP and anti-PC 
antibodies in different strains and variants (Lysenko et al.,2000). The difference 
in location of PC between pathogenic and commensal Neisseria could, therefore, 
explain the difference in serum-killing effects of CRP. It could be speculated that 
PC accessible to CRP on the LPS of commensal species of Neisseria is a prime 
site for formation of the membrane attack complex (MAC), resulting in the 
formation of pores in the surface of the bacterium. In contrast, CRP binding to
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PC on the pilus of pathogenic Neisseria may be sufficient to initiate the classical 
complement cascade, but may not result in pore formation if the site on the pilus 
is remote from the bacterial cell wall or if the pilus is shed. Thus the site of the 
PC moiety on N. meningitidis would appear much better suited to the pathogenic 
nature of the meningococcus if it enables the species to escape serum killing via 
CRP and possibly, naturally occurring anti-PC antibodies.
Serum killing of both piliated and non-piliated meningococcal isolates was 
greater in complete plasma than IgG depleted plasma, probably due to the 
presence of natural and acquired anti-meningococcal antibodies that catalyse 
complement activation by binding to the C1q component of the classical 
complement cascade. Unexpectedly, however, the non-piliated mutant showed 
poorer survival than the piliated strain in all 3 types of plasma despite wells being 
inoculated with the same number of bacteria as the piliated strain. The reasons 
for the inferior survival of the non-piliated strain are unknown. Growth rates are 
comparable between the 2 strains and incubation with plasma was for 30 
minutes only, making it unlikely that the piliated strain replicated faster than the 
non-piliated mutant. The difference in survival could be due to the absence or 
presence of the pilus itself, which could have been investigated by removing pilli 
with vigorous centrifugation before incubating with plasma but as this was not the 
main focus of the investigation, the phenomenon was not studied further.
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4.3.2 CRP-opsonisation increases association of meningococci with 
macrophages
Immuno-fluorescent probing methods to visualise the uptake of 
meningococci using anti-meningococcal antibodies were marred by high 
background staining. Consequently, assays were developed using GFP- 
expressing meningococci that could be imaged on the fluorescent microscope 
without additional staining. These experiments demonstrated that CRP- 
opsonised N. meningitidis were more readily taken up by macrophages than 
unopsonised bacteria. This was the case for THP-1- and PBMC-derived 
macrophages and resulted in increases in the percent of macrophages 
associated with bacteria and the mean number of bacteria per macrophage. Due 
to the limits of the experimental procedure used, bacteria could not be confirmed 
as truly “intracellular”, thus phagocytic index was not stated in these 
experiments. Membrane staining of macrophages and z-stacking through the 
depth of the cell did, however, confirm the intracellular location of many 
meningococci.
U937-derived macrophages did not exhibit increased association with 
CRP-opsonised meningococci, possibly because of differences in the state of 
activation or expression of cell surface receptors. CRP is known to bind to Fey 
receptors FcyRI and FcyRII on both human and mouse leucocytes (Zeller et 
al.,1989; Marnell et a/.,1995; Stein et al.,2000a; Stein et al.,2000b; Bodman- 
Smith ef al.,2002b; Bodman-Smith ef a /., 2003; Bodman-Smith etal. ,2004). U937 
and THP-1 cell lines were selected for uptake experiments as they have both 
been reported to express FcyRI and FcyRII receptors (Looney etal., 1986; Fleit 
and Kobasiuk,1991; Kiener et al., 1993), but phenotypic differences obviously 
exist between different cell lines. For example, THP-1 monocytes have been 
shown to constitutively express up to four times more FcyRI than U937 cells, 
which may have an impact on CRP-mediated association with bacteria (Fleit and 
Kobasiuk,1991). In addition, the expression profile of known or putative NFkB 
target genes in response to LPS stimulation in U937 cells is much less similar 
than THP-1 cells to PBMC-derived macrophages (Sharif et al.,2007). Thus 
phenotypic differences between the two cell lines may be the reason why U937- 
derived macrophages showed no increase in association with meningococci after 
CRP-opsonisation. PBMC-derived macrophages from several donors provide the 
most relevant in vitro model for examining macrophage uptake and these cells
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demonstrated a significant increase in association with meningococci following 
opsonisation with CRP.
The effect of CRP-opsonisation on the association of N. meningitidis with 
macrophages removed from tissue culture plastic and suspended in media was 
investigated to discover if association was greater when allowed to occur in 3 
dimensions. In these experiments, 33.78 ± 13.47 percent of non-adhered 
macrophages were positive for PBS-opsonised bacteria compared to 39.68 ± 
12.76 percent of non-adhered macrophages positive for CRP-opsonised 
meningococci, but this difference was not statistically significant. Background 
bacterial co-localisation in non-adhered macrophages was higher than in 
adherent macrophages and may have made the increase caused by CRP much 
harder to detect. A positive control of heat-inactivated serum-opsonisation would 
confirm this speculation but due to limited cell numbers available, this control 
was not included in these assays. One other possible explanation is that the cell 
scraping could dislodge many of the Fey receptors that CRP may bind to for 
augmenting uptake. Staining of Fey receptors on the cells could have confirmed 
this. In future experiments, less damaging methods of detachment could be 
trialled to ensure cell surface receptors were available before incubation with 
bacteria.
CRP has been shown to increase uptake of opsonised particles and cells 
via FcyRI, and FcyRlla (Bodman-Smith et al.,2002b; Bodman-Smith et al.,2003; 
Bodman-Smith et a/.,2004). Following the discovery that CRP increased 
macrophage association with fixed meningococci, the involvement of Fey 
receptors in this association was investigated by blocking receptors with IgG. 
Purified human IgG was incubated with macrophages at a range of 
concentrations in order to block all available types of Fey receptor (although it 
follows that FcyRI receptors would have been preferentially blocked due to their 
higher affinity for monomeric IgG compared to FcyRI I). In these experiments, the 
mean percent of macrophages associated with CRP-opsonised meningococci 
decreased as the concentration of IgG that the macrophages had been 
incubated with increased, indicating that as Fey receptors are blocked, the 
opsonising effect of CRP diminishes. This suggests that CRP is indeed recruiting 
Fey receptors to facilitate the increased association of fixed N. meningitidis with 
macrophages.
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It would be interesting, in further studies, to investigate the involvement of 
each individual Fey receptor type in CRP-mediated uptake of meningococci. This 
could be achieved by antibody blockade of receptors using anti-FcyRI and anti- 
FcyRlla antibodies. Although these antibodies are commercially available, they 
are produced as whole IgG molecules which have Fc portions that would bind to 
all types of Fc receptor, not just the one targeted with the Fab2 region of the 
antibody. To overcome this, large quantities of anti-Fcy receptor antibody would 
be needed in order to pepsin-digest the Fc portion and purify the remaining Fab2 
portions. An alternative method of inactivating individual Fey receptor types to 
examine the relative involvement of each sub-class in CRP-mediated uptake of 
meningococci would be to transfect macrophages with small interfering RNA 
(siRNA) specific for each subclass to inactivate the receptors one by one.
To investigate the involvement of FcyRlla in CRP-mediated phagocytosis 
of N. meningitidis would have been particularly interesting because of the 
differences in biological activity of different alleles of this receptor. CRP has 
been shown to preferentially bind to the allelic form of the receptor that has 
arginine at position 131 (FcyRlla R131) rather than the form that has histidine at 
this position (FcyRlla H131) (Stein ef a/.,2000a). Individuals who are 
homozygous for FcyRlla R131 have increased susceptibility to bacterial 
infections including streptococcal and meningococcal disease (Bredius et 
al., 1994; Rodriguez et al., 1999; Yee et a/.,2000). It was not known which alleles 
were present in the donors used for experiments with PBMC-derived 
macrophages and haplotyping of donors may give interesting information about 
the expression profile of donors and how this may have affected CRP-mediated 
uptake.
The effect of CRP-opsonisation on macrophage phagocytosis of 
N. meningitidis was investigated in a complement-free environment. Several 
complement components act as opsonins to coat pathogens and initiate 
phagocytosis via complement receptors. Complement was deliberately excluded 
from uptake experiments so that effect of CRP alone could be measured but it is 
possible that CRP may cooperate with other opsonins to facilitate increased 
uptake of meningococci, as it has been shown to interact synergistically with 
other pattern recognition receptors in streptococcal infection (Ng etal.,2007).
This phenomenon could be investigated in the future by adding in individual 
complement proteins and examining uptake of CRP-opsonised meningococci.
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4.3.3 CRP-opsonisation does not increase association of live meningococci 
with macrophages
Uptake assays clearly demonstrated that CRP-opsonisation increases 
association of paraformaldehyde-fixed N. meningitidis with macrophages. This 
pattern was not reproducible in live meningococci which showed no significant 
increase in association with macrophages when opsonised with CRP as 
measured by fluorescent microscopy or viable counting of intracellular and 
macrophage-adhered bacteria.
It is tempting to compare association of live and fixed meningococci with 
PBMC-derived macrophages, but such a comparison is purely speculative as 
experiments were carried out on separate days and on several different donors. 
Unopsonised meningococci were actually associated with a higher percentage of 
macrophages when bacteria were live instead of dead (mean of 30.0 ± 3.05 and
21.3 ± 3.13 respectively). Whereas CRP-opsonisation caused the percentage of 
macrophages associated with dead meningococci to more than double, the 
mean number of macrophages associated with live meningococci did not 
change. When comparing the percentage of macrophages associated with 
meningococci opsonised with the positive control of heat-inactivated serum to 
unopsonised meningococci in the live and dead uptake assays, serum- 
opsonisation more than tripled the percent of macrophages associated with dead 
bacteria whereas the association of macrophages with live meningococci 
increased by just 7.5%. These findings suggest that live meningococci may be 
able to reduce the opsonic properties of both serum and CRP in some way that 
dead meningococci are incapable of doing.
Surveying the literature has not yielded any relevant information on the 
relative uptake rates of live and dead meningococci by macrophages, but it has 
been reported that another professional phagocyte, the dendritic cell exhibits 
lower uptake of live meningococci compared to dead meningococci in the 
presence of 10% foetal calf serum (Uronen-Hansson et a/.,2004). The cause of 
this decreased uptake of live meningococci is unknown, but could be due to 
changes in expression of surface molecules on the live bacterium in response to 
co-culture with macrophages. Studies on phagocytosis of the yeast 
Cryptococcus neoformans by macrophages have shown that live yeast can
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inhibit phagocytosis by macrophages, which is thought to be mediated by the 
active release of LPS or other anti-phagocytic proteins (Kozel and 
Mastroianni,1976; Luberto etal.,2003; Luo et al.,2006). Live meningococci could 
possibly employ similar defences to avoid phagocytosis by macrophages that the 
fixed meningococci are incapable of utilising.
CRP-opsonisation did not increase the number of live intracellular bacteria 
or macrophage-adhered bacteria when investigated by viable counting 
experiments. In these assays, even serum opsonisation did not significantly 
increase the number of adhered or intracellular meningococci per cell, supporting 
the hypothesis that macrophage phagocytosis is less efficient for live 
meningococci than dead meningococci. The C311 strain used in these 
experiments is a virulent, encapsulated clinical isolate. It has previously been 
shown that encapsulation protects live serogroup B meningococci from 
phagocytosis, as non-encapsulated mutants show increased adherence to 
macrophages compared to wild type encapsulated strains (Read et al., 1996).
The authors of this work postulated that the decreased adherence of the 
encapsulated strain was due to a combination of negative charge, steric 
hindrance, masking of adhesin ligands and a decrease in complement 
deposition. In the experiments detailed in this chapter, paraformaldehyde fixation 
of meningococci may have reduced the bacteria's defences to opsonisation and 
phagocytosis, and this may explain why the CRP- and serum-opsonisation 
resulted in an increase in macrophage association with dead meningococci that 
was absent in live meningococci.
To complete the investigation into the effect of CRP-opsonisation on 
phagocytosis of live meningococci, time-course assays of intracellular survival 
were performed on CRP-opsonised and non-opsonised meningococci. In these 
assays, no significant difference in the macrophage association or killing rate of 
intracellular bacteria was observed, providing further evidence that in this in vitro 
model of macrophage phagocytosis, CRP is not able to increase phagocytosis or 
cell killing of the meningococcus.
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4.3.4 Conclusions
CRP opsonisation can be a help or a hindrance to fighting an infection 
depending on the nature of the pathogen. CRP binding helps the intracellular 
parasite L. donovani to gain access to macrophages without increasing killing of 
the organism (Bodman-Smith et al.,2002a) but has been shown to increase 
uptake of live S. pneumoniae into human phagocytes and to protect mice from 
fatal infection (Mold ef a/.,1981; De Beaufort ef a/.,1997). The studies detailed in 
this chapter revealed that CRP binding increased the association of fixed 
meningococci with macrophages and indicated Fey receptors as crucial 
components of this increased association. Although unviable bacteria are of less 
danger to the host, phagocytic uptake of dead bacteria may be important in 
generating specific immune responses to surface antigens of viable 
meningococci. The investigations using live N. meningitidis did not uncover an 
increase in serum killing, macrophage association or intracellular killing of live 
CRP-bound meningococci, but it is still plausible that CRP binding to N. 
meningitidis may protect the host from meningococcal infection by less direct 
methods such as increasing the activation state of macrophages. CRP-mediated 
macrophage activation can result in changes in surface marker expression and 
increased inflammatory cytokine responses to the bacteria as is seen with CRP- 
opsonisation of S. pneumoniae (Mold and Du Clos,2006). CRP-opsonisation 
could, therefore increase the activation of macrophages in response to 
meningococci and this theory is investigated in chapter 6.
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5.1 Rational©  and a im s
Following the observation that CRP-opsonisation of paraformaldehyde-
fixed N. meningitidis caused an increase in association with macrophages that 
was inhibited by blocking Fey receptors, it was decided to investigate the effect 
of CRP-opsonisation on the association of meningococci with other phagocytic 
cells known to express Fey receptors; namely neutrophils and dendritic cells.
Granulocytes (or polymorphonuclear leucocytes) are the most numerous 
leucocytes in the blood stream, with neutrophils being the most common type of 
granulocyte. Neutrophils are short-lived but hugely active immune cells which are 
responsible for the clearance of bacteria through non-opsonic and opsonic 
phagocytosis. Neutrophils provide an important defence against meningococcal 
infection, especially in complement-deficient individuals (Ross et al., 1987; 
Schlesinger et al., 1994). They can destroy engulfed bacteria within 
phagolysosomes via the production of reactive oxygen and nitrogen species 
(ROS & RNS) and a variety of oxygen-independent enzymes and microbial 
peptides (Borregaard and Cowland,1997; Hampton eta/., 1998). Neutrophils are 
known to constitutively express FcyRI I and when activated by proinflammatory 
signals such as IFNy, can also express FcyRI (Hoffmeyer et a/.,1997). The effect 
of CRP-opsonisation on the association of meningococci with neutrophils was, 
therefore, investigated.
Neutrophils are highly efficient professional phagocytes but are classically 
short lived and do not directly present antigen to activate the specific arm of the 
immune system. Antigen presentation is not usually achieved until apoptotic 
neutrophils are phagocytosed, typically by macrophages. Dendritic cells, on the 
other hand, are highly specialised antigen presenting cells which form a link 
between innate and adaptive immunity, phagocytising pathogens in their 
immature state and maturing en-route to immune tissues to present processed 
antigens to T cells (Palucka and Banchereau,1999). Dendritic cells are the only 
antigen presenting cell capable of presenting to naTve T cells and so can initiate 
primary immune responses to previously unencountered pathogens. Dendritic 
cells can be targeted for effective vaccine delivery and inflammatory dendritic cell 
responses to N. meningitidis have been shown to be dependent on phagocytosis 
of the bacterium (Uronen-Hansson et al.,2004). If CRP could increase the uptake 
of meningococci into dendritic cells, this could affect how efficiently 
meningococcal antigens are processed and presented and would, therefore,
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modulate the specific immune response to meningococcal infection. Thus it was 
considered important to discover if CRP could increase association of 
N. meningitidis with immature dendritic cells.
5.2 R esu lts
CRP-opsonised and non-opsonised GFP-expressing paraformaldehyde- 
fixed meningococci were incubated with human peripheral blood neutrophils and 
PBMC-derived dendritic cells from volunteers which were imaged on the 
confocal fluorescent microscope. Dendritic cells were also detached from plastic 
surfaces before incubating with GFP-expressing meningococci in suspension 
and association of meningococci with these cells was measured by FACS. 
Comparisons of phagocytosis were carried out by paired Student’s t-test.
5.2.1 CRP-opsonisation increases the association o f N. meningitidis with 
neutrophils
Granulocytes were separated from volunteer blood as detailed in section
2.2.3.3 and adhered to plastic chamber slides. The separation method was 
approved for purity of cultures by giemsa-wright staining of cells which revealed 
large cells with multi-lobed nuclei. As less than 3% of granulocytes are 
eosinophils or basophils, and these cell types are poorly phagocytic, the cells in 
this assay are now referred to as neutrophils. Cells were incubated with CRP- 
opsonised or PBS-opsonised GFP-expressing meningococci and slides were 
washed and examined on the confocal fluorescent microscope as per section
2.2.14.2. Figure 5.1 displays a representative fluorescent microscope image of 
CRP-opsonised GFP-expressing meningococci colocalised with neutrophils and 
non-opsonised meningococci more sparsely associated with the neutrophils.
121
Figure 5.1 Fluorescence microscopy images of CRP-opsonised meningococci colocalised 
with neutrophils
CRP-opsonised (a) and non-opsonised meningococci (b) were incubated with peripheral-blood 
derived neutrophils in chamber slides and imaged on the confocal fluorescent microscope. Nuclei 
are stained red with propidium iodide (PI). Images are from one representative experiment.
The neutrophil uptake assay was repeated in 3 donors, enumerating cell- 
associated bacteria from 10 randomly selected fields of view in each experiment. 
Figure 5.2 reveals that significantly more neutrophils were associated with CRP- 
opsonised meningococci compared to non-opsonised meningococci (p=0.048) 
and that the average number of cell associated bacteria per neutrophil was also 
significantly higher for CRP-opsonised meningococci (p=0.013).
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Figure 5.2 Association of N. meningitidis with neutrophils
GFP-expressing N. meningitidis C311 were grown, fixed in PFA, washed and opsonised with 
CRP (red) or incubated with PBS (blue) before incubating with neutrophils adhered to plastic 
chamber slides. Slides were washed, fixed, PI stained and the percentage of neutrophils 
associated with bacteria (a) and the mean number of adherent or intracellular bacteria per 
neutrophil (b) were enumerated using the confocal fluorescence microscope. Data are expressed 
as means of 3 replicate experiments + standard deviation (* denotes a p value < 0.05).
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5.2.2 CRP-opsonisation can increase Association of meningococci with 
PBMC-derived dendritic cells
Monocytes were separated from whole human blood as per section
2.2.3.2 and adhered to plastic chamber slides. Monocytes were differentiated 
into an early dendritic cell phenotype with IL-4 and GM-CSF. Cells were 
incubated with non-opsonised or CRP-opsonised meningococci for 2 hours 
before washing and examining on the confocal fluorescent microscope as per 
section 2.2.14.2. Figure 5.3 displays a representative confocal fluorescent 
microscope image of CRP-opsonised GFP-expressing meningococci colocalised 
with dendritic cells and non-opsonised meningococci more sparsely associated 
with the dendritic cells. These monocyte-derived dendritic cells appeared 
morphologically very different from the monocyte-derived macrophages seen in 
chapter 4 when examined by light microscopy and confocal fluorescent 
microscopy.
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Figure 5.3 Fluorescence microscopy images of meningococci colocalised with PBMC- 
derived dendritic cells
CRP-opsonised (a) and non-opsonised (b) meningococci were incubated with PBMC-derived 
dendritic cells on chamber slides and imaged on the confocal fluorescent microscope. Cells were 
stained red with PI. Images are from one representative experiment.
The dendritic cell uptake assay was repeated in three donors and cell- 
associated bacteria were enumerated from 10 randomly selected fields of view in 
each experiment. Figure 5.4 displays the results of this analysis with a higher 
percentage of dendritic cells associating with meningococci opsonised with CRP 
compared to non-opsonised bacteria. The low number of donors meant that this 
difference was not statistically significant by t-test (p=0.08).
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Figure 5.4 Association of N. meningitidis with PBMC-derived dendritic cells
GFP-expressing C311 were grown, fixed in PFA, washed and opsonised with CRP (red) or 
incubated with PBS (blue) before incubating with dendritic cells (DC) adhered to plastic chamber 
slides. Slides were washed, fixed, PI stained and the percentage of dendritic cells associated 
with bacteria was enumerated. Data are expressed as means of 3 replicate experiments + 
standard deviation.
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5.2.3 CRP-opsonisation may increase Association of meningococci with 
human PBMC-derived dendritic cells released into suspension
To investigate whether dendritic cells released from plastic surfaces 
showed any difference in association with CRP-opsonised meningococci, 
dendritic cells were differentiated in 6 well tissue culture plates as per section
2.2.3.2 and released from the plate by gentle scraping. Cells were washed then 
incubated with CRP-opsonised and non-opsonised GFP-expressing 
meningococci and
10,000 cells gated by size and granularity were analysed by FACS. Figure 5.5 
displays the results of a representative experiment with association with GFP- 
expressing meningococci detected by a right shift in FL-1 fluorescence in the 
gated dendritic cell population. This figure shows that although 13.7% of 
dendritic cells were in the positive region for green fluorescence, and therefore 
positive for association with the GFP-expressing non-opsonised bacteria, 17.3% 
of dendritic cells were positive for bacteria when meningococci were pre- 
opsonised with CRP.
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Figure 5.5 Dendritic cell association with CRP-opsonised GFP-expressing N. meningitidis 
in suspension
Representative dot plots showing relative fluorescence (FITC-A, X axis) vs. size (FSC-H, Y axis) 
of dendritic cells removed from a plastic surface, following incubation with PBS alone (a), with 
non-opsonised GFP-meningococci (b) or with CRP-opsonised GFP-meningococci (c).
It was intended to repeat the dendritic cell FACS uptake assay several 
more times but this was not possible due to time constraints, thus figure 5.5 
serves as a proof of principal for the suitability of the method and as preliminary 
data to suggest that CRP may increase uptake of meningococci into dendritic 
cells in suspension.
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5.3 D iscuss ion
The aim of this chapter was to discover the effect of CRP-binding on the 
association of paraformaldehyde-fixed meningococci with important non­
macrophage phagocytes. The phagocytes of interest were the highly phagocytic 
but short lived neutrophils of the blood and the highly specialised tissue-resident 
dendritic cells which link innate and adaptive immunity.
5.3.1 CRP-opsonisation increases the association of N. meningitidis with 
neutrophils
Although antibody-mediated serum killing of N. meningitidis has long 
been held as the primary defence against meningococcal disease, the role of 
phagocytosis, and opsonophagocytosis by neutrophils in particular, has more 
recently been highlighted as having great importance, particularly with respect to 
serogroup B disease (Estabrook et a/., 1992; Bredius etal., 1994; Schlesinger et 
al., 1994). Neutrophils may be crucial for clearance of meningococci as low 
counts in sepsis patients are consistent with poor prognosis for recovery (Gedde- 
Dahl et al., 1990). Activation of neutrophils, however, is also central to the 
vascular damage and multi-organ failure seen in extreme cases of 
meningococcal sepsis (Sotto etal., 1976). Thus neutrophils can both resolve 
meningococcal infection and contribute to the pathology of sepsis.
CRP-opsonisation of piliated N. meningitidis resulted in a small but 
significant increase in association with human neutrophils. This could increase 
the efficiency with which bacteria are cleared from the site of infection, but 
because bacterial killing was not measured in this assay, it is not known if CRP- 
mediated uptake could help increase neutrophil killing of the meningococci. 
Increased phagocytosis does not always correlate with increased killing of N. 
meningitidis by neutrophils (Heyderman et al., 1999). Thus the intriguing 
possibility arises that meningococci could, under certain conditions, use 
neutrophils as a refuge during infection, although this theory requires much 
further study, including time-kill assays and measurement of reactive oxygen and 
nitrogen species production by neutrophils in response to non-opsonised and 
CRP-opsonised N. meningitidis. Encapsulated N. meningitidis is capable of 
survival and replication within THP-1- and U937-derived macrophages in 
contrast to non-capsulated mutants which do not replicate within these cells
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(Spinosa et a/.,2007), but survival of meningococci within neutrophils has not 
been confirmed in the literature. The closely related species N. gonorrhoeae has 
been shown to resist intracellular neutrophil killing and to actively replicate within 
neutrophils, even delaying apoptosis to facilitate a longer time-frame for 
replication inside the cells (Simons etal.,2005; Simons etal.,2006). To 
investigate whether N. meningitidis is capable of such activity would be of great 
interest to meningococcal research.
The CRP-mediated increase in association with meningococci was much 
smaller for neutrophils than the increase seen in macrophages (see section 
4.2.4). This difference is likely to be due to the much shorter incubation time 
used for neutrophils but may also be influenced by the scarcity of FcyRI 
receptors on neutrophils, which constitutively express FcyRI I and FcyRIII, but 
require activation for the upregulation of FcyRI expression. Additionally, CRP 
binding to FcyRlla has been shown to be dependent upon clustering of CRP 
molecules upon the surface of particles such as erythrocytes or S. pneumoniae 
(Bodman-Smith etal.,2004). It is likely, therefore, that scantily opsonised 
particles such as N. meningitidis may show poor uptake via the FcyRlla of 
neutrophils, and this could be investigated with further assays using specific 
antibody blockade of FcyRI and FcyRlla.
Priming of neutrophils in vitro with proinflammatory signals such as LPS 
has been shown to increase the uptake of meningococci (Heyderman et 
a/., 1999). Here, neutrophils were not primed, because the assay was designed 
to investigate the effect of CRP on meningococcal uptake by resting neutrophils 
and accordingly, cells were incubated with meningococci for only 20 minutes, 
immediately after separation from blood. Activated neutrophils may show a 
greater uptake of meningococci and the influence of CRP may be more, or 
indeed, less significant. The assays using resting neutrophils were designed to 
model the action of neutrophils encountering N. meningitidis early in the infection 
process. The use of activated neutrophils would better model the response of 
neutrophils summoned to the site of inflammation by signals such as LPS and 
TNFa later in the infection process. Clearly, such a model is of interest in 
uncovering the role of CRP in the response to meningococcal infection and 
should be included in further investigations.
The closely related pentaxtrin Serum amyloid P (SAP) is CRP’s 
counterpart in the mouse and has been shown to bind to N. meningitidis in vitro
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(Noursadeghi etal.,2000). Interestingly, rather than acting as an opsonin to 
increase phagocyte uptake of the organism, SAP binding of N. meningitidis 
decreases phagocytosis by neutrophils, enhancing virulence of the organism in 
the bloodstream. It is an interesting difference between CRP and SAP that 
human neutrophils display increased uptake of N. meningitidis after opsonisation 
with CRP but as these two proteins bind to different receptors, it is very possible 
that one could activate while the other down-regulates phagocytosis.
It has been shown for S. pneumoniae, that CRP-opsonisation not only 
increases uptake of bacteria into neutrophils, but also increases IL-8 production 
and oxidative burst (Rodriguez et al.,2004). The investigation into the effect of 
CRP-opsonisation on neutrophil response to meningococci was a preliminary 
exploration of association of the cells with bacteria, but could be complemented 
in the future by a more thorough analysis of neutrophil activation and bactericidal 
activity. This would include exploring the effect of CRP-opsonisation on 
meningococcal intracellular survival within neutrophils, on respiratory burst 
activation, cytokine secretion and integrin expression as well as defining the 
types of FcyR utilised in neutrophil phagocytosis of CRP-opsonised 
meningococci.
5.3.2 CRP-opsonisation can increase association of N. meningitidis with 
dendritic cells
Dendritic cells link the innate and specific immune systems by operating 
antimicrobial surveillance in non-immune sites, phagocytosing pathogens and 
maturing en-route to lymphoid organs where they can present antigen to na’fve T 
cells. Dendritic cells both initiate and guide adaptive immunity as the cytokines 
produced by antigen presenting dendritic cells, such as IL-12 or IL-10 and the 
costimulatory molecules expressed direct the development of the T cell response 
into a T helper type l, T helper type 2 or regulatory T cell response. The dendritic 
cell uptake assays detailed in this chapter indicate that CRP may be able to 
increase the uptake of N. meningitidis by immature dendritic cells, which may 
have many downstream consequences.
CRP-opsonisation has recently been shown to increase uptake of 
S. pneumoniae by dendritic cells (Thomas-Rudolph et al.,2007). That study 
demonstrated that the CRP-mediated uptake was facilitated by Fey receptors 
and led to increased antibody responses and protection when loaded dendritic
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cells were transferred into mice that were subsequently infected with virulent 
streptococci (Thomas-Rudolph ef a/.,2007). It would be interesting to discover if 
the CRP-mediated increase in association of N. meningitidis with dendritic cells 
indicated here has similar effects on activation of the cells. Phagocytic uptake of 
encapsulated meningococci by dendritic cells is classically very low, with non­
encapsulated strains showing greater adherence and uptake and reduced 
intracellular survival (Kolb-Maurer efa/.,2001; Kolb-Maurer ef a/.,2003). The 
capsule is clearly important in preventing dendritic cell detection, but phase 
variation of encapsulated strains during a meningococcal infection mean the 
capsule will not always be expressed. Several components of the outer 
membrane of N. meningitidis have been shown to activate and increase antigen 
presentation in dendritic cells, usually by upregulating the expression of MHC 
class II and the T cell costimulatory molecule CD86 on the dendritic cell surface. 
This has led to the proposal of including components such as neisserial 
adhesion molecules, very small proteoliposomes, PorA and modified 
meningococcal LPS as adjuvants in vaccines (Steeghs ef al.,2006; Bracho ef 
al.,2006; Mazzon ef al.,2007; Venier ef a/.,2007). It would be interesting to 
discover if opsonisation with CRP augments or diminishes the expression of 
these activation molecules on the dendritic cell surface in response to 
meningococci.
A recent study using human monocyte-derived dendritic cells investigated 
the effect of CRP on the differentiation, maturation and functional activities of 
dendritic cells. The study revealed that CRP (unbound to any carrier at a 
concentration of lOpg/ml) inhibited the expression of maturation markers and 
antigen presentation markers and inhibited endocytosis (Zhang ef a/.,2006). This 
inhibition of dendritic cell activity is very different from the response of dendritic 
cells to meningococci, making the prospect of discovering the effect of CRP- 
opsonised meningococci all the more attractive.
Further investigation into the effect of CRP-opsonisation on activation of 
dendritic cells will be carried out within the immunology group at the University of 
Surrey by Dr Jessica Jenson, who was a collaborator on the DC uptake assays 
included in this thesis. Following confirmatory assays of the positive effect of 
CRP-opsonisation on uptake by dendritic cells, Dr Jenson will investigate 
activation markers such as CD86 and MHC-II and cytokine production to 
examine the potential for T cell activation of CRP-meningococcal-primed
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dendritic cells. Subsequent work will include the co-culture of CRP-opsonised 
meningococci-loaded dendritic cells with T cells to examine the T cell response. 
In the preliminary assays described here, purity of dendritic cells was confirmed 
by visual inspection under the light microscope and by CD11c expression in 
FACS procedures. Future experiments will also confirm purity of dendritic cell 
cultures by FACS measurement of DC markers such as CD11c, CD80, CD83 
and CD40.
5.3.3 Conclusions
CRP-opsonisation of bacteria can increase uptake of the pathogen by Fey 
receptor-expressing cells including neutrophils and dendritic cells. Preliminary 
investigations into the effect of CRP-opsonisation on uptake of meningococci 
indicate that CRP can increase the association of the meningococcus with these 
cell types. The increased association with neutrophils may be important for 
increasing clearance of meningococci from the blood stream and at sites of 
inflammation where neutrophils are trafficked, but the effect of CRP-opsonised 
meningococci on neutrophil activation and intracellular killing has not been 
investigated. CRP-mediated dendritic cell uptake results in increased antigen 
presentation to other CRP-binding pathogens and may have similar effects with 
meningococci. Further investigation is needed to explore these possible 
consequences but the fact that CRP appears to increase the association of 
N. meningitidis with these two important phagocytes is a promising indication of 
further roles for CRP in the response to meningococcal infection.
130
C H A P T E R  S I X
T H E  E F F E C T  O F  C R P  O N  T H E  A C T I V A T I O N  
O F  M A C R O P H A G E S  B Y  
N E I S S E R I A  M E N I N G I T I D I S
1 31
6.1 Rationale and aims
The increased phagocytic association of CRP-opsonised meningococci 
with macrophages was demonstrated in chapter 4. Cross-linking of cell surface 
receptors initiated by phagocytosis transmits signals within the macrophage, 
affecting the response of that cell in terms of oxidative burst, granule release, 
cytokine release and the expression of important cell surface receptors. The 
effect of the CRP-mediated increase in uptake of meningococci on activation of 
macrophages was, therefore, investigated by measuring macrophage surface 
markers of activation and secreted inflammatory cytokines.
Cell surface markers of macrophage activation include receptors which, 
when up-regulated, may increase the efficiency of the macrophage response to 
infection. Such receptors include complement receptors (which bind and take up 
complement-coated particles), adhesion molecules (which facilitate migration of 
leucocytes to sites of inflammation and secondary immune organs), major 
histocompatabiliy complex (MHC) molecules (which aid the presentation of 
antigen to T cells), receptors that recognise pathogen-related molecular patterns 
and Fc receptors (which bind immunoglobulin-coated particles and pathogens).
In order to quantify a selection of these markers, FACS analysis was performed 
on macrophages after 24 hours incubation with CRP-opsonised and non- 
opsonised meningococci.
Inflammatory cytokines are pivotal to macrophage communication with 
other cells during infection or tissue damage. Macrophages can produce a range 
of pro- and anti-inflammatory cytokines upon contact with bacteria and other 
activating signals (such as exogenous cytokines). These cytokines can activate 
or inhibit the action of neighbouring macrophages and lymphocytes, but can also 
damage host tissues locally and systemically. In the experiments detailed in this 
chapter, cel! culture supernatants were reserved after Incubating macrophages 
with CRP-opsonised and non-opsonised meningococci in order to measure the 
levels of a range of pro- and anti-inflammatory cytokines secreted by the 
macrophages. Peak cytokine production following LPS challenge can occur 
between 1 and 48 hours after stimulation, depending on the individual cytokine 
and the concentration of LPS. Ideally, time course experiments would have 
been performed to discover the time-point of peak production of each cytokine 
tested, but as cells were being used for FACS staining experiments after 24 
hours incubation, this was not possible. In addition, collaborators at St Georges
1 3 2
Hospital, University of London have demonstrated that 24 hours is an 
appropriate time-point for monokine secretion analysis for PBMC-derived 
macrophages. In these experiments, the 24 hour time-point proved suitable for 
TNFa, IL-1 p, IL-6 and IL-10 but was less suitable for IL-8 and IL-12p70 for 
reasons that will be discussed later.
6.2 R esults
Macrophages were incubated with CRP-opsonised meningococci and 
appropriate controls in order to quantify the expression of cell surface markers of 
activation and to measure the production of inflammatory cytokines by the cells. 
These assays were originally performed using a multiplicity of infection (MOI) of 
200 bacteria per macrophage and a final CRP concentration of 5gg/ml. In these 
experiments, the high number of bacteria evoked a very large macrophage 
response and any modulatory activity of CRP was not detectable. Consequently, 
a series of experiments were performed using a much lower MOI of 10:1 and a 
final CRP concentration of lOpg/ml, which was more representative of moderate 
acute-phase levels of CRP. All data were analysed by repeated measures 
ANOVA with Tukey multiple comparison post test. P values of less than 0.05 
were considered statistically significant.
6.2.1 The effect of CRP-opsonised N. meningitidis at a high multiplicity of 
infection on activation marker expression in cell line-derived macrophages
THP-1- and U937-derived macrophages were incubated with controls and 
test treatments for 24 hours as described in section 2.2.12. The MOI was 
estimated as 200 bacteria per cell by plating out inoculum onto CBA agar before 
paraformaldehyde-fixing and counting sacrificed wells of macrophages in a 
haemocytometer. Macrophage surface markers were stained as detailed in 
section 2.2.13.2-3 and cells were examined on the BD FACScan as detailed in 
section 2.2.13. For all activation markers, 5pg/ml CRP alone had no statistically 
significant effect on either the percentage of cells positive for activation markers 
or for the mean expression of surface marker per macrophage. CD14 detection 
was minimal for both cell lines and so CD14 cell line data has been excluded 
from this analysis.
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6.2.1.1 Activation marker expression of THP-1-derived macrophages
85.4 ± 4.2 % of THP-1-derived macrophages expressed CD11b in the 
resting state (negative control) and over 77.2 ± 5.9% of positive control and 
CRP-treated cells expressed CD11b (figure 6.1a). The percentage of cells 
treated with non-opsonised N. meningitidis or CRP-opsonised N. meningitidis 
that were positive for CD11b was significantly lower than negative control cells 
(p<0.001 for both). There was a small decrease in the percentage of cells 
expressing CD11b when bacteria were opsonised with CRP compared to non- 
opsonised bacteria, but this was not statistically significant. The average 
expression of CD11b per cell, shown as mean fluorescence intensity (MFI) is 
displayed in figure 6.1b. This graph indicates that the positive control, non- 
opsonised meningococci and CRP-opsonised meningococci all reduced the 
mean CD11b expression compared to the negative control, but the differences 
were not statistically significant.
a b
Figure 6.1 Activation marker expression by THP-1-derived macrophages incubated with 
CRP-opsonised N. meningitidis
THP-1-derived macrophages were incubated with PBS (Neg), IFNy & LPS (Pos), CRP,
N. meningitidis mock-opsonised with PBS (Nm) or N. meningitidis pre-opsonised with CRP 
(Nm+CRP) for 24 hours before staining with fluorescent antibodies specific for CD11b (red), 
CD11c (blue), ICAM-1 (green) and CD64 (orange). Data are presented as percentage of cells 
positive for each marker (a) or mean fluorescence intensity of each marker (b) as means + 
standard deviation of 4 replicate experiments.
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Over 90% of all THP-1-derived macrophages were positive for CD11c 
regardless of treatment (figure 6.1a). All treatments caused an increase in the 
average CD11c expression per cell (figure 6.1b) compared to the negative 
control, but these increases were not statistically significant. The percentage of 
THP-1-derived macrophages expressing ICAM-1 was high in all conditions 
(figure 6.1a) but the average expression of ICAM-1 per cell varied with 
treatments (figure 6.1b). ICAM-1 expression in the positive control was 
significantly higher than the negative control (p<0.05). The increases in average 
ICAM-1 expression for macrophages incubated with CRP, non-opsonised 
meningococci and CRP-opsonised meningococci were not, however, statistically 
significant compared to the negative control. The percentage of THP-1-derived 
macrophages positive for CD64 expression was unaffected by the positive 
control and CRP treatments, but was significantly reduced by incubation with 
non-opsonised and CRP-opsonised meningococci (figure 6.1a, p<0.001 and 
p<0.01 respectively). Although CRP-opsonised meningococci appear to have 
caused less of a reduction in CD64 expression than non-opsonised 
meningococci, the difference was not statistically significant. Measuring the 
average CD64 expression per macrophage (figure 6.1b) revealed a reduction in 
expression caused by non-opsonised and CRP-opsonised meningococci 
compared to the negative control (both p<0.05).
In summary: the significant differences in THP-1-derived macrophage 
marker expression in response to meningococci at a high MOI were a reduction 
in CD11b and a reduction in CD64 expression.
6.2.1.2 Activation marker expression of U937-derived macrophages
Over 87% of U937-derived macrophages were positive for CD11b 
expression after every test and control treatment (figure 6.2a). The average level 
of CD11b expression per macrophage for untreated cells was significantly higher 
than the positive control cells and cells incubated with non-opsonised and CRP- 
opsonised meningococci (p<0.01, p<0.001 and p<0.001 respectively). There was 
no significant difference between the average CD11b expression per cell for 
macrophages incubated with non-opsonised and CRP-opsonised meningococci. 
A high percentage of cells were positive for CD11c in all treatments (>70% figure
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6.2a) with no significant differences in mean expression per cell between any of 
the control or test treatments (figure 6.2b).
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Figure 6.2 Activation marker expression by U937-derived macrophages incubated with 
CRP-opsonised N. meningitidis
U937-derived macrophages were incubated with PBS (Neg), IFNy & LPS (Pos), CRP,
N. meningitidis mock-opsonised with PBS (Nm) or N. meningitidis pre-opsonised with CRP 
(Nm+CRP) for 24 hours before staining with fluorescent antibodies specific for CD11b (red), 
CD11c (blue), ICAM-1 (green) and CD-64 (orange). Data are presented as percentage of cells 
positive for each marker (a) or mean fluorescence intensity of each marker (b) as means + 
standard deviation of 4 replicate experiments.
Over 90 % of U937-derived macrophages from all control and test 
treatments were positive for ICAM-1 expression (figure 6.2a). The mean 
expression of ICAM-1 per cell was significantly higher in positive control cells 
compared to negative control cells (figure 6.2b, p<0.05). ICAM-1 expression was 
non-significantly increased by CRP, non-opsonised and CRP-opsonised 
meningococci treatment of cells. The percentage of U937-derived macrophages 
positive for CD64 was greater than 73% for all control and test treatments of 
cells. The positive control treatment increased the average CD64 expression per 
cell compared to the negative control, but this increase was not statistically 
significant and there was no effect on average CD64 expression per cell for any 
of the remaining treatments compared to the negative control.
In summary: the significant difference in U937-derived macrophage 
marker expression in response to meningococci at a high MOI was a moderate 
reduction in CD11b expression.
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6.2.2 The effect of CRP-opsonised N. meningitidis at a high multiplicity of 
infection on activation marker expression in PBMC-derived macrophages
69.7 ± 10.1% of resting PBMC-derived macrophages were positive for 
CD11b expression and levels did not change with the positive control or CRP 
treatments (figure 6.3a). Treatment with non-opsonised and CRP-opsonised 
N. meningitidis, however, caused a significant decrease in the percentage of 
cells positive for CD11b compared to the untreated cells (p<0.005 for both). 
When comparing the average CD11b expression per cell between treatments, 
the only significant change in expression occurred after incubation of 
macrophages with unopsonised and CRP-opsonised meningococci (figure 6.3b, 
p<0.01 for both). Greater than 92% of all PBMC-derived macrophages were 
positive for CD11c expression and the average level of CD11c expression per 
cell did not change significantly with any of the treatments.
a b
Figure 6.3 Activation marker expression by PBMC-derived macrophages incubated with 
CRP-opsonised N. meningitidis
PBMC-derived macrophages were incubated with PBS (Neg), IFNy & LPS (Pos), CRP,
N. meningitidis mock-opsonised with PBS (Nm) or N. meningitidis pre-opsonised with CRP 
(Nm+CRP) for 24 hours before staining with fluorescent antibodies specific for CD11b (red),
CD11c (blue) and ICAM-1 (green). Data are presented as percentage of cells positive for each 
marker (a) or mean fluorescence intensity of each marker (b) as means + standard deviation of 8 
replicate experiments from separate donors.
86.3 ± 1.8% of resting PBMC-derived macrophages were positive for 
ICAM-1 expression and this value increased non-significantly to 96.6 ± 0.2% for 
positive control treated cells and no other treatments caused a significant change 
in expression compared to the negative control (figure 6.3a). Comparing the 
average ICAM-1 expression per cell, however, revealed that positive control 
treated cells expressed significantly more ICAM-1 than resting macrophages
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(figure 6.3b, p<0.01). There was no significant difference between ICAM-1 
expression in resting PBMC-derived macrophages incubated with any of the 
other treatments. No difference was observed in ICAM-1 expression in 
macrophages incubated with non-opsonised meningococci compared to 
macrophages incubated with CRP-opsonised meningococci.
Less that 50% of PBMC-derived macrophages from any treatment were 
positive for CD14 expression and there was no significant difference between the 
level of CD14 expression after any treatment compared to the negative control 
(figure 6.4a). Comparing the average expression of CD14 per cell, the positive 
control treatment caused an increase in CD14 expression that was not 
statistically significant (figure 6.4b).
Figure 6.4 Activation marker expression by PBMC-derived macrophages incubated with 
CRP-opsonised N. meningitidis
PBMC-derived macrophages were incubated with PBS (Neg), IFNy & LPS (Pos), CRP,
N. meningitidis mock-opsonised with PBS (Nm) or N. meningitidis pre-opsonised with CRP 
(Nm+CRP) for 24 hours before staining with fluorescent antibodies specific for CD14 (turquoise), 
CD64 (orange) and HLA-DR (purple). Data are presented as percentage of cells positive for each 
marker (a) or mean fluorescence intensity of each marker (b) as means + standard deviation of 8 
replicate experiments from separate donors.
The percentage of PBMC-derived macrophages expressing CD64 in the 
resting state was approximately 60%. This level of expression increased with the 
positive control treatment but the difference was not statistically significant. 
Incubation of macrophages with non-opsonised and CRP-opsonised 
meningococci caused a non-significant decrease in the percentage of cells 
positive for CD64 expression (figure 6.4a). Incubation of macrophages with 
meningococci caused a significant decrease in CD64 expression compared to 
the negative control (figure 6.4b, p<0.05).
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As PBMC-derived macrophages are a more biologically relevant model 
than cell lines, it was decided to extend the panel of markers measured to 
include antigen presentation markers. As expected of professional antigen 
presenting cells, over 73% of all PBMC-derived macrophages were positive for 
HLA-DR expression (figure 6.4a). The positive control appeared to increase the 
average level of HLA-DR expression per cell, but this increase was not 
statistically significant. Incubation with non-opsonised and CRP-opsonised 
meningococci had no effect on the level of HLA-DR expression per cell (figure 
6.4b).
In summary: the significant differences in PBMC-derived macrophage 
marker expression in response to meningococci at a high MOI were a reduction 
in CD11b and a reduction in CD64 expression.
6.2.3 The effect of CRP-opsonised N. m eningitidis at a low multiplicity of 
infection on activation marker expression in macrophages
Macrophage activation marker expression was altered by incubation with 
meningococci, but there was no difference in the response to CRP-opsonised 
meningococci compared to non-opsonised meningococci at the high MOI of 200 
bacteria per macrophage, possibly due to macrophages being overwhelmed by 
high numbers of bacteria. The assays were, therefore, repeated using a MOI of 
10 bacteria per macrophage and an increased opsonising concentration of 
100pg/ml CRP (final concentration of 10pg/ml to increase the CRP 
concentration to levels more related to moderate acute-phase levels) as detailed 
in sections 2.2.12 and 2.2.13. A new cohort of PBMC donors was recruited and a 
new batch of early-passage THP-1 cells was purchased from the European cell 
culture collection. U937 cells were not included in these experiments because of 
the poor responses observed in marker activation and bacterial association. The 
final concentration of 10pg/ml CRP had no effect on activation marker 
expression when non-aggregated CRP alone was added to the macrophages.
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81.3 ± 0.9% of resting THP-1-derived macrophages were positive for 
CD11b expression. This figure was reduced (non-significantly) after positive 
control treatments and incubation with non-opsonised and CRP-opsonised 
meningococci (figure 6.5a). The mean CD11b expression per cell decreased 
(non-significantly) with the positive control treatment but was significantly lower 
than resting macrophage expression levels when macrophages were incubated 
with non-opsonised and CRP-opsonised meningococci (figure 6.5b, p<0.01 and 
p<0.001 respectively). CD11c was highly expressed in all conditions and did not 
vary significantly in average expression per cell, as was observed in the higher 
MOI experiments (figure 6.5a and b).
6.2.3.1 A ctivation  m arker expression  o f TH P -1 -derived  m acrophages  (low
M O I)
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Figure 6.5 Activation marker expression by THP-1-derived macrophages incubated with 
CRP-opsonised N. meningitidis at a low multiplicity of infection
THP-1-dervived macrophages were incubated with PBS (Neg), IFNy & LPS (Pos), CRP,
N. meningitidis mock-opsonised with PBS (Nm) or N. meningitidis pre-opsonised with CRP 
(Nm+CRP) for 24 hours before staining with fluorescent antibodies specific for CD11b (red),
CD11c (blue) and ICAM-1 (green). Bacterial multiplicity of infection was 10:1. Data are presented 
as percentage of cells positive for each marker (a) or mean fluorescence intensity of each marker 
(b) as means + standard deviation of 5 replicate experiments.
The percentage of THP-1-derived macrophages positive for ICAM-1 
expression was significantly increased in the positive control (p<0.05) and non- 
significantly increased by incubation with non-opsonised and CRP-opsonised 
meningococci (figure 6.5a). Comparing the mean ICAM-1 expression per 
macrophage revealed that the positive control, non-opsonised and CRP- 
opsonised meningococci all significantly increased ICAM-1 expression (figure
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6.5b, p<0.001, P<0.01 and p<0.01 respectively). No difference was observed in 
the response to non-opsonised as compared with CRP-opsonised meningococci.
a b
Figure 6.6 Activation marker expression by THP-1-derived macrophages incubated with 
CRP-opsonised N. meningitidis at a low multiplicity of infection
THP-1-derived macrophages were incubated with PBS (Neg), IFNy & LPS (Pos), CRP,
N. meningitidis mock-opsonised with PBS (Nm) or N. meningitidis pre-opsonised with CRP 
(Nm+CRP) for 24 hours before staining with fluorescent antibodies specific for CD64 (orange) 
and HLA-DR (purple). Bacterial multiplicity of infection was 10:1. Data are presented as 
percentage of cells positive for each marker (a) or mean fluorescence intensity of each marker 
(b) as means + standard deviation of 5 replicate experiments.
40.1 ± 4.7% of resting THP-1-derived macrophages and 32.4 ± 8.0% of 
cells treated with LPS and IFNy were positive for CD64 expression. Incubation of 
macrophages with non-opsonised and CRP-opsonised meningococci resulted in 
a significant reduction in the percent of cells expressing CD64 to 6.7 ± 1.8% and 
4.8 ±1 .3  % respectively (figure 6.6a both p<0.001). Incubation of macrophages 
with unopsonised and CRP-opsonised meningococci also caused a significant 
reduction in the mean CD64 expression per cell (figure 6.6b, both p<0.001). The 
positive control was the only treatment to significantly increase the percentage of 
THP-1-derived macrophages positive for HLA-DR expression and the mean 
HLA-DR expression per macrophage (figure 6.6a and b). Neither non-opsonised 
nor CRP-opsonised meningococci had any effect on HLA-DR expression at this 
lower MOI.
In summary: the significant differences in THP-1-derived macrophage 
marker expression in response to meningococci at a low MOI were a reduction in 
CD11b and CD64 expression, and an increase in ICAM-1 expression.
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As observed previously using a higher MOI and lower concentration of 
CRP, both CD11b and CD11c expression were high in resting PBMC-derived 
macrophages and unchanged by any of the treatments (figure 6.7a & b). 
Although the percentage of PBMC-derived macrophages positive for ICAM-1 
expression was not significantly increased by the positive control treatment or 
incubation with non-opsonised and CRP-opsonised meningococci, the mean 
expression of ICAM-1 per macrophage was significantly increased by these 
three treatments (p<0.001 for all).
6.2 .3 .2  A ctivation  m arker expression  o f P B M C -derived  m acrophages  (low
M O I)
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Figure 6.7 Activation marker expression by PBMC-derived macrophages incubated with 
CRP-opsonised N. meningitidis at a low multiplicity of infection
PBMC-derived macrophages were incubated with PBS (Neg), IFNy & LPS (Pos), CRP,
N. meningitidis mock-opsonised with PBS (Nm) or N. meningitidis pre-opsonised with CRP 
(Nm+CRP) for 24 hours before staining with fluorescent antibodies specific for CD11b (red),
CD11c (blue) and ICAM-1 (green). Bacterial multiplicity of infection was 10:1. Data are presented 
as percentage of cells positive for each marker (a) or mean fluorescence intensity of each marker 
(b) as means + standard deviation of 8 replicate experiments.
The percentage of macrophages expressing CD14 was low in resting 
PBMC-derived macrophages and unchanged by any of the treatments (figure 
6.8a). Although incubation with non-opsonised and CRP-opsonised 
meningococci caused a slight increase in the mean expression of CD-14 per cell, 
these increases were not statistically significant (figure 6.8b). The percentage of 
PBMC-derived macrophages positive for CD64 expression was not affected by
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the positive control treatment, but was significantly decreased by incubation with 
both non-opsonised and CRP-opsonised meningococci (both p<0.05).
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Figure 6.8 Activation marker expression by PBMC-derived macrophages incubated with 
CRP-opsonised N. meningitidis at a low multiplicity of infection
PBMC-derived macrophages were incubated with PBS (Neg), IFNy & LPS (Pos), CRP,
N. meningitidis mock-opsonised with PBS (Nm) or N. meningitidis pre-opsonised with CRP 
(Nm+CRP) for 24 hours before staining with fluorescent antibodies specific for CD 14 (turquoise), 
CD64 (orange) and HLA-DR (purple). Bacterial multiplicity of infection was 10:1. Data are 
presented as percentage of cells positive for each marker (a) or mean fluorescence intensity of 
each marker (b) as means + standard deviation of 8 replicate experiments.
The mean expression of CD64 per cell was unchanged by the positive 
control treatment but significantly reduced by incubation with both non-opsonised 
and CRP-opsonised meningococci (both p<0.01). The percentage of PBMC- 
derived macrophages positive for HLA-DR expression was not significantly 
changed by any of the treatments, despite appearing to increase with positive 
control treatments (figure 6.8a). Also, no treatments significantly changed the 
mean HLA-DR expression per cell (figure 6.8b).
In summary: the significant difference in PBMC-derived macrophage 
marker expression in response to meningococci at a low MOI was a reduction in 
CD64 expression.
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Although HLA-DR expression did not significantly increase in response to 
meningococci, figures 6.8a and b indicated that HLA-DR expression by PBMC- 
derived macrophages was greater after incubation with CRP-opsonised 
meningococci compared to non-opsonised meningococci in terms of both the 
percentage of cells positive for HLA-DR expression and the mean HLA-DR 
expression per cell. However, the large inter-donor variation makes this 
difference statistically non-significant. Individual donor differences between 
HLA-DR expression on macrophages incubated with CRP-opsonised compared 
to non-opsonised meningococci were therefore examined. Figure 6.9 shows that 
5 out of 8 donors had a higher percentage of cells positive for HLA-DR 
expression and mean HLA-DR expression per cell upon incubation with the 
CRP-opsonised meningococci as compared with macrophages incubated with 
non-opsonised meningococci. This trend was not, however, statistically 
significant by paired Students t-test (p=0.255 and p=0.350 respectively).
a:
a b
Figure 6.9 HLA-DR expression by PBMC-derived macrophages incubated with CRP- 
opsonised N. meningitidis
The percentage of cells positive for HLA-DR expression (a) and mean HLA-DR expression per 
cell (b) on macrophages derived from 8 separate donors after incubation with CRP-opsonised 
N. meningitidis or non-opsonised N. meningitidis.
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6.2.4 The effect of CRP-opsonised meningococci on inflammatory cytokine 
production by macrophages infected at a high multiplicity of infection
Cell culture supernatants from all experiments detailed in sections 6.2.1-
6.2.2 were reserved. TNFa levels in aliquots of the supernatants were measured 
by in-house ELISA to allow an estimation of the dilutions required for a 
cytometric bead array (data not shown). Supernatants were then used neat and 
at a 1 in 50 dilution in a cytometric bead array, measuring a panel of 6 
inflammatory cytokines (IL-1 (3, IL-6, IL-8, IL-10, IL-12p70 and TNFa) as detailed 
in sections 2.2.17 and 2.2.18. IL-12p70 concentrations were extremely low for 
all test samples, probably because IL-12 production typically peaks within 2 
hours of inflammatory stimulation and so this data has been excluded from the 
analysis. IL-8 concentrations were often higher than the maximum detection limit 
of the assay at the dilutions used, and so IL-8 has also been excluded from 
analysis.
6.2.4.1 The effect of CRP-opsonised meningococci at high MOI on 
inflammatory cytokine production by THP-1-derived macrophages
Resting THP-1-derived macrophages produced low but detectable levels 
of TNFa. The positive control, 5pg/ml CRP and non-opsonised and CRP- 
opsonised meningococci all induced a TNFa response of over 2500pg/ml by the 
macrophages, but these increases were not statistically significant by ANOVA 
(figure 6.10a). Resting macrophages produced low levels of IL-10, with little 
response observed after incubating ceils with the positive or CRP controls. 
Incubation of macrophages with non-opsonised and CRP-opsonised 
meningococci produced a higher IL-10 response, but this increase was not 
statistically significant (figure 6.10b).
Resting THP-1-derived macrophages secreted little IL-6 and levels were 
significantly increased in the positive control (figure 6.10 c, p<0.05). CRP did not 
cause an increase in IL-6 production, but non-opsonised and CRP-opsonised 
meningococci both caused a non-significant increase, with the most IL-6 
secreted in response to non-opsonised meningococci. Resting THP-1-derived 
macrophages produced little IL-1 (3. This was increased non-significantly by the 
positive control treatment and CRP-opsonised meningococci (P>0.05, figure 
6.10d ). IL-1 (3 secretion by macrophages incubated with non-opsonised 
meningococci was significantly higher than in unstimulated cells (p<0.05).
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In summary: the statistically significant change in cytokine production by
THP-1-derived macrophages in response to meningococci at a high MOI was an 
increase in IL-1 B secretion.
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Figure 6.10 Inflammatory cytokine production by THP-1-derived macrophages in response 
to CRP-opsonised N. meningitidis at a high multiplicity of infection
THP-1-derived macrophages were incubated for 24 hours with PBS alone (red) IFNy & LPS 
(blue), 5pg/ml CRP (green) non-opsonised N. meningitidis (orange) or CRP-opsonised 
N. meningitidis (yellow) at an MOI of 200:1 before removing cell culture supernatants and 
measuring TNFa (a), IL-10 (b), IL-6 (c) and IL-1 p (d) concentrations by cytometric bead array. 
Data are represented as means of 4 replicate experiments + standard deviation.
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6.2.4.2 The effect of CRP-opsonised meningococci at high MOI on 
inflammatory cytokine production by U937-derived macrophages
Resting U937-derived macrophages secreted low levels of TNFa. 
Treatment with CRP or LPS & IFNy increased the TNFa production (statistically 
non-significant). The increase in TNFa production caused by incubation with 
non-opsonised or CRP-opsonised meningococci was, however, statistically 
significant (figure 6.11a, p<0.01 for both) but there was no difference in the 
response to non-opsonised compared to CRP-opsonised meningococci.
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Figure 6.11 Inflammatory cytokine production by U937-derived macrophages in response 
to CRP-opsonised N. meningitidis at a high multiplicity of infection
U937-derived macrophages were incubated for 24 hours with PBS alone (red) IFNy & LPS (blue), 
5pg/ml CRP (green) non-opsonised N. meningitidis (orange) or CRP-opsonised N. meningitidis 
(yellow) at an MOI of 200:1 before removing cell culture supernatants and measuring TNFa (a), 
IL-10 (b), IL-6 (c) and IL-1p (d) concentrations by cytometric bead array. Data are represented as 
means of 4 replicate experiments + standard deviation.
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Resting U937-derived macrophages produced little IL-10, with no change 
observed after incubating cells with the positive or CRP controls. Incubation of 
macrophages with non-opsonised and CRP-opsonised meningococci resulted in 
the greatest IL-10 secretion, but this increase was statistically non-significant 
(figure 6.11b).
Resting U937-derived macrophages secreted very small amounts of IL-6, 
and there was little increase in response to CRP alone. Positive control 
treatments did increase IL-6 production, as did incubation of macrophages with 
non-opsonised and CRP-opsonised meningococci (not statistically significant, 
figure 6.11c). CRP-opsonised meningococci could be capable of inducing 
greater IL-6 production than non-opsonised meningococci, but due to inter-assay 
variation, it was not possible to statistically validate this observation.
IL-1 (3 production by resting U937-derived macrophages was very low and 
increased only slightly with positive control and CRP treatments (figure 6.11d, 
not statistically significant). Incubation of macrophages with both non-opsonised 
and CRP-opsonised meningococci caused a significant increase in IL-1 p 
production (p<0.05). Although CRP-opsonised meningococci appeared to 
induce more IL-1 p production in U937-derived macrophages than non-opsonised 
meningococci, this difference was not statistically significant.
In summary: the two cytokines to be significantly up-regulated by 
incubation of U937-derived macrophages with N. meningitidis at a high MOI 
were TNFa and IL-1 (3.
6.2.4.3 The effect of CRP-opsonised meningococci at high MOI on 
inflammatory cytokine production by PBMC-derived macrophages
TNFa secretion by resting and CRP-treated PBMC-derived macrophages 
was very low but was increased (non-significantly) by the positive control, non- 
opsonised and CRP-opsonised meningococci treatments (figure 6.12a). IL-10 
production was low in resting PBMC-derived macrophages and increased non- 
significantly with positive control treatment (figure 6.12b). Incubation of PBMC- 
derived macrophages with non-opsonised and CRP-opsonised meningococci 
significantly increased IL-10 production (both p<0.05).
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Figure 6.12 Inflammatory cytokine production by PBMC-derived macrophages in response 
to CRP-opsonised N. meningitidis at a high multiplicity of infection
PBMC-derived macrophages were incubated for 24 hours with PBS alone (red) IFNy & LPS 
(blue), 5pg/ml CRP (green) non-opsonised N. meningitidis (orange) or CRP-opsonised 
N. meningitidis (yellow) at an MOI of 200:1 before removing cell culture supernatants and 
measuring TNFa (a), IL-10 (b), IL-6 (c) and IL-1 p (d) concentrations by cytometric bead array. 
Data are represented as means of 5 replicate experiments + standard deviation.
Low but detectable levels of IL-6 were secreted by resting PBMC-derived 
macrophages. Incubation of macrophages with positive control treatment and 
non-opsonised and CRP-opsonised meningococci increased IL-6 production, 
with the increases caused by the meningococci statistically significant (figure 
6.12c, p<0.05). IL-1 p production increased significantly from very low levels in 
resting macrophages to higher levels in the positive control (figure 6.12d p<0.05). 
Incubation of macrophages with non-opsonised and CRP-opsonised 
meningococci caused a smaller but still significant increase in IL-1 (3 secretion 
(p<0.05).
In summary: Incubation of PBMC-derived macrophages with 
meningococci at a high MOI resulted in an increase in the secretion of IL-10. IL-6 
and IL-13.
149
6.2.5 The effect of CRP-opsonised meningococci on inflammatory cytokine 
production by macrophages infected at a low multiplicity of infection
In order to circumvent any overloading of macrophages with bacteria and 
to test more physiologically relevant concentrations of CRP (reflecting low acute- 
phase levels of CRP that would be present in the bloodstream and tissues during 
infection): inflammatory cytokines were measured in cell culture supernatants 
from macrophages incubated with CRP-opsonised N. meningitidis at a lower 
MOI (10 bacteria per macrophage) and higher final concentration of CRP 
(10pg/ml).
6.2.5.1 The effect of CRP-opsonised meningococci at low MOI on 
inflammatory cytokine production by THP-1-derived macrophages
TNFa secretion by resting THP-1-derived macrophages was low in resting 
cells and was significantly increased in the positive control (figure 6.13a, 
p<0.001). Increasing the CRP concentration from 5pg/ml to 10pg/ml CRP had 
no effect on TNFa production in response to the CRP control. Non-opsonised 
and CRP-opsonised meningococci both stimulated a statistically significant 
increase in TNFa production (p<0.01 and p<0.001 respectively). IL-10 secretion 
was very low in resting macrophages and increased with the positive control and 
with non-opsonised and CRP-opsonised meningococci (figure 6.13 b, p<0.05, 
p<0.01 and p<0.01 respectively).
IL-6 secretion was iow in resting THP-1-derived macrophages and was 
significantly increased by the positive control, non-opsonised and CRP- 
opsonised meningococci treatments (figure 6.13c, p<0.001, p<0.05 and p<0.05 
respectively). IL-6 secretion by macrophages was unchanged by incubation with 
10pg/ml CRP. IL-1 (3 production was at low but detectable levels in resting 
THP-1-derived macrophages and was increased by the positive control 
treatment, and unaffected by incubation with 10pg/ml CRP (figure 6.13d, p<0.05 
and p>0.05 respectively). Incubation of macrophages with non-opsonised and 
CRP-opsonised meningococci caused a significant increase in IL-1 p secretion 
(p<0.05).
In summary: the cytokines to be significantly up-regulated by incubation of 
THP-1-derived macrophages with meningococci at the lower MOI were TNFa. IL- 
10 and IL-13.
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Figure 6.13 Inflammatory cytokine production by THP-1-derived macrophages in response 
to CRP-opsonised N. meningitidis at a low multiplicity of infection
THP-1-derived macrophages were incubated for 24 hours with PBS alone (red) IFNy & LPS 
(blue), 10pg/ml CRP (green) non-opsonised N. meningitidis (orange) or CRP-opsonised 
N. meningitidis (yellow) at an MOI of 10:1 before removing cell culture supernatants and 
measuring TNFa (a), IL-10 (b), IL-6 (c) and IL-1 p (d) concentrations by cytometric bead array. 
Data are represented as means of 3 replicate experiments + standard deviation.
6.2.5.2 The effect of CRP-opsonised meningococci at a low MOI on 
inflammatory cytokine production by PBMC-derived macrophages
TNFa secretion in resting PBMC-derived macrophages was very low and 
was increased by positive control treatment and incubation with non-opsonised 
and CRP-opsonised meningococci at a low MOI (figure 6.14a, p>0.05, p<0.01 
and p<0.01 respectively). There was no increase in TNFa production caused by 
incubation of macrophages with 10pg/ml CRP alone. IL-10 production was low in 
resting PBMC-derived macrophages with a small (non significant) increase 
caused by the positive control. IL-10 secretion was significantly increased by 
incubation with non-opsonised and CRP-opsonised meningococci (figure 6.14b, 
p<0.001 and p<0.001 respectively).
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Figure 6.14 Inflammatory cytokine production by PBMC-derived macrophages in response 
to CRP-opsonised N. meningitidis at a low multiplicity of infection
PBMC-derived macrophages were incubated for 24 hours with PBS alone (red) IFNy & LPS 
(blue), 10pg/ml CRP (green) non-opsonised N. meningitidis (orange) or CRP-opsonised 
N. meningitidis (yellow) at an MOI of 10:1 before removing cell culture supernatants and 
measuring TNFa (a), IL-10 (b), IL-6 (c) and IL-1 (3 (d) concentrations by cytometric bead array. 
Data are represented as means of 5 replicate experiments + standard deviation.
Low but detectable IL-6 secretion by resting donor-derived macrophages 
was non-significantly increased by the positive control treatment and significantly 
increased by incubation of macrophages with non-opsonised and CRP- 
opsonised N. meningitidis at a low MOI (figure 6.14c, p>0.05, P<0.05 and 
p<0.05 respectively). CRP at 10pg/ml did not cause any change in IL-6 
production. Low IL-1 (3 production by resting macrophages was increased by 
positive control treatments and incubation with non-opsonised and CRP- 
opsonised meningococci, with the increase in response to CRP-opsonised 
meningococci compared to the negative control being statistically significant 
(figure 6.14d, p<0.01).
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In summary: Incubation of PBMC-derived macrophages with
meningococci at a low MOI resulted in statistically significant increases in TNFa. 
IL-6 and IL-10 production and incubation with CRP-opsonised meningococci 
caused a statistically significant increase in IL-1B.
Closer scrutiny of the data for IL-10 and IL-1 (3 secretion revealed that 
although there was no significant difference in the response to CRP-opsonised 
compared to non-opsonised meningococci as measured by ANOVA, 4 out of 5 
donors produced more IL-10 in response to CRP-opsonised than non-opsonised 
meningococci (figure 6.15a) and 5 out of 5 donors produced more IL-1{3 in 
response to CRP-opsonised compared to non-opsonised meningococci (figure 
6.15b). This trend was not, however, sufficient to provide statistical significance 
by paired Students t-test (p=0.151 and p=0.123 respectively).
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Figure 6.15 IL-10 and IL-1 p production by PBMC-derived macrophages incubated with 
CRP-opsonised meningococci
Cell culture supernatants from macrophages from 5 separate donors incubated with non- 
opsonised or CRP-opsonised meningococci were measured by cytometric bead array for IL-10 
(a) and IL-1 p production (b).
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6.3 Discussion
The aim of this chapter was to explore the effects of CRP-opsonised 
N. meningitidis on the activation of human macrophages. This was achieved by 
investigating the expression of surface markers of activation and inflammatory 
cytokine production by human monocytic cell line-derived and PBMC-derived 
macrophages. Activation responses were examined after 24 hours incubation of 
macrophages with CRP-opsonised meningococci at both a high MOI (200 
bacteria per macrophage, to model a high inflammatory stimulus) and a lower 
MOI (10 bacteria per macrophage). In high MOI experiments, a final CRP 
concentration of 5pg/ml was used but this was increased to 10pg/ml in low MOI 
experiments to better represent moderately raised acute-phase levels.
6.3.1 The effect of CRP-opsonisation on surface marker expression by 
macrophages in response to N. m eningitidis
TH P-1-, U937- and PBMC-derived macrophages were incubated with 
PBS alone, IFNy and LPS, CRP alone, unopsonised N. meningitidis and CRP- 
opsonised N. meningitidis. Activation markers expressed on the surface of the 
macrophages were measured by FACS.
6.3.1.1 CD11b and CD11c expression
CD11b was expressed by resting THP-1-, U937- and PBMC-derived 
macrophages. Expression was significantly reduced by incubation with 
N. meningitidis with or without CRP-opsonisation in all three cell types during the 
high multiplicity of infection assays. At the lower multiplicity of infection, however, 
a lower percentage of THP-1-derived resting macrophages were positive for 
CD11b expression and the reduction in expression caused by N. meningitidis 
was no longer statistically significant. CD11c was expressed in a high 
percentage of all types of resting macrophage during both low and high MOI 
experiments and was unchanged by any of the treatments.
Both CD11b and CD11c co-operate individually with CD18 to form 
receptors of the p2 integrin family: complement receptor 3 (CR3, CD11b/CD18) 
and complement receptor 4 (CR4, CD11c/CD18). These receptors facilitate 
phagocytosis of particles that are opsonised with iC3b, bind to ICAM-1 on cells to 
facilitate diapedesis (Diamond et al., 1991), and bind to bacterial LPS (Wright et 
a l.,1989). The results presented here demonstrate that N. meningitidis at a MOI
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of 10 to 1 does not affect expression of these complement receptors. This finding 
is supported by the work of Mukhopadhyay et al. who demonstrated that mouse 
peritoneal macrophages incubated overnight with whole killed N. meningitidis at 
a MOI of 20:1 (twice the MOI used in the low MOI experiments presented here) 
had no effect on CR3 expression (Mukhopadhyay et a/.,2004). In contrast to this, 
at the high MOI used here, CD11b expression was down-regulated by 
N. meningitidis with or without CRP-opsonisation. This could be as a result of the 
recruitment and internalisation of complement receptors, but this seems unlikely 
because these experiments were performed in a complement-free system to 
mimic the conditions of the uptake experiments of chapter 4. Had complement 
been present, a different pattern of complement receptor expression may have 
been observed. It is possible that meningococci down-regulate macrophage 
CD11b expression in order to reduce the adhesiveness of the macrophage by 
reducing binding to integrins on cells lining the vascular walls. This hypothesis 
could be tested in the future by examining adhesion of macrophages (post 
exposure to meningococci) with epithelial cell monolayers.
CD11b in resting THP-1-derived macrophages was lower in the low MOI 
experiments than the high MOI experiments. High MOI experiments were 
performed using THP-1 cells kindly donated by Dr Fiona Green at the University 
of Surrey who brought the cell line with her from the University of Oxford. These 
cells were of unknown passage number and in the early activation marker 
experiments, the stained cells were examined using the BD FACScan flow 
cytometer. The low MOI experiments were performed several months later using 
THP-1 cells purchased from the ECCAC and used between passage numbers 5 
and 15. The stained cells were then examined on the newly purchased BD 
FACScanto flow cytometer, which may also explain the difference in MFI 
readings seen for low MOI and high MOI treated THP-1-derived macrophages. 
These differences mean that the two sets of data must be compared with 
caution. CD11b expression in PBMC-derived macrophages during the low MOI 
experiments was also lower than observed during the high MOI experiments, 
possibly due to differences in the cohort of volunteers used as both sets of 
experiments were analysed on the same BD FACScanto. In these low MOI 
PBMC-derived macrophage experiments, incubation with meningococci did not 
cause a change in the expression of CD11b.
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CD11c expression is also a useful marker for myeloid cells. A high 
percentage of CD11c positive cells indicates a high purity of PBMC-derived 
macrophages, as contaminating lymphocytes are CD11c negative. In some 
experiments, the percentage of cells positive for CD11c dropped to below 90%, 
creating the possibility that some of the activation markers and cytokines 
produced may be due to contaminating lymphocytes. By using positive selection 
of monocytes with CD14 beads, purity of the resultant macrophage population 
would be increased.
6.3.1.2 CD14 expression
CD14 expression was very low in macrophages differentiated from both 
cell lines and so these cells were not included in the analysis. Approximately 
30% of PBMC-derived macrophages were positive for CD 14, but no difference 
was seen in expression in response to any of the treatments at either the high or 
low MOI. CD14 is a monocyte marker which is down-regulated upon 
differentiation of monocytes into macrophages, thus the low level of CD14 
expression by macrophages in these assays was not unexpected. 
Meningococcal LPS binds to LPS-binding protein which can then bind to CD14, 
which lacks an intracellular signalling domain and therefore recruits toll-like 
receptor 4 (TLR4) and myeloid differentiation protein 2 (MD-2) for intracellular 
signal transduction. This can result in monocyte and macrophage production of 
pro-inflammatory cytokines such as IL-6 and IL-1 (3. In the experimental system 
presented here, CD14 was poorly detected on macrophages. It would be more 
relevant, however, to investigate CD 14 expression by monocytes in response to 
CRP-opsonised meningococci in future experiments because this interaction 
could occur in the blood phase of meningococcal infection where monocytes will 
be encountered by the bacteria alongside high acute-phase levels of CRP.
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6.3.1.3 ICAM-1 expression
The level of ICAM-1 expression in THP-1- and PBMC-derived 
macrophages was increased by the positive control treatment and by non- 
opsonised and CRP-opsonised meningococci at a low MOI. There was no 
difference between the response to non-opsonised and CRP-opsonised bacteria 
at the high MOI and expression was not significantly increased. Adhesion 
molecules, such as ICAM-1 play important roles during inflammation and injury 
by trafficking leucocytes to sites of inflammation and immune organs. ICAM-1 
has been identified as an important host molecule on epithelial cells for the 
attachment of both N. gonorrhoea and N. meningitidis and is up-regulated on 
these cells by contact with the bacteria (Jarvis et al., 1999: Robinson et al.,2004).
ICAM-1 expression is low in resting monocytes and macrophages but can 
be upregulated by TNFa and IL-1, which may have been induced in the 
macrophages in these experiments in response to the LPS and bacterial 
treatments. ICAM-1 associates with integrins during inter-cellular signal 
transduction for T cell activation and leucocyte recruitment. ICAM-1 is important 
for extravasation and diapedesis between endothelial cells to traffic phagocytes 
to appropriate tissues. The up or down regulation of ICAM-1 expression can, 
therefore, change the nature of the inflammatory response (Schleimer and 
Bochner, 1998). Up-regulation of macrophage ICAM-1 by other meningitis- 
causing pathogens is thought to increase leucocyte recruitment and thereby 
increase the inflammation of the disease (Al Numani et al. ,2003). The 
meningococcal-induced upregulation of human macrophage ICAM-1 
demonstrated here indicates a similar response in meningococcal disease which 
may lead to increased homing of macrophages as antigen presenting ceils to 
lymph nodes or as inflammatory mediators to tissues.
6.3.1.4 CD64 expression
CD64 expression in THP-1- and PBMC-derived macrophages was 
significantly down-regulated by incubation with non-opsonised and CRP- 
opsonised meningococci at both low and high MOI. In either cell type, however, 
there was no difference between the response to non-opsonised and CRP- 
opsonised meningococci. CD64 is the receptor for the Fc portion of IgG (also 
known as FcyRI) which binds monomeric IgG with the highest affinity of all Fey 
receptors. FcyRI has been demonstrated to bind free CRP with a high affinity
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when transfected into COS-7 cells, showing increased affinity of binding (30 fold) 
when the cells are co-transfected with the gamma chain on the same plasmid, 
presumably due to the increase in surface stability of the receptor molecules 
(Bodman-Smith et a l.,2002b: Rocker ef a/.,2007).
The demonstration that N. meningitidis can down regulate FcyRI on the 
surface of macrophages has important implications in the immune response to 
meningococci. The intracellular pathogen Mycobacterium tuberculosis causes a 
down regulation in IFNy-mediated CD64 expression in macrophages, facilitating 
the inhibition of innate and adaptive immune response to the pathogen 
(Nagabhushanam et a l.,2003). N. meningitidis could employ a similar strategy to 
down-regulate the immune response, but no role for CRP was observed in this 
interaction as the expression response to non-opsonised and CRP-opsonised 
meningococci was identical. Alternatively, FcyRlla instead of FcyRI could be 
interacting with CRP-opsonised particles and this marker should be explored in 
future experiments.
6.3.1.6 HLA-DR expression
HLA-DR expression in resting THP-1-derived macrophages was 
significantly up-regulated by the positive control treatment but was not affected 
by incubation with meningococci with or without CRP at either low or high MOI. 
PBMC-derived macrophages showed a much higher percentage of cells positive 
for HLA-DR expression in the resting state compared to THP-1-derived 
macrophages and in the first cohort of volunteers, no increase in expression was 
seen in response to the positive control treatment or incubation with 
meningococci at a high MOI. The PBMC-derived macrophages from the second 
cohort of volunteers had resting expression levels of HLA-DR expression lower 
than the previous cohort, which was not significantly increased by positive 
control treatment or incubation with meningococci at the low MOI.
HLA-DR is a component of the MHC-II complex of proteins and is 
upregulated by IFNy in monocytes and macrophages (Seljelid and 
Eskeland,1993). In these experiments, less than half of the THP-1 cells were 
positive for the marker and MFI was low even with the positive control treatment. 
This is not unexpected as the pre-monocyte THP-1 cell is differentiated into a 
more macrophage-like morphology by PMA treatment, but the phenotype has not 
been reported to include antigen presentation capability in the literature.
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Closer scrutiny of the PBMC-derived macrophage data revealed that, for 
the majority of donors, HLA-DR expression after incubation of macrophages with 
CRP-opsonised meningococci was greater than expression following incubation 
with non-opsonised meningococci at the low MOI. This indicates that CRP could 
induce an increased expression of HLA-DR by PBMC-derived macrophages, 
leading to enhanced antigen presentation and initiation of humoral immunity. 
Inter-donor variation is a significant impediment to obtaining statistically robust 
data from these assays. Using more donors or controlling for age, sex or recent 
infections could improve this, particularly if donors were genotyped for factors 
known to be important in response to meningococcal infection (e.g. FcyRlla 
haplotypes).
Recent work using proteoliposomes of N. meningitidis has revealed that 
these membrane vesicles can up-regulate MHC-II expression on both 
macrophages and dendritic cells as well as up regulating MHC-I, CD40, CD80, 
and CD86 and can increase the production of cytokines important in T cell 
activation (Rodriguez et a l.,2005). This was not observed in the experiments 
using whole paraformaldehyde-fixed organisms, however, as no change in 
macrophage HLA-DR expression was seen in response to meningococci. This 
data was, however, supported by studies by Mukhopadhyay et al. who observed 
that overnight incubation of mouse peritoneal macrophages with whole killed 
N. meningitidis at an MOI of 20 bacteria per macrophage had no effect on MHC- 
II expression and actually prevented the IFNy- Induced MHC-II expression seen 
in the absence of meningococci. (Mukhopadhyay et a l.,2004). These mouse 
studies also indicate that innate activation of macrophages by N. meningitidis is 
distinct from cytokine-induced activation by IFNy and that both methods of 
activation result in specific changes to the surface phenotype of the macrophage 
(Mukhopadhyay et a l.,2004). The human data presented here supports the 
hypothesis that macrophage surface markers induced by incubation with 
meningococci form a distinct phenotype from LPS and IFNy treated cells.
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6.3.2 Th e  effect o f C R P -o p so n isa tio n  on m acrophage cyto k in e  secre tio n  in 
re sp o n se  to N. meningitidis
Inflammatory cytokines were measured in cell culture supernatants from 
activation marker experiments using both cell-line- and PBMC-derived 
macrophages. TNFa, IL-10, IL-6 and IL-1 p were all induced by positive control 
treatments and by non-opsonised and CRP-opsonised N. meningitidis, but no 
differences were seen in the response to CRP-opsonised meningococci as 
compared to non-opsonised meningococci. Overall secretion of pro-inflammatory 
cytokines was very high in response to meningococci, this coupled with the lack 
of definitive CRP-opsonisation response in macrophage surface marker 
expression suggests that a high MOI could initiate an inflammatory response 
large enough to mask any modulatory effect of CRP-opsonisation. Experiments 
were, therefore, repeated with a lower MOI and a final CRP concentration more 
comparable to moderate acute phase levels at 10pg/ml. The variability of these 
assays was less pronounced in the control samples than test samples and was 
probably a result of variation in the batch cultures of N. meningitidis.
6.3.2.1 T N F a  se cre tio n
Meningococci are known to induce the secretion of high levels of 
proinflammatory cytokines such as TNFa by host cells during infection (Waage et 
al., 1987: van Deuren et al., 1995: Brandtzaeg et al.,2001). TNFa has pleiotropic 
systemic effects in the inflammatory response when produced at high levels and 
is particularly important as an early activator of other cytokines (such as IL-1 (3 
and IL-6). TNFa also stimulates the liver to produce acute phase proteins and 
the hypothalamus to produce fever-inducing prostaglandins. TNFa secretion by 
THP-1-derived and PBMC-derived macrophages was increased non-significantly 
by incubation with non-opsonised and CRP-opsonised meningococci at the high 
MOI and increased significantly in U937-derived macrophages compared to 
resting cells. In the lower MOI experiments, both meningococcal treatments 
caused a significant increase in TNFa secretion in both THP-1- and PBMC- 
derived macrophages. Although the lower MOI of meningococci induced a lower 
level of secretion of this proinflammatory cytokine, the response was less 
variable between donors. In THP-1-derived macrophages the TNFa response to 
CRP-opsonised bacteria was greater than for non-opsonised bacteria at the low
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MOI, but the difference was not statistically significant and did not occur in 
PBMC-derived macrophages.
High plasma concentrations of TNFa and IL-1 (3 are associated with high 
disease severity and mortality in meningococcal disease, because these pro- 
inflammatory cytokines induce shock and disseminated intravascular coagulation 
(Waage et a/., 1987: Waage efa/.,1987: van Deuren e ta l., 1995). A delicate 
balance exists between the pathology of high TNFa levels and poor defence of 
low TNFa levels and individuals who present a low production capacity for TNFa 
combined with a high production capacity for the anti-inflammatory cytokine IL-10 
or poor regulation of the IL-1 system have a higher risk of invasive 
meningococcal disease (Westendorp e ta l., 1995). Both multiplicities of infection 
tested here induced high levels of TNFa, greater than or comparable to those 
induced by LPS and IFNy treatment. This is consistent with the view of 
N. meningitidis as a potent stimulator of pro-inflammatory signals in the human 
host.
We might expect CRP to decrease the inflammatory TNFa response to 
N. meningitidis as it has been shown to decrease LPS-induced TNFa production 
by human alveolar macrophages (Casals e ta l. ,2003). However, this was not 
apparent from the data detailed in this chapter, possibly due to differences 
between alveolar macrophages and PBMC-derived macrophages, or more 
probably, due to the very high levels of CRP used in the alveolar macrophage 
study (125 or 250pg/ml). Testing a range of higher CRP concentrations to 
determine whether CRP is capable of immunomodulating the TNFa response of 
macrophages to meningococci should, therefore, be the goal of future 
experiments. CRP at concentrations of either 5 or 10 pg/ml had no statistically 
significant effect on TNFa secretion by macrophages. This finding is not 
concurrent with recent literature and will be discussed in section 6.3.2.5.
@.3.2.2 IL-6 secretion
The host inflammatory response to N. meningitidis is known to include 
the secretion of high levels of IL-6 and non-survivors of meningococcal disease 
have higher IL-6 levels than survivors (Vermont e ta l.,2006). IL-6 is a pluripotent 
cytokine that enhances lymphocyte maturation and alongside TNFa and IL-1 (3, 
stimulates liver hepatocytes to produce acute phase proteins such as CRP, 
fibrinogen and complement components as well as activating the hypothalamus
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to induce fever (Heinrich e ta l., 1990). In the studies detailed in this chapter, non- 
opsonised and CRP-opsonised meningococci caused a significant increase in IL- 
6 production at a high MOI in all cell types. At the low MOI, non-opsonised and 
CRP-opsonised meningococci resulted in an increase in IL-6 secretion that was 
not statistically significant in any cell type. This could indicate that higher 
numbers of meningococci will stimulate a greater pro-inflammatory cytokine 
response which is consistent with reports that bacterial load is correlated with 
severity of disease (Hackett et a/.,2002).
CRP increases inflammatory cytokine production by PBMCs in response 
to the gram positive pathogen S. pneumoniae by dramatically increasing the 
production of IL-1 (3 and IL-6 (Mold and Du Clos,2006). This increase in pro- 
inflammatory cytokine production limits bacteraemia and increases survival in 
mouse models of streptococcal infection, with the cytokines IL-6, TNFa and IL-1 (3 
identified as important components of this protection (Mold e ta l., 1981: van der et 
al., 1997). The pathogenesis of meningococcal infection is very different, 
however, primarily due to the presence of LPS in the cell wall of this Gram 
negative species. LPS, along with other cell surface components, potently 
activates the inflammatory cascade of sepsis that can result in organ failure (the 
major cause of fatality amongst meningococcal septicaemia patients). Thus, it 
would not be advantageous for the host if CRP increased the secretion of IL-6 in 
response to meningococci, and this hypothesis was supported by data from this 
chapter in which CRP did not cause a statistically significant increase in TNFa 
secretion by macrophages in response to meningococci.
Surprisingly, IL-6 secretion by U937-derived macrophages incubated with 
IFNy and LPS was approximately double the amount secreted by THP-1-derived 
macrophages in these conditions, indicating an important difference in 
inflammatory activation of these two cell types. This disparity in inflammatory 
responses between THP-1 and U937 cells has been demonstrated 
experimentally by profiling the expression of NFkB target genes by the two cell 
lines in response to LPS (Sharif et al.,2007) and care must, therefore, be taken 
in interpreting results from cell lines such as these.
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6.3.2.3 IL-1 (3 secretion
The pro-inflammatory cytokine IL-1 p is also pivotal to the acute phase 
response, enhancing the production of acute phase proteins by the liver and 
stimulating fever generation by the hypothalamus. Excessive or sustained 
production of IL-1 p during sepsis can, however, result in hypotension, multiorgan 
failure, hypoalbuminuria, and neutrophilia which contribute to the mortality of 
sepsis (Pruitt et a/., 1995). Because of the importance of this cytokine in the 
pathology of inflammatory disease, antagonists for the IL-1 receptors have been 
successfully used to treat inflammatory diseases such as arthritis (Hailegua and 
Weisman,2002). Here, incubation of macrophages with meningococci caused a 
greater increase in IL-1 (3 compared to the positive control treatments in the cell 
line-derived macrophages at the low MOI, but levels were more comparable in 
the high MOI experiments. This indicates that the lower bacterial loads were 
better at inducing IL-113 at the 24 hour time point (although this does not rule out 
an earlier peak in IL-1{3 levels at the higher MOI).
In these experiments, secretion of IL-1 (3 in response to meningococci was 
over ten times lower in PBMC-derived macrophages than in either cell line at 
both low and high MOI infections. This observation is in agreement with the 
findings of a recent transcriptomic study by Kohro et al., comparing gene 
expression in macrophages differentiated from the THP-1 cell line and PBMC- 
derived macrophages in which it was shown that IL-1 (3 was reciprocally regulated 
by differentiation in the two types of macrophage. In that study, PBMC-derived 
macrophages had reduced expression of IL-1 (3 after differentiation from 
monocytes whereas THP-1 monocytes showed an increased expression of IL-1 (3 
upon PMA-induced differentiation (Kohro e ta l.,2004). Additionally, the secretion 
of IL-1 (3 by THP-1-derived macrophages after incubation with IFNy and LPS was 
over twice the amount secreted by U937-derived macrophages. Caution must, 
therefore, be taken in extrapolating data from individual cell-lines as extreme 
reactions can be peculiarities associated with a single cell line or PMA treatment.
At the low MOI, in both THP-1- and PBMC-derived macrophages, the IL- 
1f3 response to CRP-opsonised meningococci was moderately higher than the 
response to non-opsonised meningococci but this difference was not statistically 
significant. Individual analysis of each donor, however, revealed that 5 out of 5 
donors produced more IL-1 (3 in response to CRP-opsonised meningococci as 
compared to non-opsonised meningococci, indicating that CRP could augment
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the IL-1 (3 response to meningococci. Increasing the sample size to a larger 
population of donors may reveal a statistically significant increase in IL-1 (3 
response to meningococci in the presence of CRP, which would indicate an 
increased pro-inflammatory response seen for this cytokine which was not seen 
for IL-6 or TNFa. In these experiments, free CRP did not itself initiate a 
statistically significant increase in IL-1 (3, although differently designed 
experiments have recently shown that certain concentrations of CRP can cause 
increased IL-1 p which will be discussed later (Singh et al.,2006: Nabata et 
al.,2007).
S.3.2.4 IL-10 secretion
IL-10 is largely considered to be an anti-inflammatory cytokine, originally 
known as the “cytokine synthesis inhibitory factor” because of its effects on 
inhibiting proinflammatory cytokine production and surface co-stimulatory 
molecule expression by macrophages (Moore e ta l.,2001). IL-10 secretion by 
macrophages in response to pathogens is thought to act as a negative feedback 
mechanism to limit tissue damage by downregulating the production of 
proinflammatory cytokines (De Waal Malefyt et a/.,1991). However, several 
mouse studies have indicated that IL-10 may have pro-inflammatory functions 
under certain conditions, as although systemic administration of IL-10 prevents 
type-1 diabetes in non-obese diabetic (NOD) mice, when the gene is 
transgenically expressed in the mouse pancreas, it can accelerate the onset of 
diabetes (Pennline e ta l., 1994: Hill and Sarvetnick,2002). In the studies detailed 
here, non-opsonised and CRP-opsonised meningococci caused the largest 
increase in IL-10 secretion in all cell types, but secretion by U937- and THP1- 
derived macrophages was over tenfold lower than PBMC-derived macrophages 
at both low and high MOI. Interestingly, PBMC-derived macrophages incubated 
with meningococci at the low MOI secreted approximately twice as much IL-10 
as PBMC-derived macrophages incubated with the high MOI of meningococci. 
This data indicates that the anti-inflammatory signal may be reduced by higher 
numbers of bacteria, permitting extreme inflammation during conditions of high 
bacterial load.
In PBMC-derived macrophages, a greater amount of IL-10 was induced 
by CRP-opsonised meningococci in 4 out of 5 donors as compared to levels 
induced by non-opsonised meningococci, but these differences were small and
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not statistically significant. By extending this study to a larger number of donors, 
the immunomodulatory effect of CRP on IL-10 in response to meningococci 
would be further elucidated. CRP may, therefore, have a protective role in 
reducing the damage caused by the extreme amplification of pro-inflammatory 
cytokines induced by meningococci.
Other soluble pattern recognition receptors are known to have modulatory 
effects on the inflammatory response to meningococci. MBL, for example, has 
been shown to enhance IL-10 production in response to N. meningitidis, limiting 
damage to the host, although it also increases production of the pro- 
inflammatory cytokine IL-1 (3 (Sprong et al.,2004). Inflammation is a complex 
balance between pathogen destruction and host damage, especially in the case 
of meningococcal disease. Even small changes in levels of individual cytokines 
may have a significant impact on the overall cytokine profile and subsequent 
inflammatory response. The results from these studies imply that CRP, by virtue 
of increasing the IL-10 response to meningococci, could have a role in limiting 
inflammatory damage to the host.
6.3.2.S The effect of free CRP on macrophage cytokine secretion
The studies detailed in this chapter demonstrated that free CRP at a final 
concentration of 5pg/ml or 10pg/ml did not significantly increase the secretion of 
any of the cytokines tested. Reports by other groups using azide-free, LPS-free, 
human CRP have found that free CRP can cause the secretion of relatively low 
amounts of TNFa, IL-6 and IL-1 (3 in macrophages. These studies, however, used 
different experimental designs (eg. 12.5 and 25 pg/ml CRP for 24 hours or 
5pg/ml for 12 hours) and although observed increases were statistically 
significant, they were very small (hundreds of picograms per 10 million cells) 
compared to the equivalent of tens of nanograms per 10 million PBMC-derived 
macrophages treated with positive control in the experiments detailed in this 
chapter (Singh et a l.,2006: Nabata et al.,2007). This disparity between the data 
published on CRP-stimulated cytokine production could be caused by 
differences in experimental procedures and further exploration is needed to shed 
light on this fascinating area.
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6.3.3 Further experimentation
During this investigation, the surface activation markers measured 
consisted of CD11b, CD11c, CD14, ICAM-1, HLA-DR and the FcyRI receptor 
CD64. CRP is known to bind to both FcyRI and FcyRN on monocytes and 
macrophages and FcyRII has been identified on the surface of U937- and THP- 
1-and PBMC-derived macrophages (Fleitand Kobasiuk,1991: Huang et 
al.,2000). FcyRII expression in response to CRP-bound meningococci was not 
investigated in this study because preliminary FACS staining experiments by a 
final year student supervised by myself and Dr Kikki Bodman-Smith found that 
less than 1% of THP-1-derived macrophages were positive for FcyRII staining 
either by IV.3 or FL18.26 antibodies, and this level of expression was not 
increased by IFNy activation (data not shown).
It would be very interesting to investigate the effect of CRP-opsonised 
meningococci on PBMC-derived macrophage FcyRII expression because FcyRI 
and FcyRII have both been identified as important for macrophage cytokine 
responses to CRP-bound S. pneum oniae  (Mold e ta l.,2006). In the study by Mold 
et al., CRP opsonisation increased the levels of TNFa and IL-1 (3 produced by 
human macrophages in response to S. pneumoniae, and this increase was no 
longer observed when a mutant protein of CRP that binds PC but cannot bind to 
Fey receptors was used instead of native CRP. Blockade by antibodies specific 
for either FcyRI or FcyRII both reduced the cytokine responses in those assays. 
Human macrophages express 2 types of FcyRlla allele with different affinities for 
CRP which may affect the expression response of different donors with different 
haplotypes. The study by Mold et al. also reported that individuals homozygous 
for the high affinity CRP receptor FcyRlla R-131 showed a greater cytokine 
response to CRP-opsonised streptococci than individuals homozygous for the 
lower affinity H-131 allele. It would, therefore, be appropriate to haplotype donors 
by PCR and compare the cytokine and FcyRII expression responses to CRP- 
bound meningococci in donors of different haplotype.
As CRP-opsonisation increased the association of N. meningitidis with 
macrophages, it follows that macrophages incubated with CRP-opsonised 
meningococci may contain a greater number of meningococci than macrophages 
incubated with unopsonised meningococci. The effect on macrophage activation 
marker or cytokine secretion could, at least in part, be due to the increased 
bacterial load of the macrophage rather than the properties of the bound CRP
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itself. This could be verified experimentally by normalising the bacterial load. As 
it was demonstrated that increased association of macrophages with CRP-bound 
meningococci could be reduced by blocking Fey receptors with human IgG, it 
would also be interesting to block Fey receptors on the surface of the 
macrophage before infection and to investigate the effect of reduced bacterial 
load on activation marker expression and cytokine production.
Although it was demonstrated here that CRP-opsonisation did not affect 
cytokine responses to meningococcal challenge of macrophages, pre-treatment 
of both macrophages and meningococci with CRP may provide a different 
result. Other research has shown that pre-treatment of PBMC-derived 
macrophages with 25pg/ml CRP reduces the macrophage IL-10 response to 
LPS as well as increasing the production of inflammatory cytokines IL-6 and 
TNFa (Singh et a l.,2006). This is the reverse to the experiments with CRP- 
opsonised meningococci presented here. Further work is required to determine if 
pre-treatment of macrophages with CRP as well as opsonisation with 
meningococci affects macrophage inflammatory cytokine secretion in response 
to meningococci.
Surface markers and inflammatory cytokines were quantified by flow- 
cytometry based methods in order to measure the amounts of protein produced 
by the cells. Although transcription of cytokine and receptor messenger RNA can 
be measured sensitively by quantitative-reverse-transcriptase-PCR, this does not 
necessarily correlate with protein expression. Transcriptional studies of surface 
markers and cytokines would, however, be of interest and would complement the 
data presented in this study.
Although the focus of this chapter was on surface marker expression and 
extracellular cytokine production, this is only a small component of the possible 
effects on macrophage activation. Cross-linking of Fey receptors in response to 
bacterial uptake is known to activate intracellular signalling cascades that can 
result in the production of anti-bacterial reactive oxygen and nitrogen species. 
Investigations into the effect of CRP-opsonised meningococci on macrophage 
respiratory burst activity would, therefore, be of great interest. Other important 
activation signals such as macrophage chemokines (which potently attract 
leucocytes to the site of inflammation) including macrophage inflammatory 
proteins (MIP) and macrophage chemoattractant proteins (MCP) and other 
adhesion molecules, such as macrophage adhesion molecule (MAM) should
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also be measured in further studies. Although beyond the scope of this project, it 
would also be of interest to investigate whether CRP-opsonisation of 
meningococci affects antigen presentation and T cell activation. Co-culture 
experiments of naive T cells with macrophages pre-exposed to non-opsonised 
and CRP-opsonised meningococci could reveal if CRP is capable of potentiating 
meningococcal antigen presentation by macrophages.
6.3.4 Conclusions
In conclusion, the data presented in this chapter support the theory that 
N. meningitidis can activate macrophages and initiate a proinfiammatory 
response by virtue of its pathogen-associated molecular patterns (as 
macrophages were activated in the absence of immunoglobulin or complement). 
Meningococci induced the expression of macrophage adhesion molecules and 
decreased the expression of FcyRI and CD11b (at a high MOI) as well as 
increasing production of the proinfiammatory cytokines TNFa, IL-6 and IL-p and 
moderately increasing secretion of the anti-inflammatory IL-10. These findings 
were consistent with observations in the literature surrounding the inflammatory 
response to the meningococcus.
Although CRP-opsonisation had little effect on macrophage surface 
marker and cytokine production in response to meningococci at the high MOI of 
200:1, at a lower MOI of 10:1, a specific phenotype for macrophages incubated 
with CRP-opsonised meningococci was described. This evidence suggests that 
CRP may be capable of increasing macrophage HLA-DR expression, which 
would increase the presentation of antigens and accelerate the specific immune 
response. The evidence also suggests that CRP-opsonisation may increase IL- 
10 and IL-1 (5 production in response to meningococci, although the limited 
numbers of human donors used in these experiments have not yielded 
statistically significant results for these parameters. Further investigation will 
confirm whether or not CRP-opsonisation can increase antigen presentation and 
limit the “cytokine storm” of the inflammatory response to meningococcal 
infection by dampening down some proinfiammatory cytokines and promoting a 
mild increase in anti-inflammatory cytokines, making CRP an immunomodulator 
of meningococcal disease.
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169
7.1 General discussion
Meningococcal disease remains a serious threat to the world’s population, 
with a safe, effective and broad-acting serogroup B vaccine still awaiting 
production. Despite ample research to identify meningococcal antigens as 
vaccine candidates, many mysteries still remain about the pathogenesis of 
meningococcal disease which could hold important information on how to better 
direct vaccines and treatments. Both specific and innate immunity are important 
in the response to meningococcal infection, with many innate defences provided 
by pattern recognition molecules such as CRP. The aims of this thesis were to 
define and characterise the binding of CRP to N. meningitidis and to uncover 
some of the immunological consequences of this binding in terms of cellular and 
non-cellular innate immune defences. Armed with this information, the ultimate 
aim was to determine whether CRP binding to N. meningitidis is of net benefit to 
the pathogen or to the host. This chapter summarises the progress made in 
characterising the binding between CRP and N. meningitidis and in uncovering 
the effects of this binding on serum killing, phagocyte uptake and macrophage 
activation by N. meningitidis. In light of these novel findings, future lines of 
investigation are discussed, followed by a new hypothesis on the role of CRP in 
innate immune responses to N. meningitidis.
7.1.1 Characterisation and consequences of CRP binding to 
N. m en in g itid is
These investigations have revealed that CRP binds to piliated 
N. meningitidis and that this binding is of low-affinity, calcium-dependent and 
specific for PC. The binding was characterised using paraformaldehyde-fixed 
meningococci and was also shown to occur with live meningococci. As predicted, 
CRP binding to the fixed organism resulted in a significantly increased 
association of the meningococcus with macrophages and neutrophils. In 
preliminary investigations, CRP-opsonisation also increased the association of 
meningococci with dendritic cells. Fey receptors were implicated in the increased 
association of bacteria with macrophages, because blocking of Fey receptors 
abrogated the CRP-mediated association with the meningococci. In contrast to 
this, CRP opsonisation of live meningococci did not increase association of 
meningococci with macrophages and preliminary studies indicated that there 
was no effect on killing of the bacteria within the macrophage. This suggests that
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CRP binding of N. meningitidis may not directly facilitate an increased clearance 
of live meningococci by phagocytes during an infection, but that does not rule out 
other methods of increasing immune protection such as activation of the 
macrophages’ inflammatory and antigen presentation responses.
CRP-opsonisation had no effect on complement-mediated killing of 
N. meningitidis either in the presence or absence of IgG. These results were a 
little surprising given that commensal species of Neisseria, which express PC on 
their LPS are known to exhibit increased serum killing in the presence of CRP, 
with a direct correlation between increased PC expression and increased CRP- 
mediated serum killing (Serino and Virji,2002). The fact that PC on the pilus of 
the meningococcus does not facilitate CRP-mediated serum killing may be a 
useful survival strategy for the pathogen. PC is obviously an important molecule 
for bacteria inhabiting the human respiratory tract (as it is present on the surface 
of many species that colonise the area) but PC is a target for both bactericidal 
antibodies and CRP. In fact, the immunogenicity of this moiety has led to the 
suggestion of incorporating PC in potential broad-spectrum vaccines against PC- 
expressing respiratory pathogens such as N. meningitidis, H.influenzae and 
S. pneumoniae (Bay et al., 2004). The fact that N. meningitidis is not subject to 
the increased serum-killing by CRP that commensals experience is yet another 
important difference between closely related species of different pathogenicity. It 
is tempting to speculate that the location of PC on the pilus, remote from the 
bacterial cell wall and the low avidity of the binding interaction are the causal 
factors which prevent CRP-mediated complement fixation resulting in MAC 
formation and bacterial lysis of N. meningitidis. It could, however, transpire that 
CRP bound to PC on the pilus can recruit the first components of the 
complement cascade, but that activation is not sufficient for full MAC formation 
(as binding of individual complement components was not examined in the 
serum killing studies).
The investigation into the activation of macrophages incubated with CRP- 
opsonised N. meningitidis at a MOI of 10 bacteria per macrophage indicated that 
CRP-opsonisation may modulate the response of macrophages to the 
meningococcus. In particular, HLA-DR expression could increase with CRP- 
opsonisation of N. meningitidis, which if confirmed, would mean that CRP can 
increase meningococcal antigen presentation by macrophages. The implications 
of this theory are that CRP could potentiate the specific immune response to
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meningococcal antigens by increasing presentation of antigen to T cells which 
could, in turn, stimulate the production of bactericidal antibodies from specific B 
cells, leading to a more rapid adaptive response.
Macrophage studies also indicated a possible CRP-specific phenotype for 
cytokine production in response to meningococci. IL-10 secretion in response to 
meningococci by macrophages from the majority of donors was increased by 
CRP-opsonisation of the bacteria (not statistically significant). Meningococcal 
sepsis is characterised by high levels of inflammation which can lead to vascular 
coagulation and organ damage. If the pattern seen for PBMC-derived 
macrophages in these assays were to continue in a larger population study, it 
would indicate that CRP can modulate the inflammatory response to 
meningococci by increasing macrophage production of this predominantly anti­
inflammatory cytokine. This suggests that CRP is working to limit damage to the 
host, caused by the “cytokine storm” as IL-10 works as a negative feedback 
stimulus, targeting local cells to reduce their production of pro-infiammatory 
cytokines such as TNFa, 11-1, IL-6 and IL-8.
In contrast to this possible anti-inflammatory effect, CRP-opsonisation 
also caused a trend towards increase in IL-1 p production by macrophages in 
response to meningococci (not statistically significant). A larger population study 
may overcome the issues of inter-donor variation to confirm the correlation 
between CRP-opsonisation and increased IL-1 p production. Such a pattern 
would mean that CRP binding to the meningococcus may also direct 
inflammation by increasing IL-1 (3, a cytokine known to augment the acute phase 
response by recruiting neutrophils and monocytes to the site of infection and to 
increase production of CRP by the liver (Zhang et al., 1995). A CRP-mediated 
increase in IL-1 (3 production by macrophages in response to meningococci would 
be concurrent with findings for the gram positive bacteria S. pneumoniae, which 
causes greater macrophage IL-1 (3 production when opsonised by CRP (Mold 
and Du Clos,2006). Further investigation is needed to confirm the net effect of 
CRP-opsonisation on the inflammatory cytokine response of macrophages to 
meningococci.
Preliminary studies indicated that CRP-opsonisation can increase 
association of meningococci with both neutrophils and dendritic cells.
Neutrophils play pivotal roles in fighting blood infections such as meningococcal 
septicaemia because they are the most numerous leucocytes of the blood and
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are unparalleled in their killing ability for phagocytosed pathogens. The study did 
not include an investigation into neutrophil activation or intracellular killing, but 
the CRP-mediated increased association of meningococci with these cells 
suggests that increased bactericidal killing may occur, dependent on the ability of 
the meningococcus to survive within the neutrophil. Despite recent work 
highlighting the importance of the meningococcal capsule in promoting 
intracellular survival of N. meningitidis within macrophages and non-phagocytic 
cells (Spinosa et al.,2007), there is little literature reporting survival of N. 
meningitidis within neutrophils. It has been observed, however, that some 
strains are better at evading neutrophil killing than others (Estabrook et al., 1992). 
There is also much evidence that the closely related species N. gonorrhoeae can 
survive, and even replicate within neutrophils (Casey et al., 1979; Parsons et 
al., 1981; Casey e ta l., 1986; Simons et al., 2005), thus the effect of CRP- 
opsonisation on intracellular killing of N. meningitidis deserves further study.
Dendritic cells exhibited a moderate increase in association with 
paraformaldehyde-fixed meningococci when opsonised by CRP in preliminary 
experiments. Dendritic cells have received much attention in meningococcal 
research because of their important role in orchestrating specific immune 
responses to meningococcal antigens, much needed in the development of 
efficacious vaccines against serogroup B disease. Human CRP has recently 
been shown to increase uptake of opsonised S. pneumoniae by murine dendritic 
cells. Furthermore it increased antigen presentation and subsequent memory 
IgG responses to streptococcal antigens in recipient mice, which were then 
protected from subsequent challenge with virulent streptococci (Thomas- 
Rudolph et al.,2007). It is possible that CRP-mediated uptake of N. meningitidis 
by dendritic cells could afford similar increases in meningococcal antigen 
presentation. This would, in turn, mean that CRP could increase antibody 
responses to meningococcal antigens and would, therefore, be considered highly 
useful in protecting the host from meningococcal infection.
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7 .1 .2  F u r th e r  a v e n u e s  o f  in v e s t ig a t io n
These studies into the effects of CRP binding to N. meningitidis on 
immune responses to meningococcal infection have led to many potential 
avenues of further investigation. Several ideas have been discussed at the end 
of chapters 3 to 6 but additional lines of investigation will now be explored.
Firstly, the majority of assays in these investigations utilised 
paraformaldehyde-fixed meningococci to overcome the variation of working with 
live cultures and to allow techniques to be employed outside of containment level 
2* facilities. Although it was confirmed that CRP was able to bind to live 
meningococci as well as fixed cells, the affinity of the interaction with live 
organisms has not been characterised and preliminary experiments indicated 
that the CRP-mediated increase in association of fixed meningococci with 
macrophages was not repeated by live meningococci. It would be appropriate to 
determine the effects of CRP-opsonisation on macrophage activation by live 
bacteria, uncovering useful information on how macrophages respond 
differentially to live and dead meningococcal cells. Studies into the effects of 
CRP-opsonised fixed meningococci are still relevant to infection because despite 
being inert, dead meningococci can activate inflammation by LPS and other 
surface structures. Perhaps even more importantly, these surface structures may 
be useful targets for antibody responses to live meningococci.
Marked differences were observed in macrophage responses to CRP- 
opsonised N. meningitidis at an MOI of 200 bacteria per macrophage when 
compared to a lower MOI of 10 bacteria per macrophage, both in terms of the 
activation markers expressed and cytokines secreted. It was not possible to 
determine from these experiments whether these differences were due to the 
higher CRP concentration or the lower number of bacteria used in the lower MOI 
experiments. If more time and resources were available, the assays would have 
been repeated changing only one variable at a time. Experiments with the 
closely related N. gonorrhoeae have shown that changing the dose of bacteria 
from 10 bacteria per macrophage to 0.1 bacteria per macrophage diminishes 
TNFa production whilst maintaining IL-8 production by monocytes, thus MOI can 
have a considerable impact on leucocyte responses to pathogenic Neisseria 
(Patrone et a l.,2006). It would be interesting to examine activation marker and 
cytokine secretion by macrophages incubated with non-opsonised and CRP- 
opsonised meningococci at a range of lower multiplicities of infection to
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investigate whether an even lower MOI could stimulate a greater contrast in the 
macrophage response to meningococci opsonised with a range of 
concentrations of CRP.
Fey receptors were implicated in the CRP-mediated increased association 
of meningococci with phagocytes, but the relative roles of each receptor type 
have not yet been investigated. FcyRI and FcyRII are both known to mediate 
uptake of bacteria into phagocytes and could be separately inactivated by 
antibody blockade or specific small interfering RNA (siRNA) inactivation of 
receptor genes to study the relative importance in each receptor type. An 
alternative strategy would be to transfect Fey receptors into cell lines that do not 
normally express these receptors, such as COS cells which were used in 
previous studies to investigate the phagocytic uptake of CRP-opsonised 
erythrocytes (Bodman-Smith et a l.,2004). These methods could be employed in 
order to discover which receptor or receptors are crucial for the CRP-mediated 
uptake of meningococci.
A better understanding of the involvement of Fey receptors in the uptake 
of CRP-bound meningococci may also lead to related studies examining the 
effect of CRP-opsonisation of meningococci on the invasion of Fcy-expressing 
non-phagocytic cells, such as airway epithelial cells (Salik et a/., 1999). Epithelial 
cells of the mucosa are sites of pathogen invasion and are also considered to 
have a function in antigen sampling to stimulate local T cells (Oei et a/.,2004). 
CRP is known to be present in the respiratory epithelium and secreted by 
epithelial cells (Gould and Weiser,2001). It would, therefore, be highly relevant to 
discover if CRP-opsonisation increased uptake of meningococci into epithelial 
cells in vitro. Conversely, CRP-opsonisation may result in decreased uptake of 
meningococci by epithelial cells due to masking of other important ligands for 
initial attachment, such as the pilus tip adhesin PilC which is thought to bind to 
CD46 on host cells (Kallstrom et al., 1997). It is also possible that N. meningitidis 
may utilise the PC present on its pilus for attachment, as has been reported for 
other PC-expressing pathogens of the respiratory tract. PC on the surface of 
S. pneumoniae and H. influenzae, for example is a known ligand for the receptor 
for platelet activating factor rPAF on the surface of epithelial cells (Cundeil et 
al., 1995; Swords et al.,2000). Attachment of these two species to respiratory 
epithelial cells is inhibited by CRP by masking the PC epitopes on the surface of 
the organisms (Gould and Weiser,2002) and this could be relevant to
175
N. meningitidis attachment. Interestingly, the study by Gould and Weiser 
reported that CRP was unable to diminish attachment of either species to 
epithelial cells in the presence of lung surfactant, which is common in the 
terminal airways. This suggests that CRP may not protect against pathogen 
attachment in this area of the respiratory tract, affording an advantage for 
invasion at this site.
CRP opsonisation increased association of meningococci with 
neutrophils, and various functions of neutrophils that could be examined with 
respect to activation by CRP-opsonised meningococci were discussed in chapter 
5. In addition to increasing bactericidal activity, neutrophil activation contributes 
to the vascular damage and multi-organ failure associated with severe 
meningococcal sepsis. CRP has been indicated as an immunomodulator of 
inflammatory activation of neutrophils, with high acute phase levels of CRP 
tending to down regulate neutrophil activation and limit damage caused by 
neutrophils during infection (Mortensen and Zhong,2000). It would be 
appropriate to examine the role of CRP in modulating granulocyte activation in 
response to meningococci. This would involve measuring neutrophil respiratory 
burst, inflammatory cytokine secretion and surface marker expression in 
response to CRP-opsonised meningococci.
When considering the role of CRP in immune responses in the blood, it 
would also be relevant to examine the effects of CRP-opsonised meningococci 
on phagocytosis by blood monocytes (which may also phagocytose CRP- 
opsonised bacteria via FcyR). With further time and resources available, studies 
of the interaction of CRP-opsonised N. meningitidis with monocytes would have 
been undertaken to measure effects on phagocytic uptake, intracellular killing, 
respiratory burst activity, surface marker changes and inflammatory cytokine 
secretion which may all affect pathogen survival and host damage.
The effect of CRP-opsonised meningococci on dendritic cell activation is 
of great interest because of the role of dendritic cells in initiating and directing 
specific immune responses to bacteria. CRP has recently been shown to 
increase dendritic cell activation and antigen presentation when bound to 
S. pneum oniae , helping to protect mice from streptococcal infections (Thomas- 
Rudolph et al.,2007). Discovering the role of CRP in dendritic cell responses to 
N. meningitidis will be conducive to a better understanding of specific immune 
responses initiated by meningococci. Both live and dead bacteria are present
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during an infection. Consequently, the effect of the viability of the meningococci 
should be considered throughout investigations into the effect of CRP- 
opsonisation on dendritic cell surface marker expression, cytokine secretion and 
antigen presentation in response to meningococci. It has recently been shown 
that dendritic cells respond differently to live and killed meningococci (Jones et 
al.,2007). In the study by Jones et al., live meningococci failed to initiate the 
maturation response stimulated by fixed meningococci (namely the up-reguiation 
of CD40, CD86, HLA-DR and MHC class 1 molecules). Live meningococci 
stimulated IL-12 and IL-10 production by dendritic cells but showed much lower 
association with macrophages than fixed bacteria. Thus it will be important to 
examine the response of dendritic cells to CRP-opsonised meningococci that are 
alive as well as fixed to look for differences in dendritic cell response.
When considering the central role of dendritic cells in directing specific 
immune responses against pathogens, it is important to consider the co­
evolution of host and pathogen to discover if host defences are being hijacked 
for pathogen virulence. When examining the effect of CRP-opsonisation of 
meningococci on dendritic cell function, it will be particularly important to look at 
intracellular killing since any meningococci surviving inside dendritic cells could 
be trafficked through the blood and lymph systems and cause further damage to 
the host. Thus in future experiments, intracellular killing and dendritic cell 
apoptosis should also be examined.
7.2 Proposed model for the role of CRP In the innate immune response to 
N. m en in g itid is
By combining the results of the assays performed in this investigation with 
published data on the effects of CRP binding on immune responses to other 
bacteria, a model for the potential roles of CRP in the innate immune response to 
N. meningitidis is now proposed. The model is applied to two important areas of 
meningococcal infection; invasion at the respiratory epithelium and survival in 
blood.
Figure 7.1 depicts the proposed role of CRP in immune defence from 
meningococci at the respiratory epithelium. PC is clearly a crucial moiety for 
respiratory tract colonisation as it is abundant in commensal and pathogenic 
bacteria resident in the nasopharynx, but the marker is highly immunogenic and 
is targeted by anti-PC antibodies of both IgG and salivary IgA. Additionally, PC
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displayed on these organisms can be bound by CRP present at the respiratory 
epithelial surface either secreted endogenously by epithelial cells, or transported 
from the blood stream through a more permeable epithelial layer during 
inflammation.
a
B
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Figure 7.1 Proposed model of CRP interactions with N. meningitidis at the mucosal 
surface
CRP bound to PC on the pilus of N. meningitidis at the mucosal surface may not amplify 
complement-mediated lysis of pathogenic Neisseria (a) because of the remoteness of PC from 
the bacterial membrane. CRP can, however increase phagocytic uptake by macrophages (b) and 
dendritic cells (c) possibly allowing greater phagocytic killing and/or presentation of antigens to T 
cells (f). Conversely, CRP may be utilised by the meningococcus to accelerate invasion of 
epithelial cells expressing FcyR (d). It is postulated, however, that this could be counteracted by 
inhibition of pilus mediated attachment to epithelial cells (e). CRP-mediated uptake of 
N. meningitidis may result in modulation of proinflammatory cytokine production (f) and 
increased antigen presentation (g).
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Complement proteins are known to be exuded from plasma into the 
respiratory tract and are a valuable defence against invading pathogens which 
can activate the classical, alternative and lectin complement pathways (Persson 
et a/.,1998). CRP amplifies complement-mediated killing of other bacterial 
species, but our experiments revealed no effect of CRP on complement- 
mediated killing, possibly due to the remoteness of the CRP binding site from the 
cell wall of the meningococcus. CRP is, therefore, unlikely to increase 
complement-mediated killing at the mucosal surface (figure 7.1, a). In contrast, 
CRP opsonisation of N. meningitidis could increase FcyR-mediated uptake of 
bacteria into alveolar macrophages (b) and dendritic cells (c) which are resident 
sentinels in the respiratory epithelium and lumen. This CRP-mediated uptake of 
meningococci by phagocytes is clearly of benefit to the host. CRP opsonisation 
could, however, be detrimental to the host if it increased FcyR-mediated uptake 
of meningococci by respiratory epithelial cells (d). The effect of CRP- 
opsonisation on uptake by non-phagocytic cells remains to be studied but may 
be influenced by a reduction in CD46-mediated attachment of meningococcal 
pilus to the cells (e). CRP-mediated uptake of meningococci by phagocytes 
protecting the respiratory epithelium could influence downstream responses of 
these cells. These investigations indicate that this could include increased 
antigen presentation by HLA-DR up-regulation (g) which would accelerate the 
specific immune response against meningococcal antigens. Further to this, the 
CRP-mediated uptake could also modulate the inflammatory response by 
influencing the inflammatory cytokines secreted by resident macrophages (f). 
CRP-opsonisation may increase the production of the pro-inflammatory IL-1 |B but 
also the anti-inflammatory IL-10 in response to the meningococcus, potentially 
resulting in a net reduction in inflammatory signals which would reduce damage 
at the site of infection. In conclusion; this model predicts that CRP is protective 
against invasion of meningococci at the respiratory epithelium where it can result 
in increased phagocytosis of N. meningitidis by professional phagocytes. Despite 
the lack of evidence to suggest that this increases intracellular killing, we 
propose that the increased antigen presentation could be protective by 
accelerating specific immune responses to clear the meningococcus with IgA, 
and IgG-dependent complement-mediated killing and cytotoxic T cell mediated 
killing as well as limit local tissue damage by increasing IL-10 production.
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Figure 7.2 applies the model to the bloodstream where very high levels of 
CRP are achieved during the acute phase response and CRP-opsonised 
meningococci will encounter blood monocytes and neutrophils. The data from 
this thesis suggests that CRP bound to PC on the pilus may not be sufficient to 
increase cell lysis by activation of the classical complement cascade (a), but 
uptake could be increased into neutrophils via FcyR recruitment (b). As 
monocytes also express FcyR, it is possible that CRP may increase uptake into 
these leucocytes and may additionally affect intracellular killing mechanisms (c). 
Depending on the cytokines and cell surface markers induced, this may increase 
or decrease inflammation and the consequent sepsis of meningococcocaemia 
(d). Clearly, this model is more speculative than the mucosal model, as limited 
data was collected on the effect of CRP-opsonisation on neutrophil responses to 
meningococci and monocytes were not included in the analysis. The model is 
useful, however, in highlighting the importance of further investigation which will 
uncover crucial information about the modulatory capacity of CRP in the innate 
immune response to N. meningitidis in the blood.
Figure 7.2 Proposed model of CRP interactions with N. meningitidis in the bloodstream
Serum CRP bound to PC on the pilus may not amplify complement-mediated lysis of 
N. meningitidis (a) because of the remoteness of PC from the bacterial membrane. CRP may, 
however, increase phagocytosis of opsonised meningococci by neutrophils (b) and possibly 
monocytes (c) and may influence the activation markers and production of inflammatory 
cytokines (d) to direct the inflammatory response.
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In conclusion, these investigations have revealed a novel role for CRP in 
the protective immune response to N. meningitidis. CRP can bind to piliated, PC- 
expressing meningococci in a calcium-dependent manner and this binding 
facilitates increased association of (fixed) organisms with several professional 
phagocytes. This increased association results in specific changes to the 
activation of macrophages, suggesting that CRP may be an important innate 
protection against meningococcal infection alongside the more well known 
soluble pattern recognition receptor mannose-binding Lectin. It is possible that 
CRP may also cooperate with other plasma lectins in vivo, as has been seen in 
the horseshoe crab (Ng et al.,2007), making its role even more important in 
defence against bacterial invasion. The in vitro studies undertaken here have 
uncovered many interesting actions of CRP in the immune response to the 
meningococcus, several of which may help the host fight meningococcal 
infection by increasing clearance of bacteria, increasing antigen presentation and 
limiting inflammatory damage to host cells. It is clear from the studies undertaken 
that CRP has many protective effects for the host and further experiments to 
explore the effect of CRP-opsonisation on leucocyte recognition and killing of 
meningococci may confirm that CRP binding to N. meningitidis is of net benefit to 
the host during a meningococcal infection.
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